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 i 
Abstract 
This thesis focuses on the use of unsaturated aldols as useful substrates in natural product 
synthesis. Two methodologies have been investigated for the asymmetric synthesis of highly 
substituted lactones containing multiple contiguous stereocentres from unsaturated aldol 
precursors. These lactones have potential application as building blocks for natural product 
synthesis. Firstly, synthetic applications of the retro aldol reaction are reviewed. 
 
The second chapter describes a novel methodology for the asymmetric synthesis of highly 
substituted δ-lactones from syn-aldol cyclopropanes iii. Mercury mediated cyclopropane ring-
opening of the methyl ester cyclopropanes iv followed by concomitant cyclisation produced 
organomercurial δ-lactones v, which subsequently undergo reductive demercuration in basic 
sodium borohydride to afford the highly substituted δ-lactones vi in good yield and excellent 
diastereoselectivity. The scope of this method was investigated with variation of the R1 and R2 
groups. The synthetic utility of this process was also demonstrated with the synthesis of a 
series of (+)-Prelactone natural products. 
 
 
Scheme i Novel methodology for the synthesis of highly substituted δ-lactones containing multiple 
contiguous stereocentres 
 ii 
The third chapter decribes a method of preparing hydroxy-γ-butyrolactones (viii-x) containing 
multiple contiguous stereocentres in high yield with good diastereoselectivity. Upjohn 
dihydroxylation conditions using catalytic osmium tetroxide were employed to β-alkenyl-β-
hydroxy-N-acyloxazolidin-2-ones vii with different alkene substitution patterns. This resulted in 
the formation of triols that underwent spontaneous intramolecular 5-exo-trig cyclisation 
reactions to afford hydroxy-γ-butyrolactones viii, ix or x depending on the substitution pattern 
of the alkene precursor. 
 
 
Scheme ii Dihydroxylation/lactonisation method for the asymmetric synthesis of highly substituted 
hydroxy-γ-butyrolactones 
 
The configurations of the hydroxy-γ-butyrolactones (viii-x) were established using 1H NOE 
spectroscopic analysis and X-ray crystallography. It was found that 1-substituted, 1,1-
disubstituted, (E)-1,2-disubstituted, (Z)-1,2-disubstituted, and 1,1,2-trisubstituted alkenes 
undergo dihydroxylation with anti-diastereoselectivity with respect to their γ-hydroxyl groups, 
whereas a 1,2,2-trisubstituted alkene gave the syn-diastereoisomer. The poor levels of 
diastereoselectivity observed for the Upjohn dihydroxylation/lactonisation of 1,2-cis-
disubstituted systems was improved using Sharpless asymmetric dihydroxylation conditions. 
The synthetic utility of this directed dihydroxylation/lactonisation methodology was also 
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1 Literature Review 
Synthetic Applications of the Retro Aldol Reaction 
The retro aldol reaction is often viewed as an undesirable pathway, particularly during the 
asymmetric synthesis of aldol products, and many reports focus on its minimisation.1-3 
However, there are a number of reported examples demonstrating its synthetic utility. For 
example, many authors have demonstrated using retro aldol reactions as an impressive 
technique for constructing complex carbon frameworks found in natural products, through 
intricate rearrangement reactions. The retro aldol/aldol equilibrium can also be exploited to 
epimerise stereocentres of aldol products into the thermodynamically favourable product. 
Catalytic antibodies can make use of retro aldol reactions for the kinetic resolution of racemic 
mixtures of β-hydroxyketones, and this technique has been applied to the preparation of 
synthons for several natural product syntheses. There is also great scope for use of the retro 
aldol reaction in unmasking useful aldehyde and enolate functionality, which can be trapped in 
situ in Wittig reactions and aldol-Tishchenko reactions to afford useful building blocks. This 




The aldol reaction is an extremely powerful carbon-carbon bond forming process, often 
generating two new stereocentres with good levels of stereocontrol, and has been used for 
numerous synthetic applications. Therefore, it may seem unusual to view its reverse process, 
the retro aldol reaction, as synthetically useful. The position of the aldol/retro aldol 
equilibrium is dependent on the stability of the enolate as well as the nature of the 
substituents of the reactants and products. Generally, the more stable the resultant enolate 
and aldehyde fragmentation products then the more readily the retro aldol reaction proceeds. 
The retro aldol reaction can be catalysed by acid or base, sometimes using Lewis acidic metal 
catalysts, or with an enamine/imine mechanism, and can also been thermally initiated 
(Scheme 1). However, thermal retro aldol reactions often lead to competing formation of the 
corresponding dehydration product, which limits their usefulness.4 
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Scheme 1 a) Acid catalysed, b) Base catalysed and c) Thermal retro aldol mechanism 
 
1.1.1 Retro Aldol Reaction in Nature 
The β-hydroxycarbonyl motif is ubiquitous throughout Nature and the retro aldol reaction is 
found as a key transformation in many biosynthetic pathways. For example, fructose 1,6-
bisphosphate is broken down into glyceraldehyde 3-phosphate (GAP) and dihydroxyacetone 
phosphate (DHAP) by an aldolase enzyme during glycolysis. Alternatively, a stereochemically 
promiscuous aldolase from Sulfolobus solfataricus has been shown to catalyse the retro aldol 
reaction of both D-2-keto-3-deoxygluconate and D-2-keto-3-deoxy-galactonate to afford 
pyruvate and D-glyceraldehyde.5 It is also an important reaction in producing flavours in food,6 
where many desirable flavours are created as thermal retro aldol products of sugars in 
Maillard reactions and associated degradation reactions.7-8 For example, a key component of 
ginger flavour is formed during a thermal retro aldol reaction of gingerol 1 to produce 
zingerone 2 during cooking.9 
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Scheme 2 Thermal retro aldol reaction that occurs during cooking of ginger 
 
Retro aldol reactions of sugars in biomass conversion have also been demonstrated as a 
potential renewable energy source.10 For example, Sasaki and co-workers reported in 2002 the 
use of supercritical water for the retro aldol decomposition of glucose to glyceraldehyde, 
which has use as a raw material in many industrial processes.11 The retro aldol decomposition 
of sugars also has potential in providing useful chiral building blocks from enantiopure D-sugars 
that are readily available from Nature.12 
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1.1.2 Retro Aldol Reactions for Natural Product Degradation 
The aldol motif is found in many natural products and therefore the retro aldol reaction has 
featured heavily in degradation studies of these compounds.13 Bafilomycins are 16-membered 
macrolides, which are potent inhibitors of H+-ATPases that have potential uses in the 
treatment of osteoporosis. However, native bafilomycins show acute toxicity in animals. 
Consequently, Granberg and co-workers used a thermal retro aldol reaction to obtain 
intermediate 11, which was used as a useful building block for the construction of new 
biologically active bafilomycin derivatives.14 
 
Scheme 4 Thermal retro aldol cleavage of Bafilomycin C1 10 for the synthesis of intermediate 11 that is 
useful for the synthesis of new bafilomycin analogues 
 
There has also been considerable interest in employing the retro aldol reaction for the 
degradation of the immunosuppressive antibiotic Rapamycin 12 to prepare fragmentation 
products for synthetic and biological studies. It has been found that Rapamycin 12 is 
particularly susceptible to base catalysed retro aldolisation of the aldol fragment identified in 
Figure 1. Caufield and co-workers were able to isolate some of the degradation products 
formed from β-elimination and retro aldol reactions of Rapamycin 12 when it was treated with 
methanolic sodium hydroxide.15 Danishefsky also treated derivatives of Rapamycin 12 with 
lithium diisopropylamide to obtain advanced synthetic intermediates via a retro aldol 
pathway.16-17 It was found by Luengo and co-workers that retro aldolisation could be promoted 
exclusively using the Lewis acid ZnCl2.
18 In 1999, Holt and co-workers found that a Lewis acidic 
titanium catalyst could selectively epimerise the stereocentres of the aldol fragment of 
Rapamycin 12 via action of a reversible retro aldol/aldol equilibration reaction.19 
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Figure 1 Lewis acid or base catalysed retro aldol cleavage of Rapamycin 
 
Ley and co-workers prepared highly functionalised decalin precursor 16 via base catalysed 
retro aldol reaction of Azadirachtin derivative 13 using sodium methoxide. This intermediate 
was used for the preparation of further derivatives of this antifeedant and growth disruptor for 
biological evaluation and as a relay to facilitate its eventual total synthesis in 2007.20-22 
Reagents and conditions: (i) MeI, Ag2O; (ii) H2 (1 atm), Pd/C, MeOH, 20 min; (iii) PCC, 4Å MS, CH2Cl2, rt, 
48 h; (iv) NaOMe, MeOH, rt, 24 h. 
Scheme 5 Retro aldol cleavage of a derivative of Azadirachtin 
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Kam and co-workers showed in 1999 that the likely origin of the novel pentacyclic indole 
alkaloid Danuphylline 22 is via a pathway involving a retro aldol reaction of precursor 17 found 
in the same leaf extract. It was proposed that the ring-opened alkaloid arises from the 
methylchanofruticosinate precursor 17 that provides the iminium ion 18, which is hydrolysed 
to give an unstable carbinolamine 19 that then undergoes a retro adol type reaction (20) to 
provide the natural product. A biomimetic semi-synthesis was carried out by extracting the 
abundant precursor 17 from the leaf, followed by an electrochemical oxidation. The mixture 
was then subjected to silica gel chromatography, whose acidic nature facilitated the retro aldol 
reaction of the intermediate compound 19.23 
 
Scheme 6 Biomimetic synthesis of Danuphylline via retro aldol reaction of an aminol intermediate 
derived from methylchanofruticosinate 17 
 
1.2 Epimerisation 
Retro aldol reactions are often associated with the epimerisation of one or more stereocentres 
of β-hydroxy-carbonyl fragments in natural products. For example, Appendino and co-workers 
utilised a retro aldol epimerisation reaction that is typical of the 7-hydroxy group of Baccatin III 
23 to reductively trap out the aldehyde group of a key intermediate 25 to afford 28, which was 
subsequently elaborated into a novel series of Taxol analogues (Scheme 7).24 
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Reagents and conditions: (i) CeCl3, NaBH4, MeOH, rt. 
Scheme 7 Retro aldol epimerisation of Baccatin III derivatives 
 
Studies by Deprés, Greene and co-workers into the first comprehensive total synthesis of the 
Bakkane family of natural products serendipitously revealed a crucial retro aldol/aldol 
epimerisation reaction of the spiro-fused γ-butyrolactone motif in favour of the natural 
configuration (Scheme 8). Upon exposure of 29 to TBAF, a C-7,C-9 retro aldol/aldol 
epimerisation reaction took place, transforming the unnatural C-7 configuration into the 
desired configuration for the natural product (-)-Bakkenolide III 30 in 82% yield. The authors 
employed this discovery for the synthesis of other spiro-fused γ-butyrolactones of the Bakkane 
family and postulated that this epimerisation might also occur during the biosynthesis of these 
natural products in Nature.25 
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Reagents and conditions: (i) TBAF, THF, 0 ˚C. 
Scheme 8 Epimerisation of C-7 spiro-centre via retro aldol reaction of Bakkane ring system 
 
In 2008, Moloney and co-workers showed that bicyclic hydroxypyroglutamate 31 underwent 
epimerisation via a reversible retro aldol reaction. Under mild basic conditions, 31 epimerised 
to give the thermodynamically preferred stereochemistry via a sequence of retro aldol/aldol 
reactions to afford 33 in 80% yield. Alternatively, treatment with MeI/CaCO3 did not lead to 
the expected aldehyde product 36, but instead afforded the ring expansion product 35. This is 
thought to have been formed via hydrolysis of the thioacetal and a retro aldol reaction to 
afford the ester enolate of α-ketoaldehyde intermediate 34, which ring closes onto the 
aldehyde group to afford the [4.3.0]-bicyclic ring 35 in 95% yield.26 
 
Reagents and conditions: (i) MeI/CaCO3, CH3CN-H2O (5:1), 70 ˚C, overnight; (ii) NEt3/THF, 0 ˚C, 1 h. 
Scheme 9 Retro aldol equilibration of hydroxypyroglutamates 
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In 2006, Kalesse and co-workers developed novel methodology to access four diastereomeric 
bicyclic [4.3.0] derivatives by a retro aldol reaction and subsequent epimerisation as potential 
building blocks for natural product synthesis. Unsaturated ester 37 underwent a tandem 
intramolecular Michael-aldol reaction to selectively provide either the thermodynamic product 
38, or the kinetic product 39, depending on the reaction time and temperature. It was found 
that short exposure of the kinetic product 39 to TBAF at -30 ˚C initiated a retro aldol reaction 
to afford 40 in 80% yield. Further treatment of 40 with TBAF at room temperature led to 
epimerisation α- to the keto group to afford 41 as a single product. However, treatment of 
thermodynamic product 38 under the same conditions produced a 2.8:1 diastereomeric 
mixture of 42 and 43, with this mixture subsequently being epimerised to 43 via treatment 
with TBAF at room temperature.27 
 
Reagents and conditions: (i) TMSCl, HMDS, rt, 6 h, ClCH2CH2Cl; (ii) TMSCl, HMDS, -30 ˚C, 3 h, ClCH2CH2Cl; 
(iii) TBAF (1 equiv), -30 ˚C, 3 min; (iv) TBAF (3 equiv), 3 h, rt. 
Scheme 10 Synthesis of four diastereomeric bicyclic [4.3.0] derivatives via retro aldol reaction 
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As mentioned previously, epimerisation into the thermodynamically favoured isomer via retro 
aldol/aldol reaction pathways is sometimes an unexpected and problematic issue associated 
with natural product synthesis. For example, Hsung and co-workers discovered during their 
total synthesis of Arisugacin A that an intermediate was undergoing an unexpected retro 
aldol/aldol epimerisation to afford the undesired stereochemistry. Treatment of 44 under 
K2CO3/MeOH deacetylation conditions, followed by PCC oxidation led to the undesired retro 
aldol/aldol epimerisation product 45 in 73% yield. Using molecular modelling calculations 
(AM1-SpartanTM) it was found that the cis-fused decalin 45 was in fact more stable than the 
desired trans-fused decalin 46, presumably due to steric interactions between the axial methyl 
groups. Therefore, attempts to re-equilibrate the material failed, and the authors had to 
abandon this synthetic route.28-29 
 
Reagents and conditions: (i) K2CO3, MeOH; (ii) PCC. 
Scheme 11 Unexpected epimerisation of 44 leading to the undesired stereochemistry of 45 
 
1.3 Reversible Aldol Reactions 
Carlier and co-workers demonstrated the first example of an enantioselective aldol reaction 
using lithium ephedrinate as a nucleophile that operates via a retro aldol/aldol pathway to 
afford enantiomerically enriched products (Scheme 12). Treatment of arylacetonitrile 47 and 
pivalaldehyde with lithium ephedrinate was shown to afford pure anti-48 in 40% and 77% ee. 
The authors determined that the aldol reaction was reversible by exposing racemic samples of 
aldol product to the reaction conditions, which resulted in deracemisation. It was proposed 
that asymmetric induction was induced by the lithium alkoxide of 48 forming mixed aggregate 
complexes with ephedrine that are diastereomeric and lower in energy than the corresponding 
mixed aggregate formed from alkoxide complexes of ent-48 with ephedrine.30 
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Reagents and conditions: (i) (-)-Ephedrine (1.1 equiv), 
n
BuLi (2.2 equiv), -78 ˚C, 30 min, tBuCHO (1 equiv), 
-78 ˚C, 24 h. 
Scheme 12 Stereoselective aldol/retro aldol reaction using lithium ephedrinate to induce 
enantioselectivity 
 
They subsequently demonstrated that thermally controlled HMPA-facilitated aldol/retro aldol 
reaction could be employed to give syn-selective aldol products 50 from reaction of the lithium 
enolate of arylacetonitriles 49 with aromatic aldehydes under thermodynamic control, which is 
opposite to the anti- diastereoselectivity normally observed for aldol products of 
arylacetonitriles.31 
 
Reagents and conditions: (i) LDA, -78˚C, THF, HMPA (6 equiv) then ArCHO. 
Scheme 13 HMPA promoted aldol/retro aldol reactions to achieve thermodynamic syn-aldol 50 
 
Bolm and co-workers have demonstrated enantioenrichment of an aldol product that 
crystallises as a homochiral conglomerate, using a combination of crystal growth and iterative 
retro aldol/aldol reactions to induce enantioselectivity. Solid anti-53 aldol product in an 85:15 
enantiomeric ratio was ground with ZrO2 beads in the presence of an achiral or racemic 
catalyst such as pyrrolidine, piperidine or rac-proline. Samples of the slurry were taken out and 
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analysed over time, showing that the enantiomeric ratio of the solid 53 changed significantly 
over time, to a ratio of 96:4 over one day and 98:2 after eleven days. The authors 
demonstrated that a reversible retro aldol reaction was operating to racemise 53 by 
introducing cyclohexanone as a co-reactant, which gave 43% of anti-54 after six days.32 
 
Reagents and conditions: (i) Catalyst (10 mol%) (pyrrolidine, piperidine or rac-proline), DMSO; (ii) 
cyclohexanone. 
Scheme 14 Enantioenrichment of conglomerate crystalline aldol product 53 
 
In 2010, Luo, Cheng and co-workers reported the first asymmetric retro aldol reaction 
catalysed by a simple primary amine as an aldolase antibody mimic of imine/enamine catalysis. 
This method enables the kinetic resolution of racemic aldol products to access 
enantiomerically enriched aldols that are difficult to prepare by other methods. The best 
catalyst was found to be the cyclohexyl diamine 56 in CDCl3, with the conversion and 
enantiomeric excess of the kinetic resolution of rac-55 being monitored by NMR and HPLC 
analysis over time. This revealed that the conversion reached a plateau after 50% and that the 
retro aldol cleavage reaction barely proceeded after an enantioselectivity of >95% ee was 
reached, in a nearly ideal resolution process. 
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Reagents and conditions: (i) 56 (20 mol%), CDCl3. 
Scheme 15 Kinetic resolution of 55 using a simple chiral primary amine 56 
 
The authors also reported a novel transfer aldol reaction, in which excess acetone 61 was used 
to trap out the aryl aldehyde 59 generated by the initial retro aldol reaction via a forward aldol 
reaction, whereby the chiral catalyst 56 also mediates formation of a new enantiomerically 
pure aldol product 60 with an opposite sense of chiral induction. Use of this trapping approach 
enabled high enantioselectivities to be achieved for sluggish retro aldol reactions, by 
preventing the forward aldol reaction of cyclohexanone with an arylaldehyde proceeding, 
which could potentially lead to a decrease in the overall enantiomeric excess of 57.33 
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Reagents and conditions: (i) 56 (20 mol%), CDCl3. 
Scheme 16 Transfer aldol reaction using excess acetone to facilitate kinetic resolution of rac-57 
 
In 2009, Shibasaki and co-workers developed a dynamic kinetic asymmetric transformation 
(DYKAT) process for the asymmetric synthesis of α-alkylidene-β-hydroxy esters 66. An (S)-
barium-BINOL complex generates dienolate 63 in situ, which can undergo either α- or γ- 
addition to an aldehyde to afford either α-adduct 65, or the undesired γ-adduct 64. The α-
adduct undergoes a highly enantioselective alkene isomerisation reaction to afford the 
thermodynamically stable α,β-unsaturated aldol 66 in up to 99% ee. A barium promoted retro 
aldol reaction was shown to be operating to enhance the enantioselectivity of the reaction, 
resulting in the α-adduct 66 being formed with up to 20:1 selectivity.34 
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Reagents and conditions: (i) Ba(OiPr)2 (10 mol%), (S)-BINOL (10 mol%), DME, 0 ˚C. 
Scheme 17 (S)-Ba-BINOL catalysed dynamic kinetic asymmetric transformation involving a retro aldol 
reaction 
 
Shibasaki and co-workers have also developed a catalytic asymmetric multi-component 
reaction for the synthesis of highly functionalised δ-lactones containing quaternary chiral 
centres. The three component system consists of an allenic ester 67, ketone 69 and dialkylzinc 
70 in the presence of copper acetate and (R)-DIFLUORPHOS. Initially, conjugate addition of an 
alkyl group of the chiral copper catalyst to allenic ester 67 forms a highly reactive copper 
enolate 68, which can undergo either α-addition to the ketone to form the undesired α-adduct 
71, or γ-addition to form the target γ-adduct 72. The γ-adduct then undergoes further 
irreversible cyclisation to afford thermodynamically stable lactone 73. The α-pathway was 
suppressed by addition of a Lewis base (Ph2S=O, DMSO or HMPA) and 4Å MS, to facilitate retro 
aldol reaction of the α-adduct, thus ensuring that this undesired pathway was reversed in a 
‘proof reading effect’, which increased the yields of the target α,β-unsaturated lactones 73.35 
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Reagents and conditions: (i) Cu(OAc)2 (5 mol%), (R)-DIFLUORPHOS (6 mol%), additive (DMSO, HMPA or 
Ph2S=O) (20 mol%), 4Å MS, THF, -20 ˚C. 
Scheme 18 Catalytic asymmetric multi-component reaction incorporating a crucial retro aldol pathway 
to improve the yield of lactones 73 
 
1.4 Synthetically Useful Retro Aldol Reactions of Acyclic Aldol Substrates 
Retro aldol reactions of acyclic aldol systems are not normally that synthetically useful since 
they result in cleavage into a mixture of structurally less complex enolate and aldehyde 
products. Retro aldol reactions of stable aldol substrates can be used to generate reactive 
carbonyl components in situ, which can then be incorporated into multi-step pathways. For 
example, Jha and co-workers have demonstrated a one pot synthesis of 2,2-dialkyl-3-
dialkylamino-2,3-dihydro-1H-naphtho[2,1-b]pyrans 80 from 2,2-disubstituted-3-
hydroxypropanals 74, 2-naphthol 77 and secondary cyclic amines 76. The mechanism of this 
reaction is thought to involve retro aldol reaction of -hydroxy-aldehyde 74 to form 
isobutyraldehyde 81 and formaldehyde 75. A Mannich reaction between the formaldehyde 75, 
2-naphthol 77 and a secondary amine 76 then occurs to afford 78, which subsequently 
deaminates to afford a transient α,β-unsaturated ketone 79 that undergoes a Diels-Alder 
reaction with enamine 85 (formed from the imine of isobutyroaldehyde) to afford 
naphthopyran 80.36 
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Reagents and conditions: (i) p-TSA (cat), microwave. 
Scheme 19 Mechanism for the formation of 2,2-dialkyl-3-dialkylamino-2,3-dihydro-1H-naphtho[2,1-
b]pyran 80 
 
Another less well explored approach is to generate an aldol product via nucelophilic addition 
of an oxygen nucleophile to a Michael acceptor, whose retro aldol cleavage is then employed 
to trigger a cyclisation event. For example, Razdan and co-workers have described a one pot 
synthesis of 2,4,6-triarylpyridines 90 from benzylideneacetophenones 86 using Bi(III) nitrate-
Al2O3. Formally, Micahel addition of a catalytic metal alkoxide species to 
benzylideneacetophenone 86 results in an enolate species that undergoes conjugate addition 
to another equivalent of 86. Intermolecular imine formation with urea 87 then affords 88, 
which undergoes a retro aldol cleavage-cyclisation event to afford 89 that subsequently 
aromatises to afford pyridine 90.37 




Reagents and conditions: (i) Bi(NO3)3-Al2O3, (5% w/w), 125-135 ˚C. 
Scheme 20 A retro aldol reaction facilitates the solid supported catalytic synthesis of 2,4,6-
triarylpyridines 90 
 
A potentially useful application of the retro aldol reaction is to employ a metal alkoxide of an 
aldol product that fragments to afford a metal enolate that is difficult to prepare via traditional 
metalation of the parent carbonyl compound. Yorimitsu and co-workers have reported the 
rhodium catalysed retro aldol reaction of tertiary β-hydroxyketones 91 to generate rhodium 
enolates 93, which could be used in situ for regioselective aldol reactions with an aldehyde to 
afford 92 in high yield. Unfortunately, the diastereoselectivity of the resultant aldol reactions 
of these rhodium enolates with aldehydes were poor, although these were not reported.38 




Reagents and conditions: (i) [RhCl(cod)]2 (2.5 mol%), PhCHO, TMEDA, Cs2CO3 (20 mol%), 1,4-dioxane, 20 
˚C, 3 h. 
Scheme 21 Retro aldol of β-hydoxyketones to generate rhodium enolates and subsequent aldol reaction 
 
Bull and co-workers have developed ‘temporary stereocentre’ methodology for the 
asymmetric synthesis of chiral aldehydes using the SuperQuat oxazolidin-2-one to relay 
stereocontrol. For example, a novel three step aldol/cyclopropanation/retro aldol sequence 
was developed to produce enantiopure chiral cyclopropyl-carboxaldehydes in >95% ee. The 
asymmetric boron aldol reaction of N-acyl-oxazolidin-2-one 95 with α,β-unsaturated aldehyde 
96 proceeds with excellent diastereoselectively producing β-vinyl-syn-aldol products 97. A 
subsequent asymmetric syn-cyclopropanation reaction, directed by the β-hydroxyl group of 
the aldol product, furnishes cyclopropyl-aldols 98 in >95% dr. Subsequent treatment of 
cyclopropyl-aldol 98 then with LiHMDS at 0 ˚C initiates a retro aldol reaction, to afford 
enantiopure carboxaldehydes 99 in excellent yield and diastereoselectivity. This methodology 
has been used to prepare chiral cyclopropyl-carboxaldehydes of use as synthons for natural 
product synthesis, such as in the synthesis of Cascarillic acid.39-42 




Reagents and conditions: (i) 9-BBN-OTf, N(iPr)2Et, CH2Cl2, 0 ˚C then 96, -78 ˚C; (ii) ZnEt2, CH2I2, CH2Cl2,       
-10 ˚C to 0 ˚C; (iii) LiHMDS, toluene, 0 ˚C. 
Scheme 22 Temporary stereocentre approach for the synthesis of chiral cyclopropane-carboxaldehydes 
99 
 
This ‘temporary stereocentre’ methodology has also been utilised for the stereodivergent 
synthesis of either enantiomer of α-methyloctanal using an asymmetric hydrogenation 
procedure. Aldol products 101 and 105 were synthesised using the Evans’ anti-aldol protocol 
from reaction of N-acyl-oxazolidin-2-one 95 with 2-methyleneoctanal 100 and (E)-2-methyloct-
2-enal 104 respectively. The best conditions for the substrate directed asymmetric 
hydrogenation were found to be the use of Wilkinson’s catalyst for aldol 101, which produced 
saturated aldol (4S)-102 in 96% de. Aldol 102 underwent asymmetric hydrogenation using 
Brown’s catalyst to afford saturated aldol (4R)-102 in a slightly lower 85% de, which was 
purified to >95% de. Retro aldol reactions of aldols (4S)-102 and (4R)-102 with LiHMDS in 
toluene afforded (S)-α-methyloctanal (S)-103 and (R)-α-methyloctanal (R)-103 respectively in 
>95% ee. Unfortunately, purification of these aldehydes on silica caused racemisation, 
decreasing the enantiomeric excess to 85%. Therefore, it was shown that α-methyloctanal 103 
could be derivatised in situ to afford dithiane and Wittig products as well as reduction to α-
methyloctanol with no racemisation, which function as useful chiral building blocks.41 




Reagents and conditions: (i) MgCl2, NEt3, TMSCl, EtOAc, rt, 24 h then TFA, MeOH; (ii) Wilkinson’s catalyst 
(17.5 mol%), H2 (5 bar), CH2Cl2; (iii) Brown’s catalyst (17.5 mol%), H2 (5 bar), CH2Cl2; (iv) LiHMDS, toluene, 
0 ˚C. 
Scheme 23 Temporary stereocentre approach for the synthesis of both enantiomers of α-methyloctanal 
(S)-103 and (R)-103 
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1.5 Retro Aldol Reactions for the Ring-Opening Monocyclic Systems 
In 2009, Taylor and co-workers described a number of novel cascade sequences initiated by a 
retro aldol reaction to afford a range of novel functionalised cyclopentanes. Treatment of 2,2-
di(carboethoxy)cyclopentanol 106 with MTBD (7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene) in 
the presence of Wittig or aza-Wittig reagents resulted in one pot retro 
aldol/Wittig/intramolecular Michael addition reactions to afford cyclopentanes 109 in good 
yield. Therefore, retro aldol reaction of 106 affords 107, followed by Wittig trapping of the 
resulting aldehyde, to afford intermediate 108 that undergoes an intramolecular nucleophilic 
addition reaction to afford the final cyclopentane product 109.43 
 
 
Reagents and conditions: (i) Ph3P=X, MTBD, MeCN, heat, 16-22 h. 
Scheme 24 Retro aldol/Wittig/intramolecular Michael addition cascade reaction to afford 109 
 
Hayashi and co-workers have developed a high yielding synthesis of the antiviral (-)-
Oseltamivir 119 (Tamiflu) using two ‘one pot’ reaction sequences. The first of the reaction 
sequences involved the organocatalysed Michael reaction of 110 with 111 to afford an 
intermediate 112 that underwent reaction with the Horner-Wadsworth-Emmons reagent 113 
in situ to afford a mixture of cyclohexyl products 114, 115 and 116. It was found that addition 
of the more polar solvent ethanol resulted in retro Michael reaction of 115, and tandem retro 
aldol/Horner-Wadsworth-Emmons reaction of 114 to afford a better yield for the desired 
cyclohexene 117. A second one pot reaction on 118 was then carried out involving six 
reactions to afford (-)-Oseltamivir 119 as a single diastereomer in 74% yield.44 
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Reagents and conditions: (i) (R)-2-(Diphenyl((trimethylsilyl)oxy)methyl)pyrrolidine, ClCH2CO2H (20 mol%), 
toluene, rt, 6 h; (ii) 113, toluene, 0 ˚C to rt, 4 h; (iii) EtOH, rt, 10 min; (iv) TolSH, -15 ˚C, 36 h. 
Scheme 25 Domino retro aldol/Horner-Wadsworth-Emmons reaction for a one pot synthesis of (-)-
Oseltamivir 119 
 
Funk and co-workers have employed a retro aldol cleavage reaction to remove the chiral 
auxiliary fragment of cyclopentenone 122 for the asymmetric synthesis of cycloalkanones 123. 
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The (-)-menthone auxiliary was first treated with alkenyllithium reagent 121, followed by 
hydrolysis of the acetonide fragment, to afford C-1 substituted menthol derivative 122. These 
substrates then underwent stereoselective conjugate addition reactions with cuprate 
reagents, which upon quenching with methanol resulted in the chiral auxiliary fragment 
undergoing facile retro aldol cleavage to afford β-alkylcycloalkanones 123 in high yield and 
good ee.45 
Reagents and conditions: (i) 121 then oxalic acid (2.5 equiv), CH2Cl2/H2O (8:1), 27 ˚C, 8 h; (ii) R2CuCNLi2, -
60 ˚C, 10-12 h, MeOH (10 equiv), 27 ˚C, 7-8 h. 
Scheme 26 Retro aldol reaction removes the (-)-menthone auxiliary fragment of cyclopentenone 122 
 
Takai and co-workers have developed a transition metal-catalysed synthesis of 
multisubstituted aromatic compounds that features a key retro aldol cleavage as part of its 
mechanism. Rhenium catalysed reaction between β-keto ester 124 and alkyne 125 results in 
formation of 2-pyranone 126, which can undergo Diels-Alder reaction with another alkyne 125 
followed by loss of carbon dioxide, resulting in aromatisation to afford multi-substituted 
aromatic compounds 127 in high yield and regioselectivity. 
 
Reagents and conditions: (i) [ReBr(CO)3(THF)2] (2.5 mol%), 4Å MS, (200 wt. %-Re cat.), toluene, 180 ˚C, 
24 h; (ii) Alkyne 125, 150 ˚C, 24 h. 
Scheme 27 Reaction conditions for the formation of multi-substituted aromatics 
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In the first step reaction, rhenium activated alkyne 125 undergoes a cycloaddition with enol 
128 to afford rhenium pentacycle 129. Retro aldol cleavage of this intermediate occurs to 
cleave the ring system and produce the vinyl rhenium species 130, which then undergoes 
reductive elimination to form the α,β-unsaturated carbonyl functionality of 131 followed by 




Scheme 28 Proposed mechanism for the synthesis of pyranone intermediate 126 
 
Reiser and co-workers have demonstrated a tin catalysed retro aldol reaction of cyclopropane 
136 as part of their total synthesis of (-)-Roccellaric acid 137. Furan 132 underwent asymmetric 
cyclopropanation to afford 133, which was subsequently subjected to ozonolysis and 
nucleophilic allylation to afford 134. The crude allyl product 134 was treated in situ with a 
tin(IV) catalyst, promoting a key retro aldol reaction (135) and subsequent lactonisation to 
furnish lactone 136 in 72% yield with a 95:5 anti/syn ratio. This intermediate was then used as 
a precursor to synthesise (-)-Roccellaric acid 137 in a further five steps.47 




Reagents and conditions: (i) Ethyl diazoacetate, Cu(OTf)2 (2 mol%), (–)-(S,S)- bis(4-tert-butyloxazoline), 
PhNHNH2, CH2Cl2; (ii) O3, CH2Cl2, -78 ˚C then Me2S; (iii) BF3·OEt2, -78 ˚C then allyltrimethylsilane; (iv) 
[Sn2(Bu)4(NCS)2O]2 (0.05 mol%), 1,2-ethyleneglycol, benzene, reflux. 
Scheme 29 Key retro aldol reaction used in the total synthesis of (-)-Roccellaric acid 137 
 
Reiser and co-workers also developed a diastereoselective method for the synthesis of highly 
substituted γ-butyrolactones 141 using aryl titanium reagents. Cyclopropanecarboxaldehyde 
138 was treated with various aryl titanium reagents to generate intermediate 139, which was 
treated in situ with a tin catalyst 142-144 to initiate a one pot retro aldol-acetalisation-
lactonisation sequence to afford cis- or trans- γ-aryl lactone acetals 141.48 
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Reagents and conditions: (i) BF3·OEt2, THF, -78 ˚C, 16 h; (ii) Catalyst 142-144 (10 mol%), MeOH, reflux, 
12 h. 
Scheme 30 Synthesis of γ-butyrolactones via tin mediated retro aldol reaction of 139 
 
In 1991, Kuwajima and co-workers reported a tin(IV) chloride mediated retro aldol reaction of 
2-alkoxycyclopropyl carbonyl compounds 145 to generate a three carbon 1,3-zwitterion 147, 
which underwent formal [3+2]-cycloaddition reactions with enol silyl ethers 148 to afford 
highly functionalised cyclopentanes 150 in good yield, but with relatively poor 
diastereoselectivity.49 
Synthetic Applications of the Retro Aldol Reaction 
28 
 
Reagents and conditions: (i) SnCl4, CH2Cl2, -78 ˚C, 1h. 
Scheme 31 Lewis acid mediated retro aldol reaction of 146 to form cyclopentanes 150 
 
1.6 Retro Aldol Reactions for the Ring Opening of Bicyclic Systems 
Bicyclic ring systems that undergo ring-strain promoted retro aldol rearrangements offer an 
attractive route into chiral building blocks for natural product synthesis that are difficult to 
access using more conventional methodology. Ogasawara and co-workers have employed a 
bicyclo[3.2.1]octane chiral building block 152 that undergoes an acid catalysed retro aldol 
reaction to afford hexahydrophenanthrene frameworks. These structures comprise the 
backbone of many alkaloid and diterpenoid natural products, and the synthetic utility of this 
methodology has been demonstrated for the total synthesis of (+)-Ferruginol 160. In this case, 
chiral building block 152 was first prepared from norbornane-2,5-dione 151 via an enzymatic 
resolution procedure. Treatment of bicyclo[3.2.1]octane 152 with catalytic p-TSA and ethylene 
glycol in toluene at reflux initiated an acid catalysed retro aldol reaction, in which the MOM 
group was deprotected followed by hemi-ketalisation with ethylene glycol to afford active 
intermediate 154. This intermediate 154 then undergoes a retro aldol reaction to produce 
intermediate 155, followed by an intramolecular tandem Friedel-Crafts alkylation of 156 and 
elimination/rearomatisation to afford hexahydrophenanthrene 159 in quantitative yield and 
high enantioselectivity.50 
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Reagents and conditions: (i) (CH2OH)2, p-TSA (cat), toluene, reflux. 
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Yamada and co-workers have developed a fragmentation method employing a 
bicyclo[2.2.1]heptane derivative 163, which undergoes a retro aldol reaction to afford a 
tetrasubstituted cyclopentane derivative 165. Initially, bicyclo[2.2.1]heptane 163 was prepared 
from cyclopentanone 161 and chiral ester 162 via a double Michael addition in 5.3:1 dr and 
82% yield. This intermediate underwent several protecting and functional group manipulations 
to afford bicyclic β-hydroxyketone 164. Treatment of 164 with sodium hydride and 15-crown-5 
in toluene at room temperature resulted in retro aldol cleavage to furnish the desired 
tetrasubstituted cyclopentane derivative 165, which was subsequently used as a synthon for 




Reagents and conditions: (i) LDA, THF, -78 ˚C then 162; (ii) NaH, 15-crown-5, toluene, rt. 
Scheme 33 Retro aldol cleavage of bicyclic β-hydroxyketone 164  
 
Synthetic Applications of the Retro Aldol Reaction 
31 
Yamada and co-workers have also used this type of fragmentation chemistry for the total 
synthesis of the marine diterpenoid Stolonidiol 175. Bicyclic β-hydroxyketone 173 was treated 
with K2CO3 in methanol at 40 ˚C, which initiated the retro aldol rearrangement as well as 
epimerising the C-12 stereocentre to afford tetrasubstituted cyclopentane 174 in 92% yield.53 
 
Reagents and conditions: (i) LDA, THF, -78 ˚C then 170 to rt; (ii) K2CO3, MeOH, 40 ˚C. 
Scheme 34 Retro aldol reaction of bicyclic β-hydroxyketone 173 in the total synthesis of Stolonidiol 175 
 
In 2009, Rueping and co-workers demonstrated a novel tandem retro aldol/cyclisation reaction 
to afford a tetrahydrochromenone product 182 in 96% ee and 68% yield. An asymmetric 
organocatalytic domino Michael/aldol reaction of diketone 176 and enone 177 was employed 
to afford bicyclo[3.2.1]octane-6-carbaldehyde 179 in 96% ee. Treatment of this β-
hydroxyketone 179 with base led to the diketone 181, which cyclised in situ to afford 
hemiacetal 182 in 96% ee, dr 6:1 and 68% yield.54 
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Reagents and conditions: (i) 178 (10 mol%), EtOH, rt, 7-24 h; (ii) K2CO3, MeOH. 
Scheme 35 Novel retro aldol reaction to form tetrahydrochromenones 182 
 
Tam and co-workers have reported molybdenum-mediated cleavage of bicyclic isoxazoline 
rings to afford substituted cyclopentane ring systems (189, 192, 195). The isoxazole rings (186, 
188, 193) were prepared by 1,3-dipolar cycloaddition of nitrile oxide 184 and norbornadiene 
185. It was proposed that the nitrogen atom of the isoxazoline ring (188 and 193) coordinates 
to the molybdenum 190, facilitating N-O bond cleavage. This forms a molybdenum complex 
(191 and 194) that undergoes retro aldol cleavage, which upon hydrolysis provided the final 
cyclic products (189, 192, 195) in moderate to good yield with varying levels of 
stereoselectivity.55 




Reagents and conditions: (i) (Boc)2O, DMAP, toluene, 25 ˚C; (ii) Mo(CO)6, MeCN/H2O, 80 ˚C. 
Scheme 36 Formation of ring attached systems via two cleavage reactions 
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Gelmi and co-workers have developed a new synthetic approach to diastereomeric 
cyclopentene derivatives 203 and 204 arising from retro aldol reaction of functionalised 
spirocyclic norbornene derivatives exo-198. Spiro oxazolone exo-198 was treated with the 
Lewis acid bis-(dibutylchlorotin)oxide in ethanol at reflux to afford ethyl ester exo-199 in 85% 
yield. Under mild basic conditions, ethyl ester exo-199 undergoes alcoholysis and retro aldol-
like cleavage (200) to give enolate 201, which was protonated to provide 202 as a 1:1 mixture 
of diastereomers. This mixture then undergoes double bond isomerisation to afford the more 
thermodynamically stable cyclopentene diastereomers 203 and 204 in a 1:1 ratio and 82% 
yield. Interestingly, the cyclopentane derivatives 203 and 204 could be accessed directly from 
spiro oxazolone exo-199 via reflux in methanol with sodium carbonate.56 
 
Reagents and conditions: (i) Mg(ClO4)2, CH2Cl2, 25 ˚C; (ii) EtOH, (Bu2ClSn)2O, reflux; (iii) EtOH, Na2CO3, 
reflux; (iv) MeOH, Na2CO3, reflux. 
Scheme 37 Retro aldol reaction to form cyclopentenes 
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Robina and co-workers have developed methodology that employs the ring strain of bicyclic 
systems to trigger retro aldol-like reactions of bridgehead substituted bicyclo[2.2.1]-aza-
heptanes. Racemic and enantiomerically pure N-Boc-3-tosyl-7-azabicyclo[2.2.1]hept-5-en-2-ols 
205, 208 and 210 were treated with base to afford pyrollidine 207, 209 and 211 in excellent 
yields. However, attempts to repeat this retro aldol reaction using O- and CH2- analogues at 
the N-Boc position were unsuccessful, which was proposed to be due to insufficient ring strain 
being present in these bicyclic derivatives.57 
 
Reagents and conditions: (i) NaOMe (cat), MeOH, rt; (ii) H2, Pd/C, MeOH; (iii) 1. OsO4 (cat), NMO, 
acetone-H2O (9:1); 2. 2,2-DMP, p-TSA, acetone.  
Scheme 38 Retro aldol cleavage of N-Boc-3-tosyl-7-azabicyclo[2.2.1]hept-5-en-2-ols 205, 208 and 210 
 
Totah and co-workers demonstrated a tandem retro aldol-epoxide ring opening-cyclisation 
sequence for the formation of the tricyclic core 215 of Phomactin A 216 in 95% yield. In this 
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case, O-TBS deprotection of 212 triggers a retro aldol reaction that eliminates acetaldehyde to 
afford unstable epoxide 213 that is ring opened to generate the hemi-acetal functionality of 
215. This methodology was highly stereoselective, resulting in an impressive installation of 
three out of the five possible strereocentres required.58 
 
 
Reagents and conditions: (i) TBAF. 
Scheme 39 Synthesis of a tricyclic core 215 found in Phomactin A 216 
 
Helquist and co-workers reported the formation of γ-substituted conjugated hydrazulenones 
221 via rearrangement reaction of cyclopropylcarbinol 217 to afford the unstable β-
hydroxyketone 218, which then undergoes a spontaneous retro aldol cleavage reaction to 
afford 220 followed by an aldol condensation reaction to afford 221. The authors found that 
retro aldol reaction of 218 only proceeds when R is larger than Me, presumably due to steric 
effects triggering the retro aldol fragmentation reaction.59 
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Reagents and conditions: (i) NaH, Et2O-hexane, 0 ˚C to rt. 
Scheme 40 Rearrangement of 217 followed by retro aldol/aldol to afford 221 
 
Jung and co-workers reported formation of a bridged bicyclic furan 227 by rearrangement of 
tetrahydroxydecalinone 222 under mild acidic or basic conditions in 95% yield. Therefore, 
anionic retro aldol fragmentation of the aldol fragment of 223 occurs to give enolate 224, 
which eliminates a β-hydroxyl group to give the α,β-unsaturated ketone group of 225. 
Subsequent hemi-acetal formation followed by dehydration/aromatisation then affords the 
furan ring of 227, as part of the total synthesis of Arisugacin A. It is thought that the key retro 
aldol fragmentation reaction of 223 is promoted due to relief of steric hindrance caused by its 
three axial methyl groups.60 
 
Reagents and conditions: (i) MsCl, DMAP, pyridine; (ii) TPAP, NMO, CH2Cl2. 
Scheme 41 Unexpected formation of bridged bicyclic furan 227 from rearrangement of 
tetrahydroxydecalinone 
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1.7 Retro Aldol Reactions in Tricyclic Systems 
Ogasawara and co-workers have applied Yamada’s retro aldol Friedal Crafts 
alkylation/dehydration/aromatisation methodology for the total synthesis of (-)-Morphine61 as 
well as other natural products62-65 containing hexahydrophenanthrene frameworks containing 
quaternary or tertiary benzylic stereocentres. 
 
Reagents and conditions: (i) (CH2OH)2, p-TSA (cat), benzene, reflux. 
Scheme 42 A retro aldol cleavage reaction employed as a key transformation for the synthesis of 
Morphine 236 
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This type of skeletal rearrangement protocol has also been used by Yamada and co-workers for 
the synthesis of the bicyclo[4.2.1]nonane fragment of the marine natural products 
Mediterraneols such as 244. In this case, the tricyclic intermediate 242 was treated with DBU 
in benzene to afford the desired bicyclo[4.2.1]nonane fragment 243 in 53% yield.66 
 
Reagents and conditions: (i) LDA, THF, -78 ˚C then 238; (ii) DBU, benzene, rt. 
Scheme 43 Retro aldol cleavage of the cyclic ring system of 242 for the synthesis of bicyclo[4.2.1]nonane 
fragment of Mediterraneols such as 243 
 
Yamada and co-workers also used this rearrangement chemistry for the synthesis of 
bicyclo[4.3.0]nonane derivative 249 as a synthon for preparing the CD ring moiety of a series 
of 12-oxygenated steroids, the Aragusterols. The authors found that the key retro aldol 
reaction of 248 could be triggered using a mixture of ZnCl2, NEt3 and TMSCl, or NaH and 15-
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crown-5-ether, to afford 249 and 250 after hydrolysis as a 2:1 ratio of β:α epimers at the C-8 
centre.67 
 
Reagents and conditions: (i) LDA then 246; (ii) TMSCl, ZnCl2, NEt3, 110 ˚C; (iii) AcOH-THF-H2O (2:1:1). 
Scheme 44 Retro aldol cleavage of tricyclic ring 248 for the synthesis of bicyclo[4.3.0]nonane ring 
system of Aragusterols 
 
Ranu and co-workers demonstrated that acid catalysed rearrangements of α-
hydroxycyclobutane derivatives 253 give transient cyclic β-hydroxyaldehydes 258 that undergo 
retro aldol cleavage to afford [5.3.0] ring systems 254 followed by subsequent Jones’ oxidation 
to afford 255 in 77% yield. Several six and seven membered ring systems were synthesised in 
this manner as potential cyclic synthons for the synthesis of a range of natural product 
skeletons, such as Grayanotoxin I 259 and Dolatriol 260.68-69 
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Reagents and conditions: (i) 1,3-dithiane, n-BuLi, THF; (ii) HgO (red), HBF4, THF; (iii) Jones’ reagent. 
Scheme 45 Retro aldol reaction for the synthesis of functionalised six and seven membered bicyclic ring 
systems 
 
In 2000, da Silva and co-workers demonstrated the synthesis of bicyclo[6.2.1]undecane 264 
from retro aldol reaction of the tricyclic intermediate 261, which is the bicyclic core found in 
the furanoheliangolide class of sesquiterpene natural products such as Goyazensolide 265. In 
this case, a retro aldol reaction was used to cleave the trans-annular bond to give the desired 
[6.2.1] ring system.70 
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Reagents and conditions: (i) NaH, toluene, reflux. 
Scheme 46 Formation of the bicyclic core 264 of furanoheliangolide sesquiterpenes via retro aldol 
reaction of 261 
 
In 2010, Danishefsky and co-workers reported an elegant total synthesis of the steroidal 
natural product Aplykurodinone-1 271, involving a tandem hydrolysis/retro aldol/iodo-
lactonisation sequence. They described this approach as a ‘traceless stereochemical guide’ 
that was used to secure the correct configurational relationship between the C-3 and C-7 
stereocentres of 271. Treatment of 268 with base resulted in lactone hydrolysis to afford a β-
hydroxyketone fragment that underwent retro aldol elimination of formaldehyde to afford 
acid 269 that then underwent an intramolecular iodo-lactonisation reaction to afford tricyclic 
lactone 270 in 75% yield.71 
 




Reagents and conditions: (i) Bis-(N-tert-butylsalicylaldiminato) copper(II), toluene, reflux; (ii) K2CO3, H2O, 
100 ˚C then NIS, CH2Cl2. 
Scheme 47 Hydrolytic retro aldol reaction followed by iodolactonisation for the total synthesis of 
Aplykurodinone-1 271 
 
Wang and co-workers have developed a gold-catalysed cascade reaction of propargylic esters 
tethered to cyclohexadienones. Mechanistically, the proparglylic ester 272 undergoes a 
cascade of multiple bond rearrangement reactions to afford tricyclic ketone 273 in good yield. 
However, in the presence of water, oxy-Michael addition of water is followed by retro aldol-
like reaction of 276, to afford ring-opened products 277 in high yield, which are common 
structural motifs of many natural products.72 
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Reagents and conditions: (i) [PPh3AuCl]/AgOTf (0.04 equiv/0.04 equiv), DCE, air, rt, 8-12 h. 
Scheme 48 Gold catalysed cascade reaction of propargylic esters 272 with retro aldol collapse of 
276 
 
In 2012, Porco Jr. and co-workers completed the first total synthesis of 7-epi-nemorosone, 
which involved use of a key cerium mediated retro aldol/vinyl Grignard reaction on triketone 
280 for construction of the densely functionalised skeleton of the natural product to afford 
orthogonally protected 284 in 45% yield over three steps.73 
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Reagents and conditions: (i) LiHMDS (2 equiv), THF, 0 ˚C to rt then conc. HCl (8 equiv), THF, 0 ˚C to rt; (ii) 
CeCl3 (2.5 equiv), vinylmagnesium bromide (2.5 equiv), THF, -78 ˚C to -30 ˚C; (iii) Piv2O/pyridine, DMAP 
(0.03 equiv), 0 ˚C to rt; (iv) DMAP, Ac2O, NEt3, CH2Cl2, 0 ˚C. 
Scheme 49 Tandem retro aldol/vinyl Grignard addition reaction for the synthesis of bridged-[3.3.1] ring 
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1.8 Aldol-Tishchenko Reactions 
In 2000, Nevalainen reported the first catalytic aldol-transfer reaction using aluminium 
enolates generated from the retro aldol reaction of diacetone alcohol 286, with the resultant 
aluminium enolate 291 reacting in situ with an aldehyde 287 to afford β-hydroxyketone 288 in 
moderate yield.74 
 
Reagents and conditions: (i) Al(III) catalyst (5-10 mol%), CH2Cl2, rt.  
Scheme 50 Retro aldol/aldol transfer mechanism via aluminium enolates 
 
In 2001, Schneider and co-workers developed a zirconium alkoxide catalysed aldol-Tishchenko 
reaction using ketone aldols as an enolate equivalent to furnish 1,3-anti-diol monoesters 296. 
This methodology was also independently established by Nevalainen in 2001 using 
trimethylaluminium alkoxides75 and was developed further in 2003 using alternative 
aluminium catalysts.76 The thermodynamically less stable ketol 294 undergoes a rapid and 
facile retro aldol reaction to afford zirconium enolates 299 in situ. These enolates can then 
undergo an aldol-Tishchenko reaction with aldehyde 295 to afford 1,3-anti-diol monoesters 
296 in high yield. The best conditions were found to be the use of zirconium catalyst 298 in 
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dichloromethane at 0 ˚C, which resulted in suppression of formation of any undesired acyl 
migration product 297.77-79 
 
Reagents and conditions: (i) 298 (10 mol%), CH2Cl2, 0 ˚C, 3 h. 
Scheme 51 Generation of zirconium enolates 299 through retro aldol reaction of 294 mediates aldol-
Tishchenko reaction 
 
Mahrwald and co-workers also observed a retro aldol/aldol equilibrium during their 
investigations on a titanium catalysed aldol-Tishchenko reaction with enolizable aldehydes. 
They found that their reactions gave diol 304 regardless of whether the syn-aldol 300 or anti-
aldol 301 diastereomers were used as a substrate. Treatment of syn- or anti-β-hydroxyketone 
300-301 or 302-303 with (R)-BINOLTi(OtBu)2/cinchonine in the presence of isobutyraldehyde 
followed by base hydrolysis afforded syn-anti-product 304 or 305 in high enantioselectivity in 
each case. The reactions were monitored to reveal that the Tishchenko reaction of anti-301 
was complete within three to four days, with almost no detection of any retro aldol/aldol 
equilibration having occurred. However, when syn-300 was employed, after 24 hours the 
Tishchenko reaction had not proceeded, with only retro aldol/aldol equilibration to the anti-
301 being observed. Only after six to seven days was the Tishchenko reaction complete, with 
comparable yields and enantioselectivities of 304 with those using anti-301. The authors 
explained these differences in reactivity using transition state models 308 and 311. When R = 
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Et, iPr, the 1,3-diaxial interactions between R2 and R3 are large enough (308) for the Tishchenko 
reaction of syn-306 to be unfavourable, making this process slow. A fast, reversible retro 
aldol/aldol reaction interconverts syn-306 to anti-309, whose transition state 311 does not 
have these unfavourable 1,3-diaxial interactions, and the Tishchenko reaction therefore 
proceeds rapidly and irreversibly. The authors also found that when R = Me, the 1,3-diaxial 
interactions were not as severe, and the Tishchenko reaction of the syn-aldol proceeded, 
without the need for retro aldol/aldol equilibration to occur.80 
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1.9 De Mayo Reactions 
The de Mayo reaction was first demonstrated in 1971 by Paul de Mayo,81 involving 
photochemical [2+2] cycloaddition between an enol 313 and an alkene 314, to afford a 
cyclobutanol 315 which is often then followed by spontaneous retro aldol collapse to generate 
a 1,5-diketone 316.82 
 
Scheme 53 General de Mayo photocycloaddition followed by spontaneous retro aldol reaction 
 
The de Mayo reaction has recently been reviewed by Yong-Jin Wu in 2010, where numerous 
examples can be found that detail its synthetic utility.82 Winkler and co-workers have also 
reviewed applications of the de Mayo reaction for the synthesis of natural products for the 
period prior to 1995.83 Therefore, only selected highlights of this methodology with respect to 
retro aldol fragmentation are reviewed in this section. 
 
In 1967, Wiesner and co-workers used a modified de Mayo procedure in their total synthesis 
of 12-epi-lycopodine. Precursor 317 underwent intramolecular photocycloaddition to afford 
318 in 70% yield. The ketone group was acetal protected, followed by epoxidation of the 
exocyclic alkene and subsequent reduction to afford tertiary alcohol 319 in 96% yield. Acid 
mediated deprotection of ketal 319 led to a retro aldol reaction (320) to afford 321 in 47% 
yield. This intermediate subsequently underwent an intramolecular aldol reaction to afford a 
new aldol product 322 that was then converted in four steps to furnish 12-epi-lycopodine 
323.84-85 
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Reagents and conditions: (i) hν, THF, -70 ˚C; (ii) 1. (CH2OH)2, p-TSA (cat), benzene, reflux; 2. mCPBA (1.5 
equiv), NaHCO3 (1.5 equiv), CHCl3; 3. LiBH4, THF, reflux; (iii) HCl THF-H2O, 45 min; (iv) NaOH (0.6% in H2O), 
MeOH, 36 h. 
Scheme 54 Total synthesis of 12-epi-Lycopodine 323 via a modified de Mayo photocycloaddition-retro 
aldol sequence 
 
In 1978, Oppolzer and co-workers demonstrated a total synthesis of Longifolene 329 using a 
de Mayo fragmentation strategy. 1,3-Diketone 324 was converted into a benzyloxycarbonyl 
derivative 325, which was then irradiated to trigger an intramolecular de Mayo reaction to 
afford 326 as a 2:3 mixture of stereoisomers. Hydrogenolysis of the benzyl protecting group 
initiated a clean retro aldol cleavage reaction (327) to afford 1,5-diketone 328 in 83% yield, 
which was converted in four more steps into Longifolene 329.86 This methodology was also 
employed in the total synthesis of Sativene 330.87 
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Reagents and conditions: (i) Benzyloxychloroformate (2.7 equiv), pyridine, 5 ˚C, 8 h; (ii) hν, cyclohexane, 
pyrex, 15-30 ˚C; (iii) H2 (3atm) Pd/C (10 mol%), HOAc, 25 ˚C. 
Scheme 55 Retro aldol reaction resulting in ring expansion product for the total synthesis of Longifolene 
 
In 1983, Pattenden and co-workers reported a total synthesis of Δ-8(9)-Capnellene 334 using a 
de Mayo reaction. The precursor 331 was irradiated to afford a tricyclic adduct, which was 
then bis-alkylated via treatment with LiHMDS and methyl iodide to afford geminal dimethyl 
adduct 332. This intermediate then underwent retro aldol fragmentation under basic 
conditions to furnish the ring expanded product 333 in 36% yield, which was then elaborated 
further to afford Δ-8(9)-Capnellene 334.88 
 
Reagents and conditions: (i) hν, hexane, 6 h, rt; (ii) LiHMDS, MeI, THF, -70 ˚C, 3.5 h; (iii) KOH, DMSO-H2O. 
Scheme 56 Total synthesis of Δ-
8(9)
-Capnellene 334 using de Mayo strategy 
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In 1992, Wickberg and co-workers utilised a de Mayo strategy in their total synthesis of (+)-
Aphanamol I 341. Photoaddition of alkene 335 to α,β-unsaturated ketone 336 produced a 
mixture of regioisomers 337 and 338 in 20% and 23% yield respectively. Treatment of 338 with 
dimethyloxosulfonium methylide furnished endo-epoxide 339 in 50% yield. Hydrolysis of the 
acetyl with lithium methoxide initiated a retro aldol-like reaction (340) with concomitant 
epoxide ring opening to afford (+)-Aphanamol 341 in 70% yield.89 This type of ring expansion 
methodology has also been demonstrated by Weedon and co-workers in their total synthesis 
of Hirsutene.90 
 
Reagents and conditions: (i) hν, MeCN, 12 h; (ii) Me2S(O)=CH2, THF, 3.5 h; (iii) LiOMe, MeOH, reflux, 1 h. 
Scheme 57 de Mayo strategy for the total synthesis of (+)-Aphanamol I 341 
 
Hiemstra and co-workers have developed a new route to functionalised cyclobutanes via retro 
aldol reaction of photocycloaddition products. The de Mayo sequence was initiated via 
irradiation of precursors 342-347 to afford cycloaddition products 343 and 348, which 
occurred with complete regioselectivity. Base induced retro aldol reaction then afforded 
spiro[3.4]octanes 345, spiro[3.5]nonanes 346 and novel substituted cyclobutanes 350-351 in 
good yield as a mixture of epimers.91 
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Reagents and conditions: (i) hν, MeCN/acetone; (ii) KOH, dioxane/H2O; CH2N2, MeOH. 
Scheme 58 Synthesis of highly functionalised cyclobutanes 345-346 and 350-351 via retro aldol cleavage 
of photocycloaddition products 343 and 348 
 
In 2003, Minter and co-workers demonstrated a de Mayo approach for the synthesis of the 
Galanthan ring system 356, which is a tetracyclic skeleton found in a number of alkaloids. Enol 
353 was initially synthesised from isoquinolin-1(2H)-one 352 in 63% overall yield, and then 
irradiated to initiate a de Mayo reaction to produce photocycloaddition intermediate 354, 
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which underwent a subsequent retro aldol sequence to afford 355 as a single product in 70% 
yield. Treatment of 355 with piperidine then initiated a base catalysed aldol reaction to afford 
the desired tetracycle skeleton of 356 in 78% yield.92 
 
Reagents and conditions: (i) hν, MeCN, 1.5 h; (ii) Piperidine, benzene, reflux. 
Scheme 59 de Mayo approach to the synthesis of tetracyclic Galanthan ring system 356 found 
in several alkaloids 
 
In 2002, Winkler and co-workers described the first total synthesis of (±)-Ingenol 362 using a 
modified intramolecular de Mayo photocycloaddition/retro aldol fragmentation sequence. A 
particular challenge of this synthesis was establishment of the highly unusual C-8/C-10 ‘inside-
outside’ configuration, or trans intrabridgehead configuration of the bicyclic ring system. 
Irradiation of 357 gave a 2:5 mixture of 358 and 359 isomers in 60% yield, which was separated 
via flash column chromatography. Isomer 359 was treated with methanolic K2CO3 to give 360, 
with the correct trans intrabridgehead stereochemistry for (±)-Ingenol 362.93-94 A similar 
methodology has also been applied by Winkler and co-workers for other natural product 
syntheses such as the tricyclic skeleton of Taxol diterpene analogues.95 
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Reagents and conditions: (i) hν (pyrex); (ii) K2CO3, MeOH. 
Scheme 60 Retro aldol fragmentation of a de Mayo photocycloaddition product 359 used for the 
total synthesis of (±)-Ingenol 362 
 
1.10 Aldolase Enzymes 
Aldolase enzymes are capable of catalysing both the aldol reaction and its reverse process with 
good substrate specificity and in high stereoselectivity.96 Aldolase enzymes are divided into 
two main classes according to the mechanism by which they operate. Class I aldolases utilise 
lysine residues to covalently link with the substrate, forming enamine/imine intermediates 
that activates the substrate towards stereoselective deprotonation. Class II aldolases employ 
active site bound transition metal ions such as Zn(II) as Lewis acids, which coordinate with the 
substrate to assist enolate formation.97-98 In 1993, Herbert and co-workers discovered a novel 
aldolase enzyme from Streptomyces amakusaensis that catalysed the retro aldol reaction of 
threo-β-hydroxy-α-amino acids 363 into their corresponding aldehydes 364 and glycine 365. 
The enzyme was highly selective for the (2S,3R) configuration of threo-(4-
hydroxyphenyl)serine. The substrate scope was limited to aromatic and hetero-aromatic 
compounds, but showed broad structural tolerance within this limitation.99 It was later 
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discovered that the enzyme is dependent on PLP (pyridoxal-5’-phosphate) 368 as a cofactor 
that acts to generate a Schiff base of the amino group of the substrate. The novel aldolase was 
employed for the preparation of a range of (2S,3R)-aromatic amino acids including (2R,3R)-3-
(2-furyl)serine 366 and (2R,3R)-3-(2-thienyl)serine 367, in good yield and above 95% ee.100 
 
Scheme 61 Enzymatic resolution of rac-arylserine 363 catalysed by Streptomyces aldolase 
 
Hilvert and co-workers have shown that the activity of a PLP dependant racemase enzyme can 
be changed to an aldolase by a single active site mutation. Alanine racemase from Geobacillus 
stearothermophilus was mutated by substitution of Tyr265 in the active site with an alanine 
residue to afford a mutant aldolase that catalysed the retro aldol reaction of α-substituted β-
phenylserine 370 via a Class I like enamine/iminium catalysis (Scheme 62). It was initially 
thought that this would allow the imidazole of an adjacent histidine residue to act as a general 
base in a retro aldol reaction.101 However, it was subsequently discovered by computational 
calculations that the histidine residue is too far away from the alcohol nucleophile in the active 
site, and therefore the base is likely to be the PLP cofactor. The engineered aldolase displayed 
high stereocontrol at the α-carbon configuration but low selectivity at the β-carbon of α-
substituted β-phenylserine 370.102 
 




Scheme 62 Mechanism of alrY265A catalysed retro aldol for α-substituted β-phenyl serine 369 and 370 
 
Barbas III, Tanaka and co-workers have developed small designer aldolase peptides between 
24-35 amino acid residues that have been shown to catalyse aldol, retro aldol and Michael 
reactions. A combination of design and reaction based selection was employed to create 
libraries of aldolase peptides. Randomised amino acids were appended to peptides and 1,3-
diketones were employed in selection reactions to trap reactive lysine residues that would act 
as enamine catalysts for retro aldol reactions. The designer peptides showed good rate 
acceleration and excellent substrate specificity for retro aldol reactions of substrates such as 
aromatic aldol 371.103 
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Scheme 63 Retro aldol reaction catalysed by small designer retro aldolase peptides 
 
1.11 Aldolase Antibodies 
Antibodies that catalyse enantioselective retro aldol reactions have received a large amount of 
attention in recent years. These antibodies are generated by reactive immunisation and 
generally have a much broader substrate scope than aldolase enzymes.104 Mechanistically, the 
retro aldol reaction proceeds through an enamine mechanism105 catalysed by an uncharged ε-
amino group of a reactive lysine residue in the active site, similar to the catalytic cycle 
observed for natural class I aldolases.106 One promising application is their use in 
chemotherapeutic drug activation, where a prodrug undergoes an antibody catalysed retro 
aldol reaction at the required site, thereby reducing the toxic effects of the parent drug.107-109 
Another application is their use in organic synthesis as a tool for the kinetic resolution of 
racemic aldol products. This topic has been extensively reviewed.110-112 Therefore, only 
selected highlights will be included in this section.  
 
Reactive immunisation113 is a process whereby mice are exposed to a hapten, a molecule 
specifically designed to resemble the transition state of a chemical reaction.114 In the case of 
aldolase antibodies, the hapten is usually a 1,3-diketones115 or contains a phosphinate 
residue.116 The hapten covalently traps a lysine residue of an antibody forming an enamine 
intermediate, thus mimicking the intermediates found in the transition state of an aldol 
reaction, which induces a catalytically active binding site for an aldol/retro aldol reaction to 
occur.106 The antibodies are then isolated from the immunised mice and purified for use in 
synthetic reactions.113 For example, in 1999 Barbas III, Lerner and co-workers designed a β-
diketo sulphone hapten 376 for the generation of new aldolase antibodies. The tetrahedral 
geometry of the sulphone unit mimics the transition state 374 of the carbon-carbon bond 
formation in the aldol reaction.114 
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Scheme 64 Reactive immunisation with hapten 376 to generate new aldolase antibodies 
 
In 1998, Barbas III, Lerner and co-workers employed a catalytic antibody to mediate kinetic 
resolution of simple β-hydroxyketones using an enantioselective retro aldol reaction, with 
these reactions reaching ~50% conversion after four hours, and the unreacted aldol being 
recovered in high enantiomeric excess.117 
 
 
Reagents and conditions: (i) Antibody 38C2, PBS. 
Scheme 65 Kinetic resolution of β-hydroxyketones using antibody 38C2 
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The authors had previously shown that antibodies could be used to catalyse the corresponding 
enantioselective aldol reactions, thus enabling a single antibody catalyst to be used to prepare 
both aldol enantiomers.117 
 
Scheme 66 Preparation of both enantiomers of aldol 379 using a single antibody 
 
Gouverneur and co-workers have demonstrated an unusual reversal of regioselectivity in 
aldolase antibody mediated aldol and retro reactions using unsymmetrical methyl ketones 381 
as enolate partners. In the uncatalysed aldol addition of methyl ketone 381 with para-
nitrobenzaldehyde 380, a branched regioisomer 383 is produced. However, when aldolase 
antibody 84G3 is employed the linear regioisomer 382 is favoured, with carbon-carbon bond 
formation taking place on the least substituted carbon, even when α-heteroatoms were 
present, thus showing that the antibody could differentiate between the reactive sites of an 
unsymmetrical methyl ketone 381. Both aldol enantiomers 382 could be selectively accessed 
by carrying out either aldol or retro aldol reactions with antibody 84G3 in good conversions 
and excellent enantioselectivity.118-119 
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Reagents and conditions: (i) Antibody 84G3 (25 mol%), PBS, pH 7.4, 0 ˚C; (ii) Antibody 84G3 (4 mol%), 
PBS, pH 7.4. 
Scheme 67 Unusual reversal in regioselectivity for the aldol reaction of unsymmetrical methyl ketones 
catalysed by antibody 84G3 
 
Gouverneur and co-workers have also demonstrated kinetic resolution of β-hydroxyenones 
384 using aldolase antibodies in a novel approach to the synthesis of formal hetero Diels-Alder 
adducts. The resolution process led to highly enantiomerically enriched α,β-unsaturated 
methyl ketones 385 in up to 99% ee, which underwent a ring closing reaction to afford 
pyranones 386 and 387. However, the antibodies employed did not tolerate long aliphatic R2 
substituents, which limited the overall scope of the strategy.120 
 
Reagents and conditions: (i) Antibody 84G3 or 93F3 (4-10 mol%), 9:1 PBS:MeCN, pH 7.4, rt 
Scheme 68 Kinetic resolution of β-hydroxyenones for the preparation of hetero-Diels Alder adducts 
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Catalytic antibodies have also been used to prepare aldol products for the total synthesis of 
Epothilones A-F, which are sixteen membered macrolides that stabilise tubulin formation via a 
Taxol-like mode of action.121-123 
 
 
Figure 2 Structures of Epothilone A-F 
 
Two key precursors were synthesised via kinetic resolution of racemic β-hydroxy ketones rac-
389 and rac-390, using antibodies generated against a β-diketone hapten via reactive 
immunisation. The best results were obtained for kinetic resolution of rac-thiazole aldol 388 
using antibody 84G3 that led to >98% ee at 50% conversion. Attempts to synthesise 389 via 
the corresponding antibody catalysed aldol reaction were less successful, as enantiomeric 
purity eroded over time due to the retro aldol reaction being more favoured. Aldol rac-389 
also underwent a kinetic resolution with antibody 38C2 to afford a recovered aldol product in 
98% ee at 60% conversion in 36% yield.121-123 
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Reagents and conditions: (i) Antibody 84G3, PBS, pH 7.4; (ii) Antibody 38C2, PBS, pH 7.4. 
Scheme 69 Kinetic resolution of thiazole aldol 388 and aldol 389 
 
Barbas III, Lerner and co-workers also reported kinetic resolution of tertiary β-hydroxy ketones 
rac-390 with catalytic antibodies, providing a route to ketol products containing hydroxyl 
substituted quaternary β-stereocentres. These kinetic resolutions did not proceed past 50% 
conversion, suggesting that they are highly enantioselective, with the majority of aldol 
products being obtained in excellent enantioelectivities.124 
 
Reagents and conditions: (i) Antibody 38C2, PBS. 
Scheme 70 Kinetic resolution of tertiary alcohols by antibody 38C2 
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The synthetic utility of this antibody catalysed methodology has been employed for the total 
synthesis of (+)-Frontalin 393, a sex pheromone found in beetles124 and for the total synthesis 
of a series of Brevicomin natural products with a related bicyclic skeleton to (+)-Frontalin 
393.125 
 
Reagents and conditions: (i) Antibody 38C2, PBS; (ii) Diethyl (2-oxopropyl)phosphonate, LiOH, THF; (iii) 
H2/Pd(OH)2/C. 
Scheme 71 Total synthesis of (+)-Frontalin using an antibody catalysed kinetic resolution of aldol 391 
 
1.12 Conclusion 
In summary, it is hoped that this review has demonstrated that the retro aldol reaction can be 
extremely useful for many synthetic applications. This reversible process can potentially be 
utilised to unmask useful aldehyde and enolate functionality, which can then be elaborated 
further to afford synthetically useful building blocks. Retro aldol reactions have also been used 
to initiate fragmentations reaction of complex cyclic frameworks, which is useful for the 
synthesis and structure elucidation of natural products. Its reversible nature can also be 
exploited for accessing thermodynamically stable epimers, as well as for the kinetic resolution 
of racemic mixtures of aldol substrates. It has also been utilised in the removal of chiral 
auxiliaries in the synthesis of enantiomerically pure building blocks that are of use in natural 
product synthesis. It is believed that there is still a great deal of potential for the retro aldol 
reaction to be used in many more applications for organic synthesis. 
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2 Results and Discussion 




Substituted δ-lactones are exceptionally widespread in Nature and have a broad range of 
applications.126 The δ-lactone motif is found in many natural products isolated from fungi and 
marine organisms, where they often form parts of attractants and pheromones.127 δ-Lactones 
are also shunt metabolites of prematurely terminated polyketide syntheses.128 δ-Lactones 
display a broad range of potent pharmacological activities including antitumour,129 
antimicrobial,130 and immunosuppressive activity.131 For example, the polyketide (+)-
Discodermolide 394 is an inhibitor of tumour cell growth,132 (-)-Goniofupyrone 395 is cytotoxic 
against human tumours133 and the macrocycle Lankacidin C 396 is an antibiotic and antitumour 
agent.134 The δ-lactone subunit is also present in pharmaceutical compounds such as the statin 




Figure 3 Examples of biologically active δ-lactones found in natural products 
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δ-Lactones are also important in the flavour and fragrance industry. The δ-lactone motif is 
present in compounds found in dairy products and is important in the flavour of fruit. For 
example, decalactone 398 has been identified in the (R)-configuration in apricots, peaches and 
strawberries but in the (S)-configuration in raspberries.136 Glucono δ-lactone 399 is a naturally 
occurring food additive found in honey, fruit juice and wine. 
 
 
Figure 4 δ-Lactone natural products found in food 
 
δ-Lactones are also useful precursors to medicinally interesting compounds such as L-
Callipeltose 406, the deoxyamino sugar of L-Callipeltoside A, a potential antitumour agent.137-
138 The total synthesis by Evans and co-workers began with well-established protecting group 
procedures of the amino acid D-threonine 400 to afford N-Cbz-D-threonine methyl ester 401. 
Stereoselective aldol addition of the lithium enolate of 1,4-dioxaspiro[4.5]decan-2-one 402, 
provided aldol 403 with high diastereoselecivity, which was deprotected and methylated to 
furnish δ-lactone 404 in 71% yield. A Rychnovsky’s one-pot lactone reduction-acylation 
procedure, using diisobutylaluminium hydride followed by acetic anhydride, was employed to 
afford lactol 405, which underwent reduction of the Cbz group to furnish the cyclic carbamate 
unit. Further elaboration completed the total synthesis of L-Callipeltose 406 in an overall 13% 
yield across ten steps.138 




Reagents and conditions: (i) LDA, then 402; (ii) AcOH, H2O; (iii) Me3O.BF3, 2,6-di-tert-butyl-4-
methylpyridine; (iv) DIBAL then Ac2O, pyridine, DMAP; (v) NaH, THF; (vi) DBU, Cl3CCN; (vii) MeOH, TMS-
OTf, CH2Cl2. 
Scheme 72 Intermediate δ-lactone for the synthesis of L-Callipeltose 406 
 
2.2 Synthesis of δ-Lactones with Multiple Contiguous Stereocentres 
The diverse range of pharmacological activity displayed by natural products containing a δ-
lactone unit, as well as the versatility of substituted δ-lactone fragments in synthetic 
strategies, has resulted in the development of a wide variety of methodology for their 
asymmetric synthesis.139-142 Furthermore, highly substituted δ-lactones can perform as useful 
building blocks in the synthesis of polyketide natural products containing stereotetrads.143 
Many strategies have been developed for the synthesis of precursors containing four or more 
contiguous stereocentres for natural product synthesis.144-146 
 
One of the most popular approaches for the asymmetric synthesis of highly substituted δ-
lactones is the use of chiral auxiliaries to direct aldol reactions, since it allows reliable 
incorporation of multiple contiguous stereocentres into an aldol product. The advantage of 
this strategy is that the methodology can be altered to access many stereochemical 
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arrangements. There are two general strategies when using Evans’ type auxiliaries in the 
synthesis of δ-lactones containing multiple contiguous stereocentres; whereby pre-existing 
stereocentres originate in either the enolate (using β-keto-N-acyl-oxazolidin-2-ones),147-149 or 
the electrophile (using enantiopure aldehydes).128,140,150-152 
 
For example, Lee and co-workers employed β-keto-N-acyl-oxazolidin-2-one 407 in a tin 
promoted Evans’ aldol reaction with aldehyde 408 to afford aldol 409 in 82% yield. This 
subsequently underwent a reduction-lactonisation sequence to afford highly substituted δ-
lactone 410, which was used as a chiron for the total synthesis of Kendomycin 412.148 
 
 
Reagents and conditions: (i) Sn(OTf)2, NEt3, CH2Cl2, -78 ˚C; (ii) NaBH(OAc)3, AcOH, 5 ˚C; (iii) DBU, CH2Cl2; 
(iv) Pd(OAc)2, PCy3, n-Bu3SnH, Hexane-THF; (v) I2, CH2Cl2. 
Scheme 73 Chiral auxiliary directed aldol reaction to afford δ-lactone 410 precursor for the total 
synthesis of Kendomycin 412 
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Davies and co-workers have demonstrated a strategy for the synthesis of more challenging 
‘mismatched’ aldol products 415 and 416, using a N-acylated SuperQuat 413 chiral auxiliary 
and an enantiopure aldehyde 414 (Scheme 74). These aldol products could then be 
deprotected and cyclised to produce stereodefined tetrasubstituted δ-lactones 417 and 419. 
The initial reaction is a double diastereoselective SuperQuat aldol addition of acylated 
SuperQuat 413 to aldehyde 414. This provided a 57:43 mixture of separable diastereomers 415 
and 416, both isolated in >95% de, with the stereochemistry differing only at the β-position. 
Treatment of the aldol product 415 with TBAF induced O-deprotection and concomitant 
lactonisation, providing the tetrasubstituted δ-lactone 417 in an 85% yield. The same 
procedure was applied to compound 416, but this resulted in a mixture of δ-lactone 419 in a 
34% yield and deprotected aldol product 418 in a 45% yield. Subsequent separation of this 
mixture and heating 418 at reflux in toluene provided δ-lactone 419 in an overall 76% yield.140 
 
Reagents and conditions: (i) Et2BOTf, N(
i
Pr)2Et, CH2Cl2, -78 ˚C to 0 ˚C; (ii) TBAF, AcOH, THF, rt; (iii) 
Toluene, Δ. 
Scheme 74 Synthesis of δ-lactones 417 and 419 from SuperQuat auxiliary 
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2.3 Literature Precedent and Previous Work 
The mercury(II) mediated cyclopropylcarbinol ring opening reaction is well documented and 
has been previously employed for the synthesis of oxygen heterocycles.153-155 For example, 
Collum and co-workers have reported that disubstituted δ-lactones can be synthesised from 
cyclopropane 420 in a mercury mediated ring-opening reaction with mercury trifluoroacetate. 
Subsequent radical demercuration with tributyltin hydride furnished δ-lactone 421 in 12:1 
ratio of δ-lactone 421 to γ-lactone 422.153-154 Cossy and co-workers have also utilised this highly 





Reagent and conditions (i) Hg(OCOCF3)2, CH2Cl2, rt then saturated KBr; (ii) n-Bu3SnH, cat. AIBN, THF.  
Scheme 75 Mercury mediated synthesis of disubstituted δ-lactone 421 and 424 
 
Cossy and co-workers have also applied this methodology to the synthesis of the highly 
functionalised C-1-C-10 fragment of the polyketide natural product Zincophorin 427. The 
resulting tetrahydropyran was obtained in excellent yield (85%) and diastereoselectivity (dr > 
93:7).156-157 
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Reagents and conditions: (i) Hg(OCOCF3)2, CH2Cl2, rt then aq. KBr; (ii) n-Bu3SnH, cat. AIBN, THF/toluene, 
60 ˚C. 
Scheme 76 Synthesis of the C-1-C-10 fragment 426 of Zincophorin 427 
 
As discussed earlier, the Bull group has previously reported a novel approach for the synthesis 
of chiral cyclopropane carboxaldehydes using temporary stereocentres,40 which has been 
applied to the synthesis of the natural products Grenadamide158 and Cascarillic acid.42 The 
asymmetric aldol reaction was achieved using the SuperQuat chiral auxiliary to afford syn-aldol 
products 429. A substrate directed cyclopropanation reaction furnished cyclopropanes 430, 
which underwent a retro-aldol reaction to afford the cyclopropane carboxaldehydes 431 in 
>95% de. The acylated auxiliary 95 could then be separated from the reaction mixture and 
recycled. 
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Reagents and conditions: (i) 9-BBN-OTf , N(
i
Pr2)Et, CH2Cl2, -78 to 0 ˚C; (ii) Et2Zn, CH2I2, CH2Cl2, -10 to 0 ˚C; 
(iii) LiHMDS (1.1 equiv), toluene. 
Scheme 77 Synthesis of cyclopropane carboxaldehydes 431 using temporary stereocentres 
 
The aim of this project was to investigate novel methodology for the asymmetric synthesis of 
tetrasubstituted δ-lactones via mercury mediated ring-opening of cyclopropanated aldol 
products. Given the literature precedent, it was initially proposed that this methodology could 
be applied to our cyclopropanated syn-aldol products to afford highly substituted δ-lactones 
with high diastereoselectivity. 
 
The proposed asymmetric synthesis of δ-lactones 437 is shown in Scheme 78. It had been 
previously shown within the Bull group that mercury mediated ring-opening of 
cyclopropanated aldol products 434 led to α,β-unsaturated δ-lactones 438. Although α,β-
unsaturated δ-lactones are useful precursors in natural product synthesis, this strategy is 
undesirable since two stereocentres are destroyed in the lactonisation process. Using the 
previously described literature precedent,153 the chiral auxiliary was replaced with a methyl 
ester 435 and it was found that oxymercuration of this product led directly to organomercurial 
δ-lactone 436 retaining all four contiguous stereocentres. A subsequent reductive 
demercuration step with basic sodium borohydride furnished the highly substituted δ-lactone 
437. 
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Scheme 78 Novel methodology for the synthesis of highly substituted δ-lactones 437 
 
This project aimed to explore the scope and limitations of this novel methodology for the 
asymmetric synthesis of highly substituted δ-lactones, as well as strategies for their conversion 
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2.4 The Asymmetric Aldol Reaction 
The aldol reaction is one of the most important carbon-carbon bond forming reactions in 
organic synthesis. It involves the addition of an enolate 440 to an aldehyde or ketone 441 to 
produce a β-hydroxyketone 442 with the generation of two new stereocentres. Under certain 
conditions, the β-hydroxyketone 442 can dehydrate to form an α,β-unsaturated ketone 443. 
 
Scheme 79 General aldol reaction 
 
2.4.1 Stereoselectivity in the Aldol Reaction 
The stereochemical outcome of the aldol reaction can be controlled using chiral auxiliaries. 
Evans and co-workers first reported the use of a chiral oxazolidinone auxiliary 444 with boron 
enolates to control the enantioselectivity of the aldol reaction.159 Davies and co-workers 
subsequently demonstrated that a modified chiral oxazolidinone auxiliary with 5,5-
substitution, known as the ‘SuperQuat’ auxiliary 445, often provides greater stereoselectivity 
compared with Evans’ auxiliary.160 
 
Figure 5 Chiral oxazolidinone auxiliaries 
 
The stereoselectivity of the aldol reaction originates from both the enolate geometry and the 
influence of the auxiliary. Aldol products potentially contain two stereocentres and therefore 
up to four different stereoisomers can be formed during the aldol reaction. The 
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diastereoselectivity of the aldol reaction is controlled by the geometry of the enolate, whereas 
the enantioselectivity is controlled by the auxiliary. 
 
Boron reagents are often employed in directed aldol additions to generate the desired enolate 
geometry. Bulky boron substituents such as cyclohexyl groups result in E enolates 448, 
whereas substitutents that are less sterically demanding, such as butyl groups or 9-BBN (9-
borabicyclononane), result in the formation of the Z enolate 447. The desired enolate is 
produced by treatment of the ketone with the boron triflate reagent in the presence of an 
amine base. The Lewis acidic boron coordinates to the oxygen of the carbonyl group to aid 
deprotonation of the ketone by the base. The geometry of the boron enolate is important for 
the stereochemical outcome of the aldol reaction. The Z enolate 447 provides the syn product 




Scheme 80 Diastereoselectivity in the aldol reaction is determined by enolate geometry 
 
The stereochemical outcome of the aldol reaction is rationalised using a closed six-membered 
transition state known as the Zimmerman-Traxler model. The boron associated with the 
enolate binds to the oxygen of the incoming aldehyde to form a chair-like six-membered ring. 
The Z enolate 447 must orientate itself with its substituents fixed in the axial position (Scheme 
81). However, the incoming aldehyde can orientate itself with its R2 group in either the axial or 
equatorial position, leading to two possible transition states 453 and 455. The axial position is 
disfavoured due to the unfavourable pseudo 1,3-diaxial interaction between the R1 group of 
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the enolate and the R2 group of the aldehyde (455). Therefore, the reaction proceeds through 
the transition state in which the R2 group is equatorial to minimise steric interactions (453) to 
afford the syn product 454. Therefore, enolate geometry controls the overall 
diastereoselectivity, but not the enantioselectivity so a racemic mixture is obtained.161-162 
 
 
Scheme 81 Zimmerman-Traxler transition states for a Z boron enolate 447 
 
The absolute stereochemistry of the aldol reaction can be controlled using chiral auxiliaries 
such as the SuperQuat auxiliary 445. The chiral auxiliary is used to control which syn 
enantiomer is produced when a Z boron enolate is used in the aldol reaction.163 The Lewis 
acidic boron coordinates both oxygen atoms of the enolate and chiral auxiliary in the Z enolate 
(457). However, the incoming aldehyde 458 forces the boron atom to detach from the oxygen 
atom of the oxazolidinone and coordinate to the oxygen of the incoming aldehyde instead 
(459). This causes the conformational lock of the auxiliary to be broken, leaving the carbon-
nitrogen bond of the auxiliary free to rotate by 180˚ from its original position into a lower 
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This new conformation minimises the adverse dipole-dipole interactions between the two 
carbon-oxygen bonds, which are parallel to each other in the boron enolate. The incoming 
aldehyde approaches from the Re face where the dipole is minimised resulting in syn 
enantiomer 462.159,164-165 
 
Scheme 82 Minimisation of adverse dipole-dipole interactions in the aldol reaction favours formation of 
syn-aldol 462 
 
The absolute stereochemical outcome can also be explained using Zimmerman-Traxler 
transition states.159 The boron coordinates to the incoming aldehyde creating four possible 
transition states (465-468). The R group of the aldehyde must adopt a pseudo equatorial 
position to minimise the 1,3-diaxial interactions. The most favourable transition state 465 
minimises the dipole-dipole interactions by positioning the carbon-oxygen bonds of the 
auxiliary and the aldehyde antiparallel, as well as minimising steric interactions induced by the 
directing benzyl group of the SuperQuat. This leads solely to the syn product 463.163 
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Scheme 83 Zimmerman-Traxler transition states using SuperQuat auxiliary to control facial selectivity of 
syn-aldol reaction 
 
2.4.2 Asymmetric Synthesis of Unsaturated syn-Aldol Products 
Our novel strategy for the synthesis of highly substituted δ-lactones 437 allows for variation at 
two of the substituents, R1 and R2 (Scheme 84). Structural variation at R1 could be introduced 
by employment of different acid chlorides 469 in the auxiliary N-acylation step. The R2 




Scheme 84 Variation of substituents R1 and R2 on δ-lactone 437 framework 
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A range of N-acylated oxazolidin-2-ones were synthesised to investigate the scope of this 
methodology. SuperQuat auxiliary 445 in THF was treated with n-butyl lithium (2.5 M in 
hexane) at -78 ˚C followed by the addition of the appropriate acid chloride 469. The resulting 
solution was allowed to warm to room temperature over two hours before quenching with 
saturated ammonium chloride. The crude product was purified by either flash silica 
chromatography or recrystallisation. 
. 
Reagents and conditions: (i) n-BuLi (1.1 equiv), THF, -78 ˚C, 30 min, 469 (1 equiv), -78 ˚C, 2 h. 
Scheme 85 Synthesis of N-acylated SuperQuat auxiliary products 432 
 
The following acylated SuperQuat auxiliary products were synthesised in high yield using the 























































χp refers to SuperQuat auxiliary; 
bisolated yield after column chromatography 
Table 1 N-Acylated oxazolidin-2-one products 432 
Asymmetric Synthesis of Chiral δ-Lactones Containing Multiple Contiguous Stereocentres 
80 
The N-acylated auxiliary products in Table 1 were then used to synthesise the unsaturated syn-
aldol products 433. The acylated auxiliary 432 was treated with dibutylboron triflate (1.1 
equiv) followed by diisopropylethylamine (1.3 equiv) in dichloromethane at 0 ˚C. After 30 
minutes, the solution was cooled to -78 ˚C and the appropriate aldehyde 470 (1.3 equiv) added 
before the solution was allowed to warm to ambient temperature overnight. The reaction was 
quenched with pH 7 buffer solution, methanol and hydrogen peroxide, and was stirred for a 
further two hours. The crude product were then purified using flash silica chromatography to 




Reagents and conditions: (i) Bu2BOTf, N(
iPr)2Et, CH2Cl2, 0 ˚C then aldehyde 470, -78 ˚C. 
Scheme 86 Synthesis of unsaturated syn-aldol products 433 
 
This asymmetric syn-aldol methodology was applied to (S)-4-benzyl-5,5-dimethyl-3-
propionyloxazolidin-2-one (R1 = Me) using different aldehydes 470 as substrates to introduce 
variation at the R2 position. The following syn-aldol products were synthesised in high yield 






























































































χp refers to SuperQuat auxiliary; 
b
isolated yield after column chromatography 
Table 2 Unsaturated syn-aldol products produced from different α,β-unsaturated aldehydes 
 
The following syn-aldol products were then synthesised via reaction of different N-acylated 
oxazolidin-2-ones with crotonaldehyde in high yield and high de (Table 3). 
 






































χp refers to SuperQuat auxiliary; 
bisolated yield after column chromatography 
Table 3 Unsaturated syn-aldol products prepared using different N-acylated auxiliaries 
 
An asymmetric aldol reaction was attempted using N-acylated oxazolidin-2-one 472 where R1 = 
Ph. However, this aldol product showed a high propensity to undergo a retro-aldol reaction 
during purification by flash silica chromatography, possibly due to the acidic nature of the 
silica. This problem persisted with the pure material in subsequent reactions. Therefore, it was 
decided to use the para-methoxyphenyl derivative 473 instead to illustrate aromatic diversity 
at the R1 position. This aldol product 481 showed much less of a tendency to retro-aldol, so the 
synthesis could be continued using this product. 
 
The syn-configuration of the aldol product was confirmed from the value of the J(2,3) coupling 
constant of >6 Hz in each case. The configuration of the alkene in the unsaturated syn-aldol 
products 474-475 and 477-479 was confirmed using the 1H NMR spectra. The characteristic 
alkene protons were present between 5.40-5.90 ppm when R2 = aliphatic and 6.9-6.2 ppm 
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2.5 Non-Evans’ anti-aldol 
A non-Evans’ anti-aldol product 483 was prepared to investigate the effect of using substrates 
with an alternative stereochemistry at the α-position. According to a literature procedure, (S)-
4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 95 was dissolved in dry ethyl acetate along 
with a catalytic amount of magnesium chloride and sodium hexafluoroantimonate.166 
Triethylamine was added dropwise followed by cinnamaldehyde 482 and freshly distilled 
chlorotrimethylsilane. The crude product underwent desilylation on work up, followed by 
purification via flash silica chromatography to afford the anti-aldol product 483 in 82% yield 
and in >95% de. The 1H and 13C NMR spectra were similar to that of syn-aldol product 483, 
although the most noticeable difference in chemical shift was that of the CHAHBPh proton of 
the auxiliary, which had shifted from 2.91 ppm to 2.67 ppm due to the different orientation of 
the α-methyl group.166 
 
 
Reagents and conditions: (i) MgCl2 (0.1 equiv), NaSbF6 (0.3 equiv), NEt3, TMSCl, dry EtOAc, rt, 24 h. 
Scheme 87 Synthesis of non-Evans anti-aldol product 483 
 
Mechanistically, it is thought that the magnesium coordinates to the N-acyl auxiliary 95 to 
generate a metal enolate 485, which reacts with the aldehyde to afford intermediate 487. This 
aldol reaction is reversible, but is trapped by silylation with TMSCl aiding the release of the 
magnesium ion to proceed further in the catalytic cycle. It has been proposed that boat 
transition state 489 leads to the anti-aldol product, which is different to the Zimmerman-
Traxler transition state observed in the Evans’ syn-aldol reaction.167 
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Scheme 88 Catalytic cycle for magnesium chloride catalysed anti-aldol reaction 
 
Attempts were made to synthesise other anti-aldol products using different aldehydes. 
However, these failed possibly owing to the non-general nature of this procedure, which is 
most successful when non-enolisable electrophiles such as aromatic and unsaturated 
aldehydes are employed for reaction. The syn-aldol products 474-479 were then taken along 
with anti-aldol product 483 onto the next stage of the synthesis. 
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2.6 Directed Cyclopropanation 
The next step in the synthesis was a directed cyclopropanation reaction of the allylic alcohol 
functionality of aldol products 474-479 using diethylzinc and diiodomethane to afford a series 
of syn-cyclopropane products. The use of a directed cyclopropanation reaction on these types 
of α,β-unsaturated aldol product is an efficient strategy for the construction of two new 
stereocentres in one step. The Bull group has previously demonstrated the utility of the 
directed cyclopropanation reaction on α,β-unsaturated aldol products to afford syn-
cyclopropanes in high yield and excellent diastereoselectivity.40 This methodology utilises 
Furukawa’s cyclopropanation conditions that have previously been applied to the synthesis of 
Grenadamide within the Bull group.158 
 
2.6.1 Stereoselectivity in the Directed Cyclopropanation Reaction 
Simmons and Smith first reported the use of diiodomethane and zinc-copper couple to convert 
alkenes into cyclopropanes.168-169 The reaction has been shown to proceed through a three 
membered ‘butterfly-type’ transition state 490170-171 in which IZnCH2I is the active 
cyclopropanating agent.172 The reaction is stereospecific with respect to the alkene geometry 
and is influenced by both electronic and steric factors.173-174 
 
 
Scheme 89 Simmons-Smith ‘butterfly-type’ transition state 
 
Many variations of this method were reported shortly after this seminal publication, including 
a report by Wittig who described that treatment of zinc iodide with diazomethane afforded an 
alternative method for the preparation of active cyclopropanating species.175 In 1966, 
Furukawa found that diethylzinc could be substituted for the Zn-Cu couple to prepare the 
reactive species.176-177 
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Winstein and co-workers reported the first application of a Simmons-Smith reaction to an 
allylic alcohol 491. The oxygen atom coordinates to the zinc to direct the methylene group to 
the neighbouring alkene to afford the syn product 492 as a single stereoisomer in 75% yield.178 
It has also been found that the overall rate of reaction with allylic alcohols is much faster than 
with simple alkenes (>1000 fold), with the cyclopropane group forming on the same side as the 
hydroxyl group in most cases.179-180 There have been many reports of directed 





Scheme 90 Hydroxyl-directed Simmons-Smith cyclopropanation reaction 
 
The stereoselectivity of the cycloropanation reaction with acyclic allylic alcohols can be 
explained using the allylic strain model. The ‘staggered’ model proposed by Houk considers the 
possible allylic conformation for the transition states in the addition of the cyclopropane 
carbon to the double bond.183-184 Coordination of the active species EtZnCH2I with the alcohol 
directs formation of the cyclopropyl group syn with respect to the hydroxyl group. Therefore, 
the modified conditions of the Simmons-Smith reaction developed by Furukawa are syn-
selective due to minimisation of A1,3 strain in the transition state.181 
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Scheme 91 Transition states for the stereoselective cyclopropanation of allylic alcohols 
 
2.6.2 Synthesis of syn-Cyclopropane Products 
A series of syn-cyclopropane products were prepared from the α,β-unsaturated aldol products 
474-479. Each syn-aldol substrate was treated with diethylzinc (5 equiv) and diiodomethane (5 
equiv) in dry dichloromethane at 0 ˚C under nitrogen, and the solution was stirred for two 
hours in the absence of light. The reaction was quenched with saturated sodium sulfite and 
the resulting white precipitate dissolved in 1 M HCl. After extraction, the crude product was 
purified via flash column chromatography or recrystallisation. 
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Reagents and conditions: (i) Et2Zn (5 equiv), CH2I2 (5 equiv), CH2Cl2, 0 ˚C, 2 h. 
Scheme 92 Synthesis of syn-aldol cyclopropane products 434 
 
The 1H NMR spectra confirmed that the cyclopropanation reactions had been successful, with 
the absence of the alkene peaks between 5-7 ppm indicating that all the starting material had 
been consumed. The characteristic shielded cyclopropane proton multiplets between 0 and 1 
ppm indicated that the cyclopropane had been formed in high diastereoselectivity. This 
methodology was applied to the α,β-unsaturated aldol products 474-479, 480-481 and 483 to 


























































































































χp refers to SuperQuat auxiliary; 
b
isolated yield after column chromatography 
Table 4 Cyclopropanated syn-aldol products 
 
2.7 Removal of the Auxiliary 
It had been observed previously in the Bull group that direct mercury mediated ring-opening of 
the syn-aldol cyclopropane products 434 led to the α,β-unsaturated δ-lactone product 438 
with cleavage of the auxiliary 445. This reaction is undesirable since two of the contiguous 
stereocentres are destroyed. Furthermore, separation of the SuperQuat auxiliary from the δ-
lactone during purification presents a further unnecessary challenge. 
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Reagents and conditions: (i) Hg(OCOCF3)2, CH2Cl2, rt, 24 h then aq. NaCl. 
Scheme 93 Synthesis of undesired α,β-unsaturated δ-lactone 438 
 
Mechanistically, it is thought that the mercury ion coordinates to the cyclopropane ring 
facilitating regioselective ring-opening via nucleophilic attack by the endocyclic carbonyl group 
(502), resulting in iminium species 503. This species then undergoes rapid E1cB elimination to 
afford intermediate 505, which upon hydrolysis produces α,β-unsaturated lactone 438 along 
with the parent oxazolidin-2-one 445. 
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Scheme 94 Proposed mechanism for the formation of α,β-unsaturated lactone 438 
 
It was found that removal of the auxiliary 445 using sodium methoxide to afford the methyl 
ester 435 prior to oxymercuration led to the desired highly substituted δ-lactone product 437 
upon oxymercuration. This method also provides a simpler purification for removing the 
auxiliary by flash silica chromatography. Therefore, syn-aldol cyclopropane products 434 were 
treated with sodium methoxide (1 equiv, 0.5 M in methanol) at room temperature and the 
resulting solution was stirred for five minutes before being quenched with brine. The crude 
mixture was purified using flash silica chromatography to separate the methyl ester product 
435 from the auxiliary 445. This methodology was applied to syn-aldol cyclopropane products 
493-501 to afford methyl ester products 506-514 (Table 5). 
 
Asymmetric Synthesis of Chiral δ-Lactones Containing Multiple Contiguous Stereocentres 
92 
 
Reagents and conditions: (i) NaOMe (1 equiv, 0.5 M in methanol), CH2Cl2, rt, 5 min. 
Scheme 95 Transesterification of syn-aldol cyclopropane products 434 
 
Methyl ester 510 required a longer reaction time of 24 hours at room temperature. This is 
possibly due to the steric hindrance of the isopropyl group at the α-position of the syn-aldol 
cyclopropane product, which slows down the rate of nucleophilic substitution of the auxiliary 





















































































































χp refers to SuperQuat auxiliary; 
bisolated yield after column chromatography 
Table 5 Synthesis of methyl ester products 
 
A problem that was encountered with this step in the synthesis was that methyl ester 511 co-
eluted with the free SuperQuat auxiliary during flash silica chromatography in all attempted 
solvent systems. A pure sample of methyl ester 511 could not be isolated and was always 
contaminated with auxiliary. Therefore, it was decided that SuperQuat auxiliary be substituted 
for Evans’ auxiliary for this analogue. This synthesis afforded a pure sample of methyl ester 
511 in 76% yield. 
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Reagents and conditions: (i) n-BuLi (1.1 equiv),THF, -78 ˚C for 30 min, propionyl chloride (1 equiv), -78 ˚C, 
2 h; (ii) Bu2BOTf (1.1 equiv), N(
iPr)2Et (1.3 equiv), CH2Cl2, 0 ˚C then aldehyde 516, -78 ˚C to rt; (iii) Et2Zn (5 
equiv), CH2I2 (5 equiv), CH2Cl2, 0 ˚C, 2 h; (iv) NaOMe (1 equiv), CH2Cl2, rt, 5 min. 
Scheme 96 Synthesis of methyl ester 511 using Evans’ auxiliary 444 
 
2.8 Lactonisation via Mercury(II) Mediated Cyclopropane Ring-Opening 
Mercury mediated ring-opening of cyclopropanes is well documented and occurs with high 
regio- and stereoselectivity.153-155 For example, Cossy and co-workers have reported 
stereoselective oxymercuration of cyclopropanealkanols 519 to afford 1,3-diols 521 after 
hydrolysis and reductive demercuration of 520. The mechanism involves a concerted 
electrophilic ring-opening of the cyclopropanealkanols at the most electron rich carbon-carbon 
bond with anti nucleophilic attack of the trifluoroacetate ion. This concerted mechanism 
explains the high level of stereoselectivity observed,155 and this methodology has been applied 
by Cossy and co-workers to the synthesis of polypropionate units with up to four contiguous 
stereocentres.185-186 
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Reagent and conditions (i) Hg(OCOCF3)2, CH2Cl2, then aq. NaCl; (ii) LiAlH4, THF. 
Scheme 97 Mercury mediated cyclopropane ring-opening reaction to form 1,3-diols 521 
 
2.8.1 Oxymercuration of Methyl Ester Products 
Previous investigations in the Bull group into the mercury(II) mediated cyclopropane ring-
opening of methyl ester product 507 had resulted in clean conversion into the 
organomercurial δ-lactone 522 in high yield. However, the crucial step in this synthesis was 
demercuration of this species to afford highly substituted δ-lactone 527, which could serve as 
a synthetically useful building block in natural product synthesis. Therefore, methyl ester 507 
was treated with mercury trifluoroacetate (2.5 equiv) in dichloromethane and the resulting 
yellow solution was stirred at room temperature for 48 hours. The mixture was quenched with 
brine and was stirred for a further hour. The crude product was not analysed or purified due to 
toxicity issues and was taken through immediately to the demercuration step. 
 
Reagents and conditions: (i) Hg(OCOCF3)2, CH2Cl2, rt, 24h then aq. NaCl. 
Scheme 98 Synthesis of organomercurial δ-lactone 527 
 
It is thought that the oxymercuration reaction of methyl ester 435 proceeds via a different 
mechanism to that for formation of α,β-unsaturated lactone 438, since the methyl ester group 
in 435 is a poorer anchimeric nucleophile than the N-acyl-oxazolidin-2-one fragment of 434. It 
is proposed that the mercury ion coordinates to the cyclopropane ring of 435, activating it 
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towards nucleophilic attack by a trifluoroacetate ion in an SN2 fashion, ring-opening the 
cyclopropane with inversion of stereochemistry and forming a carbon-mercury bond (523). 
This organomercurial intermediate 524 is then hydrolysed upon quenching with brine, to 
afford intermediate 525, which undergoes an intramolecular cyclisation reaction to afford 
organomercurial δ-lactone 438 (Scheme 99).153,185-186 
 
 
Scheme 99 Mechanism for mercury(II) mediated lactonisation of methyl ester cyclopropyl-aldols 435 
 
The predicted stereochemistry of organomercurial δ-lactone 522 was confirmed using an 1H 
NOE spectrum (interactions shown in Figure 6). Proton G shows a strong interaction with 
proton D confirming the cis relationship of these axial protons. Further to this, G is also shown 
to interact with the adjacent equatorial proton on F. The interaction of proton B with E again 
confirms the cis relationship. Furthermore no interaction is observed between protons B and G 
verifying the predicted trans geometry for these two stereocentres. From this study, the 
stereochemistry of δ-lactone 522 can be confirmed as (2R,3R,4S,5S), with its solution phase 
conformation being consistent with that of a distorted chair conformer. 





H NOESY interactions between protons in δ-lactone 522 
 
2.8.2 Reductive Demercuration of Organomercurial δ-Lactones 
The final step in the synthesis was demercuration of the organomercurial species to afford 
highly substituted δ-lactones. An initial attempt to demercurate the organomercurial δ-lactone 
522 following methodology demonstrated by Cossy and co-workers186 employed tributyltin 
hydride and AIBN in a radical demercuration. However, separation of the product from the 
tributyltin residues proved unsuccessful and this method was abandoned. 
 
A literature search provided an alternative reductive demercuration method developed by 
Collum and co-workers.154 Organomercurial δ-lactone 522 was dissolved in methanol and 
cooled to 0 ˚C. Sodium borohydride (3 equiv) was dissolved in 3.5 M NaOH and added to the 
methanolic solution of organomercurial δ-lactone 522. The solution immediately turned grey 
and was stirred for two minutes at room temperature before being quenched to pH 2 using 1 
M HCl. The crude residues were passed through a silica plug and purified via flash silica 
chromatography to provide demercurated δ-lactone 527 in 81% yield. 
 
Reagents and conditions: (i) NaBH4 (3 equiv), NaOH (3.5 M), MeOH, rt, 2 min then 1 M HCl quench. 
Scheme 100 Reductive demercuration of organomercurial δ-lactone 522 
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This methodology was then applied to the organomercurial δ-lactones resulting from methyl 
esters 506-514 to afford highly substituted δ-lactones 526-532 in high yield and high de. The 
methyl ester products underwent mercury(II) mediated cyclisation to afford the crude 
organomercurial δ-lactone species, which was not purified or analysed and was immediately 

































































































Isolated yield after column chromatography 
Table 6 Synthesis of δ-lactone products 526-532 
 
The reactions of methyl ester 512 and 513 were unsuccessful. The 1H NMR spectra of the 
crude demercurated product showed the starting material had been completely consumed to 
afford a complex mixture of products. It was unclear as to whether some of the desired 
demercurated highly substituted δ-lactone was present and purification was not undertaken 
on these compounds. 
 
2.8.3 Confirmation of Stereochemistry 
The stereochemistry of the demercurated highly substituted δ-lactone 527 was again 
confirmed using NOE spectroscopy. The 1H NOE spectrum revealed strong interactions 
between both sets of axial protons on either side of the chair conformation. Furthermore, 
there were no interactions observed between protons with a trans relationship on the ring. 
This confirms the cis relationship of the axial protons, thus establishing the stereochemistry as 
(3S,4R,5R,6R). 
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Figure 7 1H NOE interactions in δ-lactone 527 
 
An X-ray crystal structure of δ-lactone 527 provided unequivocal confirmation of the predicted 











Figure 8 X-Ray crystal structure of δ-lactone 527 
 
2.9 Synthesis of Highly Substituted δ-Lactones with a Synthetic Handle 
Highly substituted δ-lactones are potentially versatile building blocks for the synthesis of 
stereomeric analogues of polyketide natural products. However, the incorporation of building 
blocks containing stereotetrads is simplified if the fragment is bifunctional and orthogonally 
addressable. Therefore, it was decided to synthesise a highly substituted δ-lactone with a 
synthetic handle, using the methodology previously described. A benzyl protected alcohol on 
the R2 substituent of the lactone fragment was chosen as the synthetic handle, since a simple 
deprotection via hydrogenation would furnish an alcohol group that could be functionalised to 
afford a synthon for natural product syntheses. 
 
Asymmetric Synthesis of Chiral δ-Lactones Containing Multiple Contiguous Stereocentres 
101 
The proposed synthesis began with the synthesis of aldehyde 535 (Scheme 101), which would 
subsequently be used in an asymmetric aldol reaction. A literature procedure developed by 
Anderson and co-workers was followed for the synthesis.187 The starting material was 
commercially available (Z)-but-2-ene-1,4-diol 533, which underwent a mono-benzyl protection 
(534) in 73% yield and a Swern oxidation to furnish the cis-aldehyde 535 in 84% yield in a 99:1 
cis:trans ratio. The cis-aldehyde was then used immediately in an asymmetric aldol reaction to 
furnish cis-aldol product 536 in 88% yield. 
 
Reagents and conditions: (i) NaH, DMF then BnBr, -20 ˚C, 5 h then H2O; (ii) (COCl)2, DMSO, CH2Cl2, -55 ˚C, 
15 min then NEt3, 15 min then H2O; (iii) 95, Bu2BOTf, NEt3, CH2Cl2, -10 ˚C, 30 min then -78 ˚C, aldehyde 
535, 45 min, then 0 ˚C, 3 h. 
Scheme 101 Synthesis of cis-aldol product 536 
 
It was also discovered that the trans isomer 537 could be obtained in a 99:1 ratio by stirring 
cis-aldehyde 535 overnight at room temperature in dichloromethane (1 mL) with a catalytic 
quantity of para-toluenesulphonic acid. This was subsequently used as a substrate in a syn-
aldol reaction using the same conditions to afford trans-aldol product 538 in 89% yield. 
 
Reagents and conditions: (i) (COCl)2, DMSO, CH2Cl2, -55 ˚C, 15 min then NEt3, 15 min then H2O. Stir at 
room temperature in CH2Cl2 with p-TSA (cat.) overnight; (iii) 95, Bu2BOTf, NEt3, CH2Cl2, -10 ˚C, 30 min 
then -78 ˚C, aldehyde 537, 45 min, then 0 ˚C, 3 h. 
Scheme 102 Synthesis of trans-aldol product 537 
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Aldol products 536 and 538 underwent cyclopropanation in 89% and 95% yield respectively to 
afford syn-aldol cyclopropane products 539 and 541, which were then transesterified with 
sodium methoxide to furnish methyl esters 540 and 542 in high yield. 
 
Reagents and conditions: (i) Et2Zn, CH2I2, CH2Cl2, 0 ˚C, 2 h.; (ii) NaOMe, CH2Cl2, rt, 5 min. 
Scheme 103 Synthesis of methyl esters 540 and 542 
 
Methyl ester 542 was treated with mercury trifluoroacetate in dichloromethane and was 
stirred for 72 hours at room temperature. The resulting organomercurial δ-lactone 543 then 
underwent reductive demercuration with sodium borohydride in 3.5 M sodium hydroxide in 
methanol for one hour before quenching with 1 M HCl to pH 2. The crude product was purified 
via flash silica chromatography to afford highly substituted δ-lactone 544 in 82% yield as a 
single diastereomer. However, repeating this procedure on cis-cyclopropyl-methyl ester 540 
led to a complex mixture of products. Unfortunately, it appears that this methodology is not 
successful for the ring-opening of cyclopropanes derived from cis-alkene functionality. 
 
Reagents and conditions: (i) Hg(OCOCF3)2, CH2Cl2, rt, 72h; (ii) NaBH4, NaOH (3.5 M), MeOH, rt, 1 h then 1 
M HCl. 
Scheme 104 Synthesis of δ-lactone 544 containing a terminal O-benzyl group as a potential synthetic 
handle 
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2.10 Synthesis of N-Protected (S,S)-2-Aminomethyl-1-Cyclopropanecarboxylic Acid 
The synthetic utility of the retro aldol reaction has been discussed previously in Chapter 1, 
including previous work by the Bull group for the synthesis of cyclopropane carboxaldehydes, 
which can function as chiral building blocks for natural product synthesis (Page 19-21). This 
retro aldol methodology has now been applied to the synthesis of γ-amino acid 549,188 which 
has applications in foldamer science.* Initially, syn-cyclopropyl aldol 541 was treated with 




Reagents and conditions: (i) LiHMDS (2.2 equiv), toluene, 0 ˚C, 3h. 
Scheme 105 Retro aldol reaction to afford chiral cyclopropane-carboxaldehydes 
 
Aldehyde 545 underwent reductive amination with sodium triacetoxyborohydride and 
dibenzylamine to afford amine 546 in 62% yield.189 An attempt to debenzylate 546 under 
transfer hydrogenation conditions led to a 50:50 mixture of 547:548 after Boc protection of 
the amine. However, it was found that treatment of this mixture with Pd(OH)2 in THF under a 
hydrogen atmosphere produced the desired compound 548 in quantitative yield. Finally, 





* Work completed in collaboration with Prof. D.J. Aitken and co-workers. 
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Reagents and conditions: (i) NaBH(OAc)3, Bn2NH, 545, DCE, 4Å MS, rt, 4 h; (ii) Pd/C (10%), 546, HCO2H, 
MeOH, rt, 16 h then Boc2O, NaOH, MeOH, rt, 16 h; (iii) Pd(OH)2/C (20%, 60% wet), THF, H2, rt, 2.5 h; (iv) 
Jones’ reagent, acetone, 0 ˚C, 2 h then rt, 2 h. 
Scheme 106 Synthesis of N-protected (S,S)-2-aminomethyl-1-cyclopropanecarboxylic acid 549 
 
2.11 Total Synthesis of (+)-Prelactone B, E and V 
This novel methodology for the synthesis of δ-lactones was then applied to the synthesis of 
(+)-Prelactone B, E and V 566-568, a series of highly functionalised lactones isolated from 
bafilomycin-producing microorganisms such as Streptomyces griseu.190-191 Their discovery 
supports the hypothesis that polyketide chains are functionalised in an iterative fashion in the 
biosynthesis of macrolides, where they are formed as ‘shunt-end’ metabolites via premature 
cleavage from polyketide synthase. These molecules have been shown to exhibit antibacterial, 
antifungal and immunosuppressive activities as well as ATPase inhibition.192 Many total 
syntheses have been reported.192-194 
 
The first consideration when applying our methodology to the synthesis of this natural product 
series is that the α-position of the Prelactones 566-568 is unsubstituted and therefore R1 = H. It 
is well known that α-unsubstituted enolates lead to poor stereocontrol in the Evans’ aldol 
reaction.195 Therefore, an α-chloro substituent was employed to increase the stereoselectivity 
of the asymmetric syn-aldol addition196 that could be removed at a later stage.197 
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The boron enolate of α-chloropropionyl-N-acyl-oxazolidin-2-one was reacted with 
crotonaldehyde, (E)-pent-2-enal and (E)-4-methylpent-2-enal to afford syn-aldol products 554, 
555 and 556 respectively. This reaction had a propensity to undergo retro aldolisation, 
particularly during purification on silica, possibly due to the stabilising effect of the α-chloro 
substituent on the resulting enolate, which had an impact on the overall yield of these 
reactions. These syn-aldol products underwent directed cyclopropanation using the conditions 
previously described to afford 557-559, followed by dechlorination using zinc dust and 
ammonium chloride in methanol to produce 560-562 in moderate to good yield. The auxiliary 
fragments of 560-562 were removed via methanolysis, and the resulting methyl esters 563-565 
were treated with Hg(OCOCF3)2/NaCl(aq), followed by reductive demercuration with 
NaBH4/NaOH/MeOH, to furnish (+)-Prelactone B, E and V 566-568 in acceptable yields and 




Reagents and conditions: (i) 9-BBNOTf or Bu2OTf, N(
iPr)2Et, CH2Cl2, 0 ˚C, 551-553, -78 ˚C to rt; (ii) Et2Zn, 
CH2I2, CH2Cl2, 0 ˚C, 2 h; (iii) Zn, NH4Cl, MeOH, rt; (iv) NaOMe (0.5 M in MeOH) CH2Cl2, rt, 5 min; (v) 
Hg(OCOCF3)2, CH2Cl2, rt, 24h then aq. NaCl then NaBH4, NaOH (3.5 M), MeOH, rt, 2 min then 1 M HCl 
quench. 
Scheme 107 Total synthesis of (+)-Prelactone B, E and V 566-568 
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2.12 Conclusion 
Novel methodology for the asymmetric synthesis of highly substituted δ-lactones containing 
four contiguous stereocentres from syn-aldol cyclopropanes has been demonstrated. An 
asymmetric aldol reaction followed by the directed cyclopropanation reaction furnishes syn-
aldol cyclopropanes 434 in moderate to high yield, with subsequent removal of the chiral 
auxiliary affording the corresponding methyl ester cyclopropane products 435. The key step 
involves mercury mediated cyclopropane ring-opening of the methyl ester cyclopropanes to 
furnish an intermediate that undergoes concomitant cyclisation to afford organomercurial δ-
lactones 436. These intermediates subsequently undergo reductive demercuration in basic 
sodium borohydride to afford the highly substituted δ-lactones 437. 
Scheme 108 Asymmetric synthesis of chiral δ-lactones containing multiple contiguous stereocentres 
 
The scope of the novel methodology has been investigated, with variation at the R1 and R2 
substituents. A highly substituted δ-lactone with an O-benzyl synthetic handle has also been 
successfully synthesised for use as a building block for natural product synthesis. This novel 
methodology has also been applied to the total synthesis of (+)-Prelactone B, E and V in good 
yield and excellent diastereoselectivity. Uses for this research could potentially include use as 
precursors to generate stereotetrads for natural product synthesis; determination of the 
stereochemistry in unassigned stereotetrad structures for natural products; and preparation of 
unnatural analogues of important polyketides and the synthesis of polyketide libraries.198 
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3 Results and Discussion 




Highly substituted γ-butyrolactones are found as fragments in many natural products that 
display a broad range of biological activity. One of the most relevant examples is Vitamin C, L-
ascorbic acid 569, an essential nutrient that functions as an antioxidant and a cofactor in many 
vital enzymatic pathways. Many naturally occurring γ-butyrolactones also possess interesting 
pharmacological properties such as antibacterial,199-201 antifungal,202-203 anti-inflammatory204 
and cytotoxic205-206 activities. For example, (-)-Stemoamide 570 was isolated from the root of 
Stemona tuberos, which is used in traditional Chinese and Japanese medicine for the 
treatment of respiratory diseases.207-208 Substituted γ-butyrolactones are also responsible for 




Figure 9 Natural products containing γ-butyrolactones fragments 
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Highly substituted γ-butyrolactones have also been utilised as chiral building blocks for the 
synthesis of natural products containing multiple contiguous stereocentres.210-216 For example, 
Tatsuta and co-workers used a highly substituted γ-butyrolactone as a precursor in their total 
synthesis of the tetracyclic antibiotic (-)-Tetrodecamycin 578. Enantiomerically pure lactone 
575 was reduced with lithium borohydride to afford straight chain diol 576 in high yield. This 
underwent a series of well established synthetic procedures to furnish intermediate 577, 
which was used to complete the first total synthesis of the natural product (-)-Tetrodecamycin 
578.217 
 
Reagents and conditions: (i) LiBH4, THF, 65 ˚C, 38 h. 
Scheme 109 Highly substituted γ-butyrolactone 575 as a precursor for the synthesis of (-)-
Tetrodecamycin 578 
 
The ubiquitous nature of trisubtituted γ-butyrolactones in Nature, as well as their versatile 
synthetic utility has led to the development of a wide range of methodology for their 
asymmetric synthesis.218-225 Hydroxy-γ-butyrolactones are an important subset within this 
compound class, and consequently a number of approaches have been established for their 
asymmetric synthesis.226-235 Many of these strategies rely on diastereoselective addition of an 
enolate to an appropriately substituted electrophile.228-229,231 
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3.2 Dihydroxylation Approaches for the Asymmetric Synthesis of Highly 
Substituted Hydroxy-γ-Butyrolactones 
A popular approach is dihydroxylation of β,γ-unsaturated carbonyl systems using osmium 
tetroxide, followed by spontaneous intramolecular lactonisation to afford a γ-butyrolactone 
skeleton.236-241 For example, Shirai and co-workers developed novel methodology for the 
asymmetric synthesis of hydroxy-γ-butyrolactones containing three contiguous stereocentres. 
Lactam 579 was treated with standard Upjohn dihydroxylation conditions of OsO4 and N-
methyl-morpholine-N-oxide (NMO) to afford a diastereomeric mixture of diols 580 and 581, 
which subsequently underwent an acid-catalysed ring switch reaction to afford a mixture of 
trisubstituted-γ-butyrolactones 582 and 583.236 
 
Reagents and conditions: (i) cat. OsO4, NMO, quinuclidine, CH2Cl2, 0 ˚C; (ii) p-TsOH∙H2O, C6H6, rt. 
Scheme 110 Synthesis of trisubstituted γ-butyrolactones 582 and 583 via dihydroxylation followed by an 
acid-catalysed lactonisation reaction 
 
Jenkinson and co-workers have synthesised C-3 and C-4 branched sugar lactones via 
dihydroxylation of Wittig products 584. The best results were obtained using tartaric acid as a 
ligand, which was shown to increase the rate of reaction and alter selectivity. The resultant 
mixture of diols 585 and 586 was separated via column chromatography followed by acid 
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catalysed acetal deprotection and subsequent lactonisation to afford 587 and 588 in good 
yields.237 
 
Reagents and conditions: (i) K2OsO4, NMO, H2O, 
t
BuOH, tartaric acid; (ii) Dowex (50W X8, H
+
), H2O. 
Scheme 111 Synthesis of branched sugar lactones via dihydroxylation methodology 
 
Sharpless and co-workers completed a stereoselective synthesis of both enantiomers of 
Muricatacin using dihydroxylation methodology. Treatment of 589 with AD-mix-α afforded 
lactone 590 in 84% yield, whilst AD-mix-β afforded 591 in 82% yield, both in >95% ee.238 
 
Scheme 112 Total synthesis of (+)- and (-)- Muricatacin 590 and 591 via Sharpless Asymmetric 
Dihydroxylation 
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3.3 Previous Work and Initial Results 
The Bull group have previously shown that β,γ-alkenyl-β-hydroxy-N-acyloxazolidin-2-one 592 
undergoes an epoxidation/lactonisation sequence when treated with catalytic VO(acac)2 and 
tert-butylhydroperoxide to afford highly substituted hydroxy-γ-butyrolactone 595. Initially, the 
epoxidation reaction proceeds with high levels of diastereocontrol to afford unstable 
intermediate 593. This undergoes an intramolecular epoxide ring opening reaction via 
nucleophilic attack of the exocyclic carbonyl of the oxazolidin-2-one fragment through a 
neighbouring group participation mechanism (593) to generate iminium intermediate 594, 
with clean inversion of stereochemistry at the C-5 position. Hydrolysis of iminium intermediate 
594 furnishes the highly substituted hydroxy-γ-butyrolatone 595 in high yield and 
diastereoselectivity with release of the SuperQuat auxiliary 445.242-243 
 
Reagents and conditions: (i) VO(acac)2 (10 mol%), 
tBuOOH, benzene, rt, 12h. 
Scheme 113 Epoxidation/lactonisation sequence to afford hydroxy-γ-butyrolactone 595 
 
Following on from this work, the Bull group decided to investigate another approach using 
Upjohn dihydroxylation conditions,244 with the aim of accessing complementary diastereomers 
of this type of hydroxy-γ-butyrolactone. The epoxidation/lactonisation sequence described 
above leads to inversion of configuration at the C-5 position. However, dihydroxylation of 
alkene 596 was predicted to lead to anti-diastereoselectivity with respect to the β-hydroxyl 
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group to afford unstable triol 597, which would spontaneously lactonise to furnish 
diastereomeric hydroxy-γ-butyrolactone 598 and SuperQuat auxiliary 445.243 
 
 
Reagents and conditions: (i) OsO4 (10 mol%), NMO, acetone:H2O (8:1). 
Scheme 114 Dihydroxylation/lactonisation sequence to afford hydroxy-γ-butyrolactones 598 
 
The stereochemical configuration of hydroxy-γ-butyrolactone 595 produced in the 
epoxidation/lactonisation sequence had previously been unequivocally assigned as (3S,4S,5S) 
using X-ray crystallographic analysis.242-243 The corresponding dihydroxylation/lactonisation 
sequence of β-alkenyl-β-hydroxy-N-acyloxazolidin-2-one 592 was investigated to confirm that 
the configuration at the C-5 position would be inverted, leading to a different diastereomer of 
hydroxy-γ-butyrolactone 595. Aldol 592 was treated with standard Upjohn conditions of 10 
mol% OsO4 and N-methylmorpholine-N-oxide (NMO) in acetone:H2O (8:1) at room 
temperature to afford a new hydroxy-γ-butyrolactone 599 in 69% yield and in >49:1 dr. 
 
 
Reagents and conditions: (i) OsO4 (10 mol%), NMO, acetone:H2O (8:1). 
Scheme 115 Dihydroxylation/lactonisation sequence of unsaturated aldol 592 to afford hydroxy-γ-
butyrolactone 599 with strong 
1
H NOE interactions in 599 confirming stereochemistry 
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1H NOE spectroscopic analysis was used to assign the stereochemical configuration of the new 
hydroxy-γ-butyrolactone 599. This revealed a strong interaction between the C-3 proton and 
the methylene protons of the C-5 ethyl group, as well as a strong interaction between the C-4 
proton and the C-5 CH2OH methylene protons, indicating a (3S,4S,5R) configuration. This 
stereochemical assignment is consistent with the expected anti-diastereoselectivity of the 
dihydroxylation of unsaturated aldol 592 with respect to the β-hydroxyl group. 
 
Therefore, the epoxidation/lactonisation sequence of unsaturated aldol 592 leads to 
(3S,4S,5S)-hydroxy-γ-butyrolactone 595. However, application of the 
dihydroxylation/lactoniation methodology to the same unsaturated aldol product 592 leads to 
(3S,4S,5R)-hydroxy-γ-butyrolactone 599, which is the complementary C-5 diastereoisomer. The 
Bull group have previously focused on the synthesis of this type of hydroxy-γ-butyrolactone 
with variation at both the α-position and of the alkene substituents. However, no direct 
comparison has been carried out for dihydroxylation of different isomers of alkene with the 
same substituents.243 
 
This chapter will therefore focus on a direct comparison between dihydroxylation reactions of 
alkenes containing different substitution patterns for the synthesis of functionalised hydroxy-
γ-butyrolactones containing multiple contiguous stereocentres, with the major 
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3.4 Asymmetric Synthesis of Unsaturated syn-Aldol Products 
A series of aldol products was prepared according to the methodology previously described in 
Chapter 2. The alkene geometry of the unsaturated aldol products was varied using the same 
substitutents in order to investigate the effect of the alkene substitution pattern on the 
stereochemical outcome of the dihydroxylation/lactonisation reaction. The CH2OBn group was 
chosen as a suitable substituent since both cis- and trans-alkenes could be accessed using the 
methodology previously described in Chapter 2. The resultant lactones containing a terminal 
O-benzyl fragment represent particularly useful synthetic building blocks for the synthesis of 
polyketide synthetic targets.143 
 
Reagents and conditions: (i) Bu2BOTf/ 9-BBNOTf, N(
iPr)2Et/NEt3, CH2Cl2, 0 ˚C then aldehyde 600, -78 ˚C. 
Scheme 116 Synthesis of α,β-unsaturated syn-aldol products 601 
 
The synthesis of non-commercially available aldehydes was carried out using established 
literature procedures. Aldehyde 604 was synthesised in three steps from butane-1,4-diol 602. 
Mono-benzyl protection of 602 followed by Swern oxidation, produced aldehyde 603 in 75% 
yield. This was treated with 37% aqueous formaldehyde solution and dimethylamine 
hydrochloride in a Mannich/elimination type reaction to furnish 4-(benzyloxy)-2-
methylenebutanal 604 in 78% yield.245 
 
 
Reagents and conditions: (i) NaH, BnBr, THF, reflux then H2O; (ii) (COCl)2, DMSO, CH2Cl2, -55 ˚C, 15 min 
then NEt3, 15 min then H2O; (iii) CH2O (37% solution in H2O), NEt2H∙HCl, 70 ˚C, 24 h. 
Scheme 117 Synthesis of aldehyde 604 
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Aldehyde 610 was synthesised from 2-(benzyloxy)ethanol 605 in four steps following a 
literature procedure.246 Swern oxidation of 605 produced aldehyde 606 in 91% yield, which 
was treated with (carbethoxyethylidene)triphenylphosphorane 607 in a Horner-Wadsworth-
Emmons reaction to afford 608 in 65% yield. Reduction of ester 608 with DIBAL followed by 




Reagents and conditions: (i) (COCl)2, DMSO, CH2Cl2, -55 ˚C, 15 min then NEt3, 15 min then H2O; (ii) 607, 
CH2Cl2, 0 ˚C, 30 min; (iii) DIBAL, Et2O, -78 ˚C, 1 h then 0 ˚C, 1 h; (iv) (COCl)2, DMSO, CH2Cl2, -55 ˚C, 15 min 
then NEt3, 15 min then H2O. 
Scheme 118 Synthesis of aldehyde 610 
 
The synthesis of (E)-4-(benzyloxy)but-2-enal 537 and (Z)-4-(benzyloxy)but-2-enal 535187 and 




























































































aχp refers to SuperQuat auxiliary; 
bisolated yield after column chromatography 
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3.5 Upjohn Dihydroxylation 
The Upjohn dihydroxylation reaction was first reported in 1976 for the preparation of cis-1,2-
diols from alkenes using catalytic osmium tetroxide and stoichiometric N-methyl-morpholine-
N-oxide (NMO) as the re-oxidant. It was developed as an alternative to using stoichiometric 
quantities of toxic, volatile and expensive osmium tetroxide.244 It is one of the most widely 
used reactions in organic synthesis due to its mildness, generality and specificity.247 
 
Scheme 119 General Upjohn dihydroxylation 
 
3.5.1 Mechanism of Upjohn Dihydroxylation 
Osmium tetroxide 619 adds across the alkene bond 617 in a [3+2] cycloaddition reaction, 
generating an osmate ester 620, which is subsequently hydrolysed with two equivalents of 
water 621 to afford a cis-1,2-diol 618 and reduced dihydroxydioxoosmium 622. This osmium 
species is re-oxidised by NMO 623, which regenerates the osmium tetroxide catalyst 619. 
 
Scheme 120 Mechanism of the Upjohn dihydroxylation 
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The mechanism of the reaction is controversial and has been the subject of intense 
investigation.247 Until recently, there was disagreement between two proposed pathways. 
Originally, Criegee proposed a concerted [3+2] cycloaddition of the O=Os=O bond to the 
alkene bond to form an osmate ester 620.248 In 1977, Sharpless challenged this mechanism by 
proposing a stepwise [2+2] cycloaddition of the alkene bond to the Os=O bond to form an 
osmaoxetane ester 625, which subsequently rearranges to produce the five membered cyclic 
osmate ester 620 in the rate determining step.249 
 
 
Scheme 121 Proposed [2+2] cycloaddition pathway of Upjohn dihydroxylation 
 
It has subsequently been shown in several studies that the concerted [3+2] cycloaddition is the 
favoured pathway. It has been shown that the high activation barrier of the [2+2] cycloaddition 
makes it highly improbable,250-252 with this conclusion being supported by computational 
modelling253 and experimental kinetic isotope effects.254 
 
3.5.2 Synthesis of Highly Substituted Hydroxy-γ-Butyrolactones 
Unsaturated syn-aldol products 613-616, 536, 538 were treated with catalytic osmium 
tetroxide and stoichiometric N-methyl-morpholine-N-oxide (NMO) in acetone:H2O (8:1) at 
room temperature. The resulting mixture was stirred for twenty four hours, filtered through 
Celite® and purified via flash column chromatography to afford a series of hydroxy-γ-
butyrolactones 632-637 in good yield and generally high diastereoselectivity (Table 8).
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aχp refers to SuperQuat auxiliary. 
bMajor diastereoisomer formed. cConfiguration of hydroxy-γ-
butyrolactones confirmed by 
1
H NOE spectroscopic analysis. 
d
Determined by analysis of the crude 
1
H 
NMR spectra. eIsolated yields after purification by column chromatography.  
Table 8 Dihydroxylation of aldols 613-616, 536, 538 to afford hydroxy-γ-butyrolactones 632-637 
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The stereochemical configuration of each of the hydroxy-γ-butyrolactones 632-637 was 
determined by 1H NOE spectroscopic analysis and X-ray crystallography, as well as by 
comparison with literature precedent for each of the alkene substitution patterns. In depth 
analysis of how the configuration of these lactones was assigned is discussed in the next 
section of this chapter. 
 
Reaction of acrolein aldol 613 under Upjohn dihydroxylation conditions provided a 3:1 mixture 
of diastereomers in 79% yield, the major diastereomer 632 being formed with anti-
diastereocontrol. It was found that dihydroxylation/lactonisation reaction of 1,1-disubstituted 
aldol 614 proceeded with good levels of anti-diastereoselectivity to afford hydroxy-γ-
butyrolactone 633 in a 10:1 mixture of diastereomers and 87% yield. A noticeable difference in 
selectivity was observed between dihydroxylation of 1,2-trans-disubstituted aldol 538 and 1,2-
cis-disubstituted aldol 536, with the trans-system giving a higher level of anti-
diastereoselectivity than the cis-system. 1,2-trans-Disubstituted aldol 538 underwent 
dihydroxylation/lactonisation to form hydroxy-γ-butryolactone 634 in 77% yield with a 4:1 
diastereomeric ratio. Conversely, 1,2-cis-disubstituted aldol 536 was found to undergo 
dihydroxylation/lactonisation with poor levels of diastereocontrol in a 2:1 mixture in favour of 
the anti-diastereomer 635 in 74% yield, with the opposite C-6 configuration to that observed 
for reaction of the 1,2-trans-disubstituted aldol 538. Pleasingly, reaction of (E)-1,1,2-
trisubstituted aldol 615 produced excellent levels of anti-diastereoselectivity, providing 
hydroxy-γ-butyrolactone 636 in 93% yield as a single diastereomer in a >49:1 ratio. However, 
the dihydroxylation reaction of 1,2,2-trisubstituted aldol 616 proceeded with reduced 
diastereoselectivity resulting in a 5:1 mixture, with the major hydroxy-γ-butyrolactone 637 
having the opposite C-5 configuration to that observed for previous examples. Consequently, 
the 1,2,2-trisubstituted aldol 616 preferentially undergoes dihydroxylation with syn-
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3.6 Assignment of Stereochemistry of Hydroxy-γ-Butyrolactones 
3.6.1 Literature Examples 
There are numerous examples of Upjohn dihydroxylation reactions in the literature and the 
topic has been extensively reviewed.173,255-258 It has been shown that 1-monosubstituted,259-260 
1,1-disubstituted,261 1,2-trans-disubstituted,259-260 and 1,1,2-trisubstituted262 alkene systems 





Scheme 122 Literature examples of Upjohn dihydroxylation reactions of allylic alcohols with different 
alkene substitution patterns giving anti-diastereoselectivity 
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However, 1,2-cis-disubstituted259-260 and 1,2,2-trisubstituted259-260 alkene systems have been 
shown to undergo dihydroxylation with modest levels of syn-diastereoselectivity. 
 
 
Scheme 123 Literature examples of Upjohn dihydroxylation reactions of allylic alcohols with different 
alkene substitution patterns giving syn-diastereoselectivity 
 
3.6.2 Stereochemical Models 
Several models have been proposed to predict and rationalise the observed 
diastereoselectivity of osmium catalysed dihydroxylation reactions of allylic alcohols.261,263 
These include models described by Kishi,264-265 Houk184,266-268 and Vedejs.269-270 All of these 
stereochemical models are based on the assumption that the step that determines product 
diastereoselectivity involves competitive attack of the osmium reagent onto one of the two 
faces of the alkene, in an irreversible [3+2] cycloaddition to produce an osmate ester.263 
 
 
Figure 10 Proposed stereochemical models for anti-diastereoselectivity in OsO4 dihydroxylation 
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Kishi proposed an empirical model based on minimisation of both A1,3 strain and electrostatic 
repulsion between the OsO4 and the C-O bond. Allylic strain is minimised by positioning the 
smallest substituent (HA) of the stereogenic centre parallel to the double bond. The OsO4 then 
approaches from the opposite side to the C-O bond to avoid electrostatic repulsion between 




Scheme 124 Kishi model for anti-diastereoselectivity in dihydroxylation of allylic alcohols 
 
Houk used computational techniques in an extension of the transition state model developed 
to rationalise the stereochemical outcome of nitrile oxide cycloadditions.267 Houk suggested an 
‘inside alkoxy’ model,271 in which the hydroxyl group is directed towards the incoming OsO4 
reagent. The alkyl substitutent R1 is positioned anti to the attacking oxidant to avoid steric 
hindrance. Houk calculated that this conformation is the lowest energy state because 
electrostatic repulsions between the electron rich alkoxy group and the unfavourable σ/π 
interactions of the alkene are minimised. It follows that as the size of R1 increases, the 
diastereoselectivity also increases, with this model predicting anti diastereoselectivity.184,266-268 
 
 
Scheme 125 Houk model for anti-diastereoselectivity in dihydroxylation of allylic alcohols 
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Vedejs suggested that steric interactions between the substrate and the oxidant are dominant 
in determining the diastereoselectivity. The favoured transition state positions the smallest 
substituent (HA) perpendicular to the alkene diastereoface undergoing dihydroxylation. The 
large alkyl substitutent R1 is placed on the opposite face of OsO4 attack to minimise steric 
hindrance. The stereogenic proton (HA) minimises steric interactions with the incoming OsO4 
and consequently this model also predicts anti-diastereoselectivity.263,269-270 
 
 
Scheme 126 Vedejs model for anti-diastereoselectivity in dihydroxylation of allylic alcohols 
 
Although a vast number of highly diastereoselective substrate directed dihydroxylations have 
been reported, the stereocontrol is yet to be fully understood. The use of a single model is 
insufficient as it does not succeed in predicting the stereochemical outcome for 
dihydroxylation of all alkene substitution patterns.263 For example, Evans found disagreement 
between Kishi’s model and experimental data on the dihydroxylation of 1,1-disubstituted 
alkenes.261 It was observed that the diastereoselectivity increases as the size of the R1 alkyl 
group increases, which directly contradicts the Kishi model prediction. Therefore, Evans 
suggested that this data set is better explained using the model proposed by Houk.261 
 
Rationalising the diastereoselectivity of 1,2-cis-disubstitited alkenes is also problematic.263 
Kishi reported enhanced anti-diastereoselectivity for 1,2-cis-disubstituted alkenes compared 
with 1,2-trans-disubstituted alkenes.263-265 However, Donohoe found that 1,2-cis-disubstituted 
systems gave syn-diastereoselectivity.260 These observations are hard to explain using the 
models previously described. Donohoe proposed that the Kishi model may be used if the OsO4 
approaches from the same side as the free hydroxyl group. This is further enhanced if the alkyl 
group R1 is large, which may allow steric interactions to override electronic factors.260 
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Scheme 127 Modified Kishi model for syn-diastereoselectivity in dihydroxylation of cis-alkenes 
 
Another consideration is that many experimental observations leading to these models are 
based on dihydroxylation of protected allylic alcohols, and relatively little work has been 
undertaken on unprotected allylic alcohols.260 Therefore, it was decided that evaluation of the 
steric and electronic features of any given substrate would need to be analysed on an 
individual basis to predict the stereochemical outcome of dihydroxylation.263 
 
3.6.3 1H NOE Spectroscopic Analysis 
The stereochemistry of hydroxy-γ-butyrolactones 632-637 was assigned using 1H NOE 
spectroscopy and the conclusions then compared with literature examples for the 
dihydroxylation of each type of substitution pattern. 
 
Figure 11 Strong interactions in the 1H NOE spectra of the hydroxy-γ-butyrolactones (632-637) 
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The 1H NOE spectrum of hydroxy-γ-butyrolactone 632 derived from 1-monosubstituted aldol 
613 showed strong interaction between the C-3 proton and the C-5 proton, confirming these 
protons lie on the same face of the lactone ring. There is also a strong interaction between the 
C-4 proton and the C-5 CH2OH methylene protons, indicating a (3S,4S,5R) configuration. This 
assignment is consistent with anti-diastereoselectivity observed in literature examples of 
osmium catalysed dihydroxylations for this type of alkene substitution pattern.259-260 
 
The stereochemistry of hydroxy-γ-butyrolactone 633, derived from 1,1-disubstitued aldol 614, 
was unequivocally determined to be (3S,4S,5R) through X-ray crystallographic analysis (Figure 
12). Additionally, the 1H NOE spectrum of this lactone revealed strong interactions between 
the C-3 proton and C-5 methylene protons of the O-benzyl substituent, as well as between the 
C-3 methyl protons and the C-5 CH2OH methylene protons, confirming the configuration of the 
C-5 stereocentre. This assignment is also consistent with the literature precedent for anti-
diastereoselective dihydroxylation of 1,1-disubstituted alkenes by Evans and co-workers.261 
 
 
Figure 12 X-ray crystal structure of (3S,4S,5R)-633 
 
The 1H NOE spectrum of hydroxy-γ-butyrolactone 634, derived from 1,2-trans-disubstituted 
aldol 538, showed strong interaction between the C-3 proton and the C-5 proton, confirming 
these protons lie on the same face of the lactone ring. The stereochemistry was assigned as 
(3S,4S,5S), which corresponds to an anti-diastereoselective dihydroxylation and this is 
supported by the literature examples reported by Donohoe and co-workers.259-260 
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The 1H NOE spectrum for the major diastereomer 635 from the dihydroxylation/lactonisation 
of 1,2-cis-disubstituted alkene 536 revealed a strong interaction between the C-3 proton and 
C-5 proton, proving that these protons are on the same face of the lactone. Therefore, the 
stereochemistry was assigned as (3S,4S,5S), which corresponds to anti-diasteroselectivity. This 
is in contrast with the findings of Donohoe and co-workers, who found that simple 1,2-cis-
disubstituted allylic alcohols gave low levels of syn-diastereoselectivity in a 2:1 mixture using 
Upjohn conditions.259-260 However, the low levels of diastereoselectivity observed in both cases 
suggests that the directing effects of the allylic alcohol in 1,2-cis-disubstituted systems is 
limited, so it is therefore not surprising that different substrates result in different selectivities 
with poor diastereomeric ratios.259-260 
 
The 1H NOE spectrum of hydroxy-γ-butyrolactone 636 from aldol 615 showed strong 
interactions between protons C-3 and C-5 methyl protons as well as between C-3 methyl group 
and C-5 CHOH proton, leading to a stereochemical assignment of (3S,4S,5S) corresponding to 
anti-diastereoselectivity. The high levels of anti-diastereoselectivity of >49:1 are consistent 
with results for the dihydroxylation of (E)-1,1,2-trisubstituted systems in the literature.262 
 
The stereochemistry of the major diastereomer 637 of the dihydroxylation/lactonisation 
reaction of 1,2,2-trisubstituted aldol 616 was determined as (3S,4S,5R), which corresponds to 
syn-diastereoselectivity. The 1H NOE spectrum showed a strong interaction between methyl 
protons on the C-3 and C-5 proton, proving that these protons lie on the same face of the 
lactone ring. This observation is consistent with results published by Donohoe and co-workers 
for the dihydroxylation 1,2,2-trisubstituted allylic alcohols.259-260 The 1H NMR spectrum of the 
major diastereomer revealed a vicinal coupling constant between protons on C-4 and C-5 of 3J 
= 7.4 Hz, which is indicative of a syn-relationship between these protons. Conversely, the 1H 
NMR spectrum of the minor diastereomer showed a vicinal coupling constant between the C-3 
proton and the C-5 proton of 3J = 4.0 Hz, which is consistent with an anti-relationship between 
these protons in this diastereoisomer. 
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3.7 Reassignment of Literature Published by Dias and Co-workers 
Dias and co-workers had previously described the dihydroxylation/lactonisation of a small 
series of closely related Evans derived γ-alkenyl-O-silyl aldol products (638-641).239 
Surprisingly, the configuration of the resulting O-silyl-γ-butyrolactones (642-645) was reported 
as (3S,4S,5S), which was different to the results we had obtained. Remarkably, lactones 647 
and 649 as reported must have arisen from an unprecedented antarafacial dihydroxylation 
reaction occurring with syn-diastereoselectivity to the β-O-silyl hydroxyl group (Scheme 128). 
 
 
Scheme 128 Dias and co-workers’ dihydroxylation/lactonisation of O-TBS protected unsaturated aldols 
638-641 
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This led the Bull group to investigate the effect of the O-silyl group on these type of 
dihydroxylation/lactonisation reactions.243 Therefore, unsaturated aldol 592 was O-TBS 
protected using TBS-OTf and 2,6-lutidine and subjected to the standard Upjohn 
dihydroxylation/lactonisation conditions, resulting in the O-TBS γ-butyrolactone 651 in a 3:1 
dr. This mixture was then deprotected using TBAF to provide hydroxy-γ-butyrolactone 599 in 
65% yield and 3:1 dr (Scheme 129). The 1H, 13C, and NOE spectra were identical to those of the 




Reagents and conditions: (i) OsO4 (10 mol%), NMO, acetone:H2O (8:1); (ii) TBAF, CH2Cl2. 
Scheme 129 Dihydroxylation/lactonisation of unprotected aldol 592 and O-TBS aldol 650 afford the 
same major diastereoisomer of hydroxy-γ-butyrolactone 599 
 
In light of this result, it was proposed that both the free hydroxyl and O-silyl protected 
unsaturated aldol derivatives of 592 undergo dihydroxylation with anti-diastereoselectivity to 
the stereodirecting group. Therefore, it is suggested that the stereochemical assignments of 
the O-silyl-γ-butyrolactones (646-649) previously reported by Dias and co-workers are 
incorrect and propose that the configuration of these lactones should be reassigned as shown 
in Scheme 130. 
 
It should be noted that Dias and co-workers subsequently reported formation of (3S,4S,5R)-
stereochemistry for γ-butyrolactone 646 derived from the dihydroxylation/lactonisation of 
aldol 638, which was used for a natural product synthesis.272 This assignment is different to 
that reported in their original paper, but is consistent with our results. 
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3.8 Improving the Diastereoselectivity - Sharpless Asymmetric Dihydroxylation 
Upjohn dihydroxylation conditions followed by concomitant lactonisation gave high levels of 
diastereoselectivity for the majority of alkene substitution patterns described. However, 1,2-
cis-disubstituted aldol 536 resulted in a disappointing 2:1 mixture of diastereomers in favour of 
anti-diastereoselectivity. Therefore, it was proposed that Sharpless asymmetric 
dihydroxylation conditions273-274 should be investigated to try to improve the 
diastereoselectivity of this reaction. 
 
3.8.1 Sharpless Asymmetric Dihydroxylation – AD mix 
Sharpless asymmetric dihydroxylations are usually performed with pre-mixed reagents known 
as AD-mix. The components of this mixture are K2OsO2(OH)4, K3Fe(CN)6, K2CO3 and a chiral 
quinine ligand. The K2Os2(OH)4 acts as a source of OsO4, which is generated in situ. Potassium 
ferricyanide functions as the re-oxidant in the catalytic cycle and potassium carbonate as a 
buffer. Coordination of the chiral amine ligands, (DHQD)2PHAL 656 and (DHQ)2PHAL 657, to 
the osmium catalyst leads to formation of a chiral complex, which can distinguish between the 
pro-chiral faces of the alkene substrate, resulting in enantioselective cis-diol formation on one 
face of the alkene in preference to the other. These chiral ligands 656 and 657 consist of two 
naturally derived dihydroquinine alkaloid units linked together by a phthalazine linker. AD-mix-
α contains (DHQ)2PHAL and AD-mix-β contains (DHDQ)2PHAL, with a catalytic quantity of OsO4 
sometimes being added to initiate the dihydroxylation reaction.275 
 
 
Figure 13 Chiral quinine ligands in AD-mix for Sharpless Asymmetric Dihydroxylation 
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3.8.2 Sharpless Asymmetric Dihydroxylation – Predicting the Enantioselectivity 
The enantioselectivity of the Sharpless asymmetric dihydroxylation can be predicted using the 




Scheme 131 Stereochemical mnemonic for predicting enantioselectivity of Sharpless asymmetric 
dihydroxylation with AD-mix 
 
The model is best suited to predicting the enantioselectivity of dihydroxylation reactions of 
trans-alkenes, but cannot usually be used to predict the stereoselective outcome of the 
dihydroxylation of 1,2-cis-disubstituted alkenes.256,276 Indeed, it is notoriously difficult to obtain 
high levels of enantioselectivity for the dihydroxylation of simple 1,2-cis-disubstituted alkenes. 
However, Sharpless found that cis-1,2-disubstituted alkenes undergo dihydroxylation with AD-
mix in comparable levels of enantioselectivity with that observed for other substitution 
patterns if a free allylic alcohol is present. It was proposed that hydrogen bonding by a free 
hydroxyl group to the oxo group on the osmium species may be responsible for the enhanced 
enantioselection observed for allylic alcohols.277-278 Sharpless suggested that the 
stereochemical mnemonic should be altered for 1,2-cis-disubstituted alkenes if the RL group is 
substituted for a hydrogen group.277-278 
 
3.8.3 Sharpless Asymmetric Dihydroxylation of 1,2-cis-Disubstituted Aldol 536 
The substrate directed Upjohn conditions led to a dihydroxylation/lactonisation sequence to 
afford lactone 635 in a 2:1 mixture, the major diastereomer of which corresponded to anti-
diastereoselectivity with respect to its β-hydroxyl group. In an attempt to improve this, aldol 
536 was treated with AD-mix in a 1:1 mixture of tert-butanol and water along with 
methylsulfonamide, an additive shown to increase the rate of reaction.275 However, the 
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reaction was only initiated once an equal volume of dichloromethane was added to aid 
solubility and a catalytic amount of OsO4 was added.  
 
Treatment of cis-1,2-disubstituted aldol 536 with AD-mix-β led to an enhancement of 
stereochemistry observed for dihydroxylation under Upjohn conditions, to afford hydroxy-γ-
butyrolactone 635 in a 17:1 mixture of diastereomers and 95% yield in favour of the anti- 
product. Pleasingly, treatment of aldol 536 with AD-mix-α led to reversal of 
diastereoselectivity compared with the Upjohn dihydroxylation conditions to afford a 1:4 
mixture of diastereomers, with the major lactone 658 being formed as the result of 
dihydroxylation with syn-diastereoselectivity with respect to the β-hydroxyl group of 536. 
 
 
Scheme 132 Sharpless asymmetric dihydroxylation of cis-1,2-disubstituted aldol 536 
 
These results are consistent with those obtained by Sharpless and co-workers on the 
dihydroxylation of a simplified (Z)-O-benzyl allylic alcohol.277-278 The diastereoselectivity 
expected using the stereochemical model for cis-1,2-disubstituted alkenes shows that 
dihydroxylation with AD-mix-β is the ‘matched’ reaction and should lead to anti-
diastereoselectivity. The mnemonic predicts that dihydroxylation with AD-mix-α is the 
‘mismatched’ reaction and therefore should have a preference for syn-diastereoselectivity. 
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However, it has been shown using Upjohn dihydroxylation that the substrate already has a 
preference for anti-diastereoselectivity. Therefore, it was surprising that the ‘mismatched’ 




Scheme 133 Modified stereochemical mnemonic for predicting enantioselectivity of Sharpless 
asymmetric dihydroxylation for 1,2-cis-disubstituted aldol 536 
 
Fortunately, the hydroxy-γ-butyrolactones 635 and 658 were separable using flash column 
chromatography. This allows either diastereomer of lactone to be prepared and isolated in 
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3.9 Total Synthesis of 2-Deoxy-D-Ribonolactone 
The synthetic utility of the dihydroxylation/lactonisation methodology was then demonstrated 
for the synthesis of 2-Deoxy-D-ribonolactone 663, which is a by-product of oxidative DNA 
damage.279-280 It has been synthesised several times previously281-284 and has also been shown 
to be a useful synthetic precursor.285-289 2-Deoxy-D-ribonolactone 663 is also of interest 
because its nucleoside derivatives can potentially act as a universal base and non-hydrogen 
bonding isosteres of nucleobases for chemical biology applications.290 Therefore, α-
chloropropionyl-N-acyl-oxaolidin-2-one 660 was treated under Evans’ asymmetric aldol 
conditions with acrolein 611 to afford syn-aldol 661 in a 45% yield and in >95% de. This 
underwent dechlorination with zinc dust and ammonium chloride in methanol to provide the 
allylic alcohol 662 in 82% yield.197 Allylic alcohol 662 was then subjected to the standard 
Upjohn dihydroxylation/lactonisation conditions to afford 2-Deoxy-D-ribonolactone 663 as a 
9:1 mixture of diastereoisomers in 87% yield. The spectroscopic data of 663 was consistent 
with that reported previously.281-284 
 
 
Reagents and conditions: (i) Bu2OTf, N(
iPr)2Et, CH2Cl2, 0 ˚C, 611, -78 ˚C to rt; (ii) Zn, NH4Cl, MeOH, rt; (iii) 
OsO4 (10 mol%), NMO, acetone:H2O (8:1). 
Scheme 134 Asymmetric synthesis of 2-Deoxy-D-ribonolactone 663 
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3.10 Conclusion 
A method of preparing hydroxy-γ-butyrolactones (632-637) containing multiple contiguous 
stereocentres in high yield with good diastereoselectivity has been developed. Osmium 
tetroxide mediated dihydroxylation of a range of β-alkenyl-β-hydroxy-N-acyloxazolidin-2-ones 
(613-616, 536, 538) results in formation of triols that undergo spontaneous intramolecular 5-
exo-trig cyclisation reactions to afford hydroxy-γ-butyrolactones. 
 
 
Scheme 135 Dihydroxylation/lactonisation method for the asymmetric synthesis of highly substituted 
hydroxy-γ-butyrolactones 
 
The configurations of the resulting hydroxy-γ-butyrolactones (632-637) were established using 
1H NOE spectroscopic analysis, which revealed that the diastereoselectivity of these directed 
dihydroxylation reactions is dependent on the alkene substitution pattern. It was found that 1-
substituted, 1,1-disubstituted, (E)-1,2-disubstituted, (Z)-1,2-disubstituted, and 1,1,2-
trisubstituted alkenes undergo dihydroxylation with anti-diastereoselectivity to their β-
hydroxyl groups, whereas a 1,2,2-trisubstituted alkene gave the syn-diastereoisomer. 
 
Sharpless asymmetric dihydroxylation conditions were employed to improve the poor levels of 
diastereoselectivity observed for the dihydroxylation/lactonisation of the (Z)-1,2-disubstituted 
aldol (536). The synthetic utility of this directed dihydroxylation/lactonisation methodology 






All reactions were performed under a nitrogen atmosphere using starting materials and 
solvents obtained from commercial sources without further purification. Chemicals were 
purchased from Acros Organics, Sigma-Aldrich, Alfa Aesar and Fluka. Dry solvents were 
obtained from an Innovative Technology Inc. PS-400-7 solvent purification system. Petrol 
refers to petroleum ether boiling at 40-60 ˚C. 
 
1H and 13C NMR spectra were recorded on a Brüker Advance 250 MHz or a Brüker Advance 300 
MHz spectrometer at 303K. The spectra were recorded in CDCl3 solution with chemical shifts 
reported relative to the residual CDCl3 as an internal standard. Chemical shift is reported in 
parts per million (ppm) and all coupling constants, J, are reported in Hertz (Hz). The multiplicity 
of the signals is designated by the following abbreviations: s, singlet; d, doublet; t, triplet; q, 
quartet; m, multiplet; dd, doublet of doublets; dt, doublet of triplets; dq, doublet of quartets; 
dhep, doublet of heptets; ddd, doublet of doublet of doublets; ddt, doublet of doublet of 
triplets; dtd, doublet of triplet of doublets; ddq; doublet of doublet of quartets; td, triplet of 
doublets; tq, triplet of quartets; qd, quartet of doublets; quin, quintet; sex, sextet; hep, heptet. 
Diastereomeric excesses (de) were determined by crude 1H NMR spectra analysis, with >95% 
de reported where the minor diastereoisomer was undetectable. 
 
Thin layer chromatography was performed using aluminium backed plates coated with Merck 
Kieselgel 60 GF254 or Macherey-Nagal SilG/UV254 nm silica gel. Plates were visualised under UV 
light (254 nm) and stained with phosphomolybdic acid or potassium permanganate followed 
by heating. Normal phase flash silica column chromatography was performed using Fisher 60Å 
silica gel (35-70 μm). Infra-red spectra were recorded on a PerkinElmer 100 FT-IR 
spectrometer. Spectra were recorded as thin films. Mass spectra were recorded using an 
electrospray Time-of-Flight MicroTOFTM mass spectrometer. Masses were recorded in either 
positive or negative mode. Samples were introduced as either flow injection or syringe pump. 
Samples were diluted with HPLC grade acetonitrile or methanol. Capillary melting points were 
determined on a Büchi 535 melting point apparatus and are reported uncorrected. Optical 
rotations were recorded on an Optical Activity Ltd AA-10 automatic polarimeter with a path 




4.1 Compounds from Chapter 2 
4.1.1 Synthesis of N-Acyl-Oxazolidin-2-ones 95, 471-473, 515 
(S)-4-Benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one, 95242 
 
n-BuLi (6.43 mL, 16.0 mmol, 2.5 M solution in hexane) was added to a solution of (S)-4-benzyl-
5,5-dimethyloxazolidin-2-one 445 (3.00 g, 14.6 mmol) in dry THF (90 mL) at -78 ˚C under 
nitrogen and was stirred for 30 minutes. Propionyl chloride (1.40 mL, 16.0 mmol) was added in 
one portion and the resulting solution was stirred for a further two hours. The reaction was 
quenched with saturated ammonium chloride and allowed to warm to ambient temperature. 
The THF was evaporated under reduced pressure, the resulting oil was redissolved in 
dichloromethane and extracted with brine. The combined organic extracts were dried over 
MgSO4 and concentrated to afford crude product. The crude product was purified via 
recrystallisation from diethyl ether and hexane to afford (S)-4-benzyl-5,5-dimethyl-3-
propionyloxazolidin-2-one 95 (3.52 g, 13.4 mmol) as a white solid in 92% yield. 1H NMR (300 
MHz, CDCl3) δH = 7.31-7.17 (5H, m, Ph), 4.48 (1H, dd, J = 9.6, 3.9 Hz, CHN), 3.12 (1H, dd, J = 
14.3, 3.9 Hz, CHHAHBPh), 2.94-2.81 (3H, m, CHAHBPh and COCH2), 1.34 (3H, s, C(CH3)(CH3)), 1.33 
(3H, s, C(CH3)(CH3)), 1.12 (3H, t, J = 7.33 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3) δC = 174.4, 
152.8, 137.1, 129.2, 128.8, 126.9, 82.3, 63.6, 35.5, 29.5, 28.7, 22.4, 8.5; IR cm-1 ν = 1765 
(C=Oox), 1703 (C=O); HRMS: m/z (ES) 262.1446, C15H20NO3 [M+H]
+ requires 262.1443; 
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n-BuLi (1.71 mL, 4.29 mmol, 2.5 M solution in hexane) was added to a solution of (S)-4-benzyl-
5,5-dimethyloxazolidin-2-one 445 (0.80 g, 3.90 mmol) in dry THF (30 mL) at -78 ˚C under 
nitrogen and was stirred for 30 minutes. Isovaleryl chloride (0.52 mL, 4.29 mmol) was added in 
one portion and the resulting solution was stirred for a further two hours. The reaction was 
quenched with saturated ammonium chloride and allowed to warm to ambient temperature. 
The THF was evaporated under reduced pressure, the resulting oil was redissolved in 
dichloromethane and extracted with brine. The combined organic extracts were dried over 
MgSO4 and concentrated to afford crude product. The crude product was purified using flash 
silica chromatography [CH2Cl2, Rf 0.71] to afford (S)-4-benzyl-5,5-dimethyl-3-(3-
methylbutanoyl)oxazolidin-2-one 471 (0.81 g, 2.80 mmol) as a colourless oil that solidified on 
standing in 72% yield. 1H NMR (300 MHz, CDCl3) δH = 7.31-7.17 (5H, m, Ph), 4.49 (1H, dd, J = 
9.5, 3.9 Hz, CHN), 3.11 (1H, dd, J = 14.3, 3.9 Hz, CHHAHBPh), 2.89-2.77 (3H, m, CHHAHBPh and 
COCH2), 2.13 (1H, hep, J = 6.8 Hz, CH(CH3)2), 1.34 (3H, s, C(CH3)(CH3)), 1.33 (3H, s, C(CH3)(CH3)), 
0.95 (3H, d, J = 1.5 Hz, CH(CH3)(CH3)), 0.93 (3H, d, J = 1.5 Hz, CH(CH3)(CH3)); 
13C NMR (75 MHz, 
CDCl3) δC = 173.0, 152.7, 137.1, 129.1, 128.8, 126.9, 82.1, 63.5, 44.1, 35.5, 28.6, 25.2, 22.6, 

















n-BuLi (1.71 mL, 4.29 mmol, 2.5 M solution in hexane) was added to a solution of (S)-4-benzyl-
5,5-dimethyloxazolidin-2-one 445 (0.80 g, 3.89 mmol) in dry THF (30 mL) at -78 ˚C under 
nitrogen and was stirred for 30 minutes. Phenylacetyl chloride (0.56 mL, 4.29 mmol) was 
added in one portion and the resulting solution was stirred for a further two hours. The 
reaction was quenched with saturated ammonium chloride and allowed to warm to ambient 
temperature. The THF was evaporated under reduced pressure, the resulting oil was 
redissolved in dichloromethane and extracted with brine. The combined organic extracts were 
dried over MgSO4 and concentrated to afford crude product. The crude product was purified 
using flash silica chromatography [CH2Cl2, Rf 0.61] to afford (S)-4-benzyl-5,5-dimethyl-3-(2-
phenylacetyl)oxazolidin-2-one 472 (0.96 g, 3.89 mmol) as a colourless oil, which solidified on 
standing in 76% yield. 1H NMR (300 MHz, CDCl3) δH = 7.33-7.15 (10H, m, Phox and Ph), 4.46 (1H, 
dd, J = 9.6, 3.8 Hz, CHN), 4.25 (2H, s, COCH2Ph), 3.11 (1H, dd, J = 14.4, 3.8 Hz, CHAHBPh), 2.82 
(1H, J = 14.4, 9.6 Hz, CHAHBPh), 1.34 (3H, s, C(CH3)(CH3)), 1.29 (3H, s, C(CH3)(CH3)); 
13C NMR (75 
MHz, CDCl3) δC = 171.6, 152.7, 137.0, 133.8, 129.8, 129.2, 128.8, 128.7, 127.3, 126.9, 82.5, 
63.9, 41.9, 35.3, 28.7, 22.4; IR cm-1 ν = 1765 (C=Oox), 1712 (C=O); HRMS: m/z (ES) 324.1605, 
C20H22NO3 [M+H]
+ requires 324.1599; 
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n-BuLi (2.14 mL, 5.36 mmol, 2.5 M solution in hexane) was added to a solution of (S)-4-benzyl-
5,5-dimethyloxazolidin-2-one 445 (1.00 g, 4.87 mmol) in dry THF (30 mL) at -78 ˚C under 
nitrogen and was stirred for 30 minutes. 4-Methoxyphenylacetyl chloride (0.82 mL, 5.36 mmol) 
was added in one portion and the resulting solution was stirred for a further two hours. The 
reaction was quenched with saturated ammonium chloride and allowed to warm to ambient 
temperature. The THF was evaporated under reduced pressure, the resulting oil was 
redissolved in dichloromethane and extracted with brine. The combined organic extracts were 
dried over MgSO4 and concentrated to afford crude product. The crude product was purified 
using flash silica chromatography [CH2Cl2, Rf 0.79] to afford (S)-4-benzyl-3-(2-(4-
methoxyphenyl)acetyl)-5,5-dimethyloxazolidin-2-one 473 (1.34 g, 3.80 mmol) as a colourless 
oil, which crystallised on standing in 78% yield. 1H NMR (300 MHz, CDCl3) δH = 7.31-7.19 (7H, 
m, Ph and C6H2H2OMe), 6.87 (2H, d, J = 8.8 Hz, C6H2H2OMe), 4.50 (1H, dd, J = 9.8, 3.7 Hz, CHN), 
4.22 (2H, s, CH2Ar), 3.79 (3H, s, OCH3), 3.13 (1H, dd, J = 14.4, 3.7 Hz, CHAHBPh), 2.85 (1H, dd, J = 
14.4, 9.6 Hz, CHAHBPh), 1.36 (3H, s, C(CH3)(CH3)), 1.32 (3H, s, C(CH3)(CH3)); 
13C NMR (75 MHz, 
CDCl3) δC = 171.9, 158.8, 152.7,136.9, 130.8, 129.1, 128.7, 126.8, 125.8, 114.1, 82.4, 63.8, 55.3, 
40.9, 35.3, 28.6, 22.4; IR cm-1 ν = 1765 (C=Oox), 1711 (C=O); HRMS: m/z (ES) 376.1515, 
C21H23NNaO4 [M+Na]
+ requires 376.1524; 
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n-BuLi (4.96 mL, 12.42 mmol, 2.5 M solution in hexane) was added to a solution of (S)-4-
benzyloxazolidin-2-one 444 (2.00 g, 11.29 mmol) in dry THF (60 mL) at -78 ˚C under nitrogen 
and was stirred for 30 minutes. Propionyl chloride (1.08 mL, 12.42 mmol) was added in one 
portion and the resulting solution was stirred for a further two hours. The reaction was 
quenched with saturated ammonium chloride and allowed to warm to ambient temperature. 
The THF was evaporated under reduced pressure, the resulting oil was redissolved in 
dichloromethane and extracted with brine. The combined organic extracts were dried over 
MgSO4 and concentrated to afford crude product. The crude product was purified via 
recrystallisation in diethyl ether and hexane to afford (S)-4-benzyl-3-propionyloxazolidin-2-one 
515 (1.90 g, 8.12 mmol) as a white crystalline solid in 72% yield. 1H NMR (300 MHz, CDCl3) δH = 
7.30-7.15 (5H, m, Ph), 4.66-4.58 (1H, m, CHN), 4.17-4.08 (2H, m, CH2O), 3.24 (1H, dd, J = 13.3, 
3.2 Hz, CHAHBPh), 2.98-2.69 (2H, m, CH2CH3), 2.73 (1H, dd, J = 13.3, 9.5 Hz, CHAHBPh), 1.15 (3H, 
t, J = 7.3 Hz, CH2CH3);
 13C NMR (75 MHz, CDCl3) δC = 174.0, 153.5, 135.4, 129.4, 128.9, 127.3, 
66.2, 55.2, 37.9, 29.2, 8.3; IR cm-1 ν = 1785 (C=Oox), 1701 (C=O); HRMS: m/z (ES) 256.0948, 
C13H15NNaO3 [M+Na]
+ requires 256.0949; 
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4.1.2 Synthesis of Syn-Aldol Products 474-481, 517 
Asymmetric Syn-Aldol Reaction – General Procedure 1 
 
The appropriate acylated auxiliary 95, 471-473, 515 (1 equiv.) was dissolved in dry 
dichloromethane at 0 ˚C under nitrogen. Dibutylboron triflate (1.1 equiv., 1.0 M in 
dichloromethane) was added dropwise. After 30 minutes, N,N-diisopropylethylamine (1.3 
equiv.) was added and the resulting solution was stirred for 30 minutes. The reaction was 
cooled to -78 ˚C. The appropriate aldehyde (1.3 equiv.) was added in one portion and the 
reaction was allowed to warm to ambient temperature overnight. The reaction was quenched 
with pH 7 buffer solution (Na2PO4/NaH2PO4) (10 mL) and was stirred for 10 minutes. Hydrogen 
peroxide (4 mL) and methanol (8 mL) were then added and the solution was stirred for a 
further two hours. The methanol was evaporated, the solution diluted with dichloromethane 
and washed with saturated NaHCO3 and brine. The combined organic extracts were dried over 















The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-5,5-
dimethyl-3-propionyloxazolidin-2-one 95 (1.50 g, 5.74 mmol), dibutylboron triflate (6.31 mL, 
6.31 mmol, 1 M in dichloromethane), diisopropylethylamine (1.28 mL, 7.46 mmol) and 
crotonaldehyde (0.61 mL, 7.46 mmol) in dichloromethane (25 mL). The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.54] to afford (S)-4-
benzyl-3-((2S,3R,E)-3-hydroxy-2-methylhex-4-enoyl)-5,5-dimethyl-oxazolidin-2-one 474 (1.80 g, 
5.45 mmol) as a colourless gum in 95% yield. 1H NMR (300 MHz, CDCl3) δH = 7.39-7.17 (5H, m, 
Ph), 5.74 (1H, dqd, J = 15.5, 6.5, 1.0 Hz, CH=CHCH3), 5.48 (1H, ddd, J = 15.5, 6.5, 1.5 Hz, 
CH=CHCH3), 4.60 (1H, dd, J = 9.0, 4.5 Hz, CHN), 4.53 (1H, m, CHOH), 3.91 (1H, qd, J = 7.0, 4.5 
Hz, COCH), 3.05 (1H, dd, J = 14.5, 4.5 Hz, CHAHBPh), 2.90 (1H, dd, J = 14.5, 9.0, CHAHBPh), 2.60 
(1H, d, J = 2.5 Hz, OH), 1.70 (3H, d, J = 6.5 Hz, CH=CHCH3), 1.39 (3H, s, (CH3)C(CH3)), 1.38 (3H, s, 
(CH3)C(CH3)), 1.15 (3H, d, J = 7.0 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3) δc = 176.9, 152.9, 137.1, 
130.6, 129.5, 129.1, 128.9, 127.3, 82.7, 73.6, 63.8, 43.2, 35.9, 28.7, 22.5, 18.2, 12.1; IR cm-1 ν = 


















The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-5,5-
dimethyl-3-propionyloxazolidin-2-one 95 (1.00 g, 3.83 mmol), dibutylboron triflate (4.21 mL, 
4.21 mmol, 1 M in dichloromethane), diisopropylethylamine (0.87 mL, 4.97 mmol) and 
cinnamaldehyde (0.62 mL, 4.97 mmol) in dichloromethane (12 mL). The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.46] to afford (S)-4-
benzyl-3-((2S,3R,E)-3-hydroxy-2-methyl-5-phenylpent-4-enoyl)-5,5-dimethyloxazolidin-2-one 
475 (1.31 g, 3.29 mmol) as a white solid in 86% yield. 1H NMR (300 MHz, CDCl3) δH = 7.40-7.20 
(10H, m, Phox and Ph), 6.66 (1H, d, J = 16.0 Hz, CH=CHPh), 6.19 (1H, dd, J = 15.9, 5.9 Hz, 
CH=CHPh), 4.62-4.59 (1H, m, CHOH), 4.54 (1H, dd, J = 8.8, 4.6 Hz, CHN), 4.01 (1H, qd, J = 6.8, 
4.3 Hz, CHCH3), 3.07 (1H, dd, J = 14.4, 4.6 Hz, CHAHBPh), 2.91 (1H, dd, J = 14.2, 8.7 Hz, 
CHAHBPh), 2.83 (1H, broad s, OH), 1.38 (3H, s, C(CH3)(CH3)), 1.31 (3H, s, C(CH3)(CH3)), 1.20 (3H, 
d, J = 7.4 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 176.7, 152.6, 136.7, 131.7, 129.2, 128.8, 
128.7, 128.6, 127.8, 127.04, 126.7, 82.5, 73.1, 63.5, 43.1, 35.6, 28.4, 22.3, 11.8; IR cm-1 ν = 3444 

















The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-5,5-
dimethyl-3-propionyloxazolidin-2-one 95 (0.80 g, 3.06 mmol), dibutylboron triflate (3.37 mL, 
3.37 mmol, 1 M in dichloromethane), diisopropylethylamine (0.69 mL, 3.98 mmol) and 3-
methyl-2-butenal (0.38 mL, 3.98 mmol) in dichloromethane (10 mL). The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.65] to afford (S)-4-
benzyl-3-((2S,3R)-3-hydroxy-2,5-dimethylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 476 (0.85 
g, 2.46 mmol) as a colourless oil in 81% yield. 1H NMR (300 MHz, CDCl3) δH = 7.33-7.19 (5H, m, 
Ph), 5.23 (1H, m, CH=C(CH3)2), 4.59 (1H, dd, J = 8.7, 5.0 Hz, CHOH), 4.51 (1H, dd, J = 8.8, 4.6 Hz, 
CHN), 3.97-3.89 (1H, m, CHCH3), 3.05 (1H, dd, J = 14.3, 4.5 Hz, CHAHBPh), 2.89 (1H, dd, J = 14.2, 
9.0 Hz, CHAHBPh), 2.32 (1H, broad s, OH), 1.71 (3H, d, J = 1.3 Hz, C=C(CH3)(CH3)), 1.67 (3H, d, J = 
1.3 Hz, C=C(CH3)(CH3)), 1.19 (3H, s, OC(CH3)(CH3)), 1.17 (3H, s, OC(CH3)(CH3)), 1.17 (3H, d, J = 
7.0 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 176.4, 152.7, 136.9, 136.8, 129.3, 128.8, 127.0, 
124.3, 82.3, 69.6, 63.5, 43.1, 35.6, 28.3, 26.0, 22.2, 18.5, 12.4; IR cm-1 ν = 3505 (OH), 1772 
(C=Oox), 1692 (C=O); HRMS: m/z (ES) 368.1843, C20H27NNaO4 [M+Na]
+ requires 368.1837; 
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The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-5,5-
dimethyl-3-propionyloxazolidin-2-one 95 (0.80 g, 3.06 mmol), dibutylboron triflate (3.37 mL, 
3.37 mmol, 1 M in dichloromethane), diisopropylethylamine (0.69 mL, 3.98 mmol) and trans-2-
nonenal (0.66 mL, 3.98 mmol) in dichloromethane (10 mL). The crude product was purified 
using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.68] to afford (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-methylundec-4-enoyl)-5,5-dimethyloxazolidin-2-one 477 (0.81 g, 2.02 
mmol) as a colourless oil in 66% yield. 1H NMR (300 MHz, CDCl3) δH = 7.31-7.18 (5H, m, Ph), 
5.76-5.66 (1H, m, CH=CHC6H13), 5.43 (1H, dd, J = 15.4, 6.4 Hz, CH=CHC6H13), 4.51 (1H, dd, J = 
9.0, 4.5 Hz, CHN), 4.34 (1H, app. t, J = 5.0 Hz, CHOH), 3.89 (1H, qd, J = 7.0, 4.3 Hz, CHCH3), 3.05 
(1H, dd, J = 14.3, 4.5 Hz, CHAHBPh), 2.88 (1H, dd, J = 14.3, 9.0 Hz, CHAHBPh), 2.68 (1H, broad s, 
OH), 2.04-1.97 (2H, m, C=CHCH2), 1.37-1.24 (14H, m, C3H8 and C(CH3)(CH3)), 1.13 (3H, d, J = 6.9 
Hz, CHCH3), 0.88-0.84 (3H, m, C5H10CH3); 
13C NMR (75 MHz, CDCl3) δC = 176.5, 152.5, 136.7, 
133.6, 129.1, 128.9, 128.7, 126.9, 82.3, 73.1, 63.4, 42.9, 35.4, 32.3, 31.7, 29.1, 28.9, 28.3, 22.6, 
22.2, 14.1, 11.7; IR cm-1 ν = 3501 (OH), 1773 (C=Oox), 1696 (C=O); HRMS: m/z (ES) 424.2451, 
C24H35NNaO4 [M+Na]
+ requires 424.2463; 
25













The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-5,5-
dimethyl-3-propionyloxazolidin-2-one 95 (0.80 g, 3.06 mmol), dibutylboron triflate (3.37 mL, 
3.37 mmol, 1 M in dichloromethane), diisopropylethylamine (0.69 mL, 3.98 mmol) and trans-4-
nitrocinnamaldehyde (0.70 g, 3.98 mmol) in dichloromethane (10 mL). The crude product was 
purified using flash silica chromatography [CH2Cl2, Rf 0.14] to afford (S)-4-benzyl-3-((2S,3R,E)-3-
hydroxy-2-methyl-5-(4-nitrophenyl)pent-4-enoyl)-5,5-dimethyloxazolidin-2-one 478 (0.89 g, 
2.03 mmol) as an orange solid in 66% yield. 1H NMR (300 MHz, CDCl3) δH = 8.16 (2H, d, J = 8.8 
Hz, C6H2H2NO2), 7.50 (2H, d, J = 8.8 Hz, C6H2H2NO2), 7.33-7.21 (5H, m, Ph), 6.75 (1H, d, J = 15.6 
Hz, CH=CHC6H4NO2), 6.35 (1H, dd, J = 16.0, 5.2 Hz, CH=CHC6H4NO2), 4.70-4.67 (1H, m, CHOH), 
4.56 (1H, dd, J = 8.7, 5.0 Hz, CHN), 3.99 (1H, qd, J = 7.1, 3.4 Hz, CHCH3), 3.13-3.09 (1H, broad s, 
OH), 2.98 (1H, dd, J = 14.3, 4.8 Hz, CHAHBPh), 2.92 (1H, dd, J = 14.6, 8.8 Hz, CHAHBPh), 1.41 (3H, 
s, C(CH3)(CH3)), 1.35 (3H, s, C(CH3)(CH3)), 1.18 (3H, d, J = 7.1 Hz, CHCH3); 
13C NMR (75 MHz, 
CDCl3) δC = 176.73, 152.5, 147.1, 143.3, 136.5, 133.7, 129.3, 129.2, 128.8, 127.2, 127.1, 124.1, 
82.6, 72.2, 63.4, 42.8, 35.6, 28.5, 22.3, 11.5; IR cm-1 ν = 3512 (OH), 1774 (C=Oox), 1670 (C=O); 
HRMS: m/z (ES) 461.1657, C24H26N2NaO6 [M+Na]
+ requires 461.1688; 
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D][  = -18.0 (c = 0.5 













(S)-4-Benzyl-3-propionyloxazolidin-2-one 515 (0.80 g, 3.43 mmol) was dissolved in dry 
dichloromethane (10 mL) at 0 ˚C under nitrogen and was stirred for 30 minutes. 9-
Borabicyclo[3.3.1]nonyl triflate (7.54 mL, 3.77 mmol, 0.5 M in hexane) was added dropwise. 
After 30 minutes, diisopropylethylamine (0.78 mL, 4.46 mmol) was added and the resulting 
solution was stirred for 30 minutes before being cooled to -78 ˚C. trans-4-
Nitrocinnamaldehyde (0.79 g, 4.46 mmol) was added in one portion and the reaction was 
allowed to warm to ambient temperature overnight. The reaction was quenched with pH 7 
buffer solution (Na2PO4/NaH2PO4) (10 mL) and was stirred for 10 minutes. Hydrogen peroxide 
(4 mL) and methanol (8 mL) were then added and the solution was stirred for a further two 
hours. The methanol was evaporated, the solution diluted with dichloromethane and washed 
with saturated NaHCO3 and brine. The combined organic extracts were dried over MgSO4 and 
concentrated to afford crude product. The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.45] to afford (S)-4-benzyl-3-((2S,3R,E)-3-
hydroxy-2-methyl-5-(4-nitrophenyl)pent-4-enoyl)oxazolidin-2-one 517 (0.97 g, 2.36 mmol) as a 
fluffy yellow solid in 69% yield. 1H NMR (300 MHz, CDCl3) δH = 8.11 (2H, d, J = 8.7 Hz, 
C6H2H2NO2), 7.46 (2H, d, J = 8.7 Hz, C6H2H2NO2), 7.31-7.13 (5H, m, Ph), 6.73 (1H, dd, J = 15.9, 
1.3 Hz, CH=CHC6H4NO2), 6.32 (1H, dd, J = 15.9, 5.1 Hz, CH=CHC6H4NO2), 4.72-4.64 (2H, m, CHN 
and CHOH), 4.21-4.14 (2H, m, OCH2), 3.92 (1H, qd, J = 7.0, 3.1 Hz, CHCH3), 3.20 (1H, dd, J = 
13.5, 3.4 Hz, CHAHBPh), 2.85 (1H, broad s, OH), 2.76 (1H, dd, J = 13.4, 9.4 Hz, CHAHBPh), 1.23 
(3H, d, J = 7.1 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 176.7, 153.2, 147.1, 143.2, 134.9, 
133.7, 129.5, 129.3, 129.1, 127.6, 127.1, 124.1, 71.9, 66.5, 55.1, 42.6, 37.9, 11.2; IR cm-1 ν = 











The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-5,5-
dimethyl-3-propionyloxazolidin-2-one 95 (0.80 g, 3.06 mmol), dibutylboron triflate (3.37 mL, 
3.37 mmol, 1 M in dichloromethane), diisopropylethylamine (0.69 mL, 3.98 mmol) and trans-4-
methoxycinnamaldehyde (0.64 g, 3.98 mmol) in dichloromethane (10 mL). The crude product 
was purified using flash silica chromatography [1:9 EtOAc:CH2Cl2, Rf 0.05] to afford (S)-4-
benzyl-3-((2S,3R,E)-3-hydroxy-5-(4-methoxyphenyl)-2-methylpent-4-enoyl)-5,5-
dimethyloxazolidin-2-one 479 (0.72 g, 1.70 mmol) as a yellow solid in 56% yield. 1H NMR (300 
MHz, CDCl3) δH = 7.33-7.20 (7H, m, Ph and C6H2H2OMe), 6.83 (2H, d, J = 8.9 Hz, C6H2H2OMe), 
6.58 (1H, d, J = 15.8 Hz, CH=CHC6H4OMe), 6.06 (1H, dd, J = 15.8, 6.2 Hz, CH=CHC6H4OMe), 4.59-
4.51 (2H, m, CHOH and CHN), 4.02 (1H, qd, J = 7.0, 4.2 Hz, CHCH3), 3.80 (3H, s, OCH3), 3.06 (1H, 
dd, J = 14.3, 4.6 Hz, CHAHBPh), 2.90 (1H, dd, J = 14.4, 8.9 Hz, CHAHBPh), 2.73 (1H, d, J = 2.2 Hz, 
OH), 1.38 (3H, s, C(CH3)(CH3)), 1.30 (3H, s, C(CH3)(CH3)), 1.20 (3H, d, J = 6.9 Hz, CHCH3); 
13C NMR 
(75 MHz, CDCl3) δC = 176.7, 156.0, 152.6, 136.9, 134.3, 129.2, 128.8, 127.1, 114.0, 82.3, 75.7, 
63.5, 55.5, 43.4, 35.4, 28.3, 26.0, 22.4, 20.6, 13.6, 12.4; IR cm-1 ν = 3509 (OH), 1770 (C=Oox), 
1692 (C=O), 1511 (OCH3); HRMS: m/z (ES) 446.1926, C25H29NNaO5 [M+Na]
+ requires 446.1943; 
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The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-5,5-
dimethyl-3-(3-methylbutanoyl)oxazolidin-2-one 471 (0.50 g, 1.73 mmol), dibutylboron triflate 
(1.90 mL, 1.90 mmol, 1 M in dichloromethane), diisopropylethylamine (0.39 mL, 2.25 mmol) 
and crotonaldehyde (0.19 mL, 2.25 mmol) in dichloromethane (8 mL). The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.48] to afford (S)-4-
benzyl-3-((2S,3R,E)-3-hydroxy-2-isopropylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 480 (0.51 
g, 1.42 mmol) as a colourless gum in 82% yield. 1H NMR (300 MHz, CDCl3) δH = 7.26-7.15 (5H, 
m, Ph), 5.74-5.58 (2H, m, CH=CHCH3), 4.54 (1H, dd, J = 10.0, 3.7 Hz, CHN), 4.36 (1H, app. t, J = 
6.9 Hz, CHOH), 4.09 (1H, dd, J = 8.8, 6.7 Hz, CH(iPr)), 3.09 (1H, dd, J = 14.3, 3.7 Hz, CHAHBPh), 
2.83 (1H, dd, J = 14.4, 9.8 Hz, CHAHBPh), 2.05-1.92 (1H, m, CH(CH3)(CH3)), 1.81 (1H, broad s, 
OH), 1.66 (3H, d, J = 5.1 Hz, CH=CHCH3), 1.28 (6H, s, C(CH3)(CH3)), 0.92 (3H, d, J = 6.7 Hz, 
CH(CH3)(CH3)), 0.84 (3H, d, J = 6.7 Hz, CH(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δC = 174.4, 
153.5, 137.1, 130.2, 129.8, 129.2, 128.8, 126.9, 82.1, 73.4, 64.0, 53.8, 35.7, 28.4, 28.3, 22.3, 
20.6, 20.1, 18.0; IR cm-1 ν = 3498 (OH), 1772 (C=Oox), 1690 (C=O); HRMS: m/z (ES) 382.1984, 
C21H29NNaO4 [M+Na]
+ requires 382.1994;  
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The title compound was prepared according to General Procedure 1 from (S)-4-benzyl-3-(2-(4-
methoxyphenyl)acetyl)-5,5-dimethyloxazolidin-2-one 473 (0.35 g, 0.99 mmol), 9-BBN triflate 
(2.17 mL, 1.09 mmol, 0.5 M in hexane), diisopropylethylamine (0.22 mL, 1.28 mmol) and 
crotonaldehyde (0.10 mL, 1.28 mmol) in dichloromethane (6 mL). The crude product was 
purified using flash silica chromatography [1:3 EtOAc:Petroleum ether, Rf 0.25] to afford (S)-4-
benzyl-3-((2S,3R,E)-3-hydroxy-2-(4-methoxyphenyl)hex-4-enoyl)-5,5-dimethyloxazolidin-2-one 
481 (0.30 g, 0.71 mmol) as a colourless gum in 72% yield. 1H NMR (300 MHz, CDCl3) δH = 7.35 
(2H, d, J = 9.0 Hz, C6H2H2OMe), 7.19-7.11 (5H, m, Ph), 6.88 (2H, d, J = 9.0 Hz, C6H2H2OMe), 5.84-
5.73 (1H, m, CH=CHCH3), 5.48 (1H, ddd, J = 15.3, 7.2, 1.6 Hz, CH=CHCH3), 5.13-5.00 (1H, m, 
CHC6H4OMe), 4.65 (1H, app. t, J = 7.5 Hz, CHOH), 4.50 (1H, dd, J = 9.2, 4.1 Hz, CHN), 3.81 (3H, s, 
OCH3), 2.90 (1H, dd, J = 14.4, 4.1 Hz, CHAHBCH3), 2.70 (1H, dd, J = 14.4, 9.2 Hz, CHAHBCH3), 2.08 
(1H, broad s, OH), 1.67 (3H, dd, J = 6.5, 1.4 Hz, CHCH3), 1.34 (3H, s, C(CH3)(CH3)), 1.31 (3H, s, 
C(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δC = 173.0, 159.4, 152.1, 136.7, 131.1, 130.6, 129.6, 
129.1, 128.7, 126.8, 126.2, 114.2, 82.2, 74.1, 63.5, 55.4, 54.4, 35.1, 28.4, 22.2, 17.9; IR cm-1 ν = 
3504 (OH), 1766 (C=Oox), 1693 (C=O), 1511 (OCH3); HRMS: m/z (ES) 446.1945, C25H29NNaO5 
[M+Na]+ requires 446.1943; 
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Based on a literature procedure,166 (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 95 
(1.00 g, 3.83 mmol), MgCl2 (0.036 g, 0.38 mmol) and NaSbF6 (0.30 g, 1.15 mmol) were 
dissolved in dry ethyl acetate (21.5 mL) at room temperature under nitrogen. Triethylamine 
(1.06 mL, 7.65 mmol) was added dropwise followed by cinnamaldehyde (0.58 mL, 4.59 mmol) 
and chlorotrimethylsilane (0.73 mL, 5.74 mmol). The reaction was stirred at room temperature 
for 24 hours. The suspension was diluted with diethyl ether and was passed through a plug of 
silica. The filtrate was concentrated and redissolved in methanol (15 mL) with two drops of 
trifluoroacetic acid. The solution was stirred at room temperature for 30 minutes and was 
concentrated to afford a yellow oil. The crude product was purified using flash silica 
chromatography [1:9 EtOAc:Petroleum ether, Rf 0.21] to afford (S)-4-benzyl-3-((2R,3R,E)-3-
hydroxy-2-methyl-5-phenylpent-4-enoyl)-5,5-dimethyloxazolidin-2-one 483 (1.23 g, 3.13 
mmol) as a colourless oil in 82% yield. 1H NMR (300 MHz, CDCl3) δH = 7.29-7.09 (10H, m Ph and 
Phox), 6.53 (1H, d, J = 15.9 Hz, CH=CHPh), 6.15 (1H, dd, J = 15.9, 6.7 Hz, CH=CHPh), 4.43 (1H, dd, 
J = 9.8, 3.6 Hz, CHN), 4.34 (1H, app. t, J = 7.1 Hz, CHOH), 4.03 (1H, app. quin., J = 6.9 Hz, 
CHCH3), 3.08 (1H, dd, J = 14.6, 3.6 Hz, CHAHBPh), 3.00 (1H, broad s, OH), 2.67 (1H, dd, J = 14.6, 
9.8 Hz, CHAHBPh), 1.23 (3H, s, C(CH3)(CH3)), 1.21 (3H, s, C(CH3)(CH3)), 1.14 (3H, d, J = 6.9 Hz, 
CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 176.5, 152.6, 137.0, 136.4, 131.9, 129.5, 128.9, 128.6, 
128.5, 127.7, 126.7, 126.5, 82.2, 75.3, 63.8, 43.5, 35.0, 28.4, 22.2, 14.4; IR cm-1 ν = 3377 (OH), 
1774 (C=Oox), 1687 (C=O); HRMS: m/z (ES) 416.1826, C24H27NNaO4 [M+Na]
+ requires 416.1837;  
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4.1.4 Synthesis of syn-Cyclopropyl Aldol Products 493-501, 518 
Directed Syn-Cyclopropanation – General Procedure 2 
 
The appropriate syn-aldol product 474-481, 483, 517 (1 equiv.) was dissolved in 
dichloromethane and stirred at 0 ˚C under nitrogen. Diethylzinc (5 equiv., 1 M in hexane) was 
added in one portion followed by diiodomethane (5 equiv.). The reaction was stirred for two 
hours in the absence of light. The reaction was quenched with saturated sodium sulphite (5 
mL) and stirred for 10 minutes before sufficient 1 M HCl was added to dissolve the white 
precipitate. The aqueous layer was separated and extracted with dichloromethane and the 
combined organic layers were washed with brine, dried over MgSO4 and concentrated to 

















The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-methylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 474 (0.72 g, 2.17 
mmol), diethylzinc (10.86 mL, 10.86 mmol, 1 M in hexane) and diiodomethane (0.87 mL, 10.86 
mmol) in dichloromethane (30 mL). The crude product was purified via recrystallisation in 
diethyl ether and hexane to afford (S)-4-benzyl-3-((2S,3R)-3-hydroxy-2-methyl-3-((1S,2S)-2-
methylcyclopropyl)propanoyl)-5,5-dimethyloxazolidin-2-one 493 (0.63 g, 1.82 mmol) as a 
white crystalline solid in 84% yield. mp = 98-101 ˚C (Et2O, hexane); 
1H NMR (300 MHz, CDCl3) 
δH = 7.31-7.18 (5H, m, Ph), 4.51 (1H, dd, J = 9.0, 4.3 Hz, CHN), 3.98 (1H, qd, J = 7.1, 3.8 Hz, 
(C=O)CH), 3.19 (1H, dd, J = 8.3, 3.7 Hz, CHOH), 3.07 (1H, dd, J = 14.3, 4.2 Hz, CHAHBPh), 2.88 
(1H, dd, J = 14.3, 9.2 Hz, CHAHBPh), 2.43 (1H, broad s, OH), 1.36 (3H, s, C(CH3)(CH3)), 1.35 (3H, s, 
C(CH3)(CH3)), 1.23 (3H, d, J = 7.1 Hz, (C=O)CHCH3), 1.01 (3H, d, J = 5.8 Hz, cyclopropyl-CH3), 
0.75-0.60 (2H, m, CHOHCHCHAHB and cyclopropyl-CHCH3), 0.54-0.48 (1H, m, cyclopropyl-
CHAHB), 0.33-0.27 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 176.8, 152.6, 
136.9, 129.2, 128.8, 127.0, 82.3, 76.2, 63.6, 43.1, 35.5, 28.6, 23.2, 22.4, 18.4, 11.8, 11.7, 11.0; 
IR cm-1 ν = 3485 (OH), 1775 (C=Oox), 1685 (C=O); HRMS: m/z (ES) 368.1827, C20H27NNaO4 
[M+Na]+ requires 368.1837;  
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The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-methyl-5-phenylpent-4-enoyl)-5,5-dimethyloxazolidin-2-one 475 (0.70 
g, 1.78 mmol), diethylzinc (8.90 mL, 8.90 mmol, 1 M in hexane) and diiodomethane (0.72 mL, 
8.90 mmol) in dichloromethane (30 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.28] to afford (S)-4-benzyl-3-((2S,3R)-3-
hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoyl)-5,5-dimethyloxazolidin-2-one 
494 (0.69 g, 1.93 mmol) as a white crystalline solid in 98% yield. 1H NMR (300 MHz, CDCl3) δH = 
7.33-7.05 (10H, m, Phox and Ph), 4.44 (1H, dd, J = 9.2, 4.1 Hz, CHN), 4.05 (1H, qd, J = 7.1, 4.4 Hz, 
CHCH3), 3.46 (1H, dd, J = 8.0, 4.4 Hz, CHOH), 3.09 (1H, dd, J = 14.3, 4.2 Hz, CHAHBPh), 2.87 (1H, 
dd, J = 14.3, 9.3 Hz, CHAHBPh), 2.51 (1H, broad s, OH), 1.94-1.88 (1H, m, cyclopropyl-Ph), 1.38-
1.31 (1H, m, CHOHCHCHAHB), 1.35 (3H, s, C(CH3)(CH3)), 1.26 (3H, d, J = 7.0 Hz, CHCH3), 1.16 (3H, 
s, C(CH3)(CH3)), 1.12-1.06 (1H, m, cyclopropyl-CHAHB), 1.02-0.96 (1H, m, cyclopropyl-CHAHB); 
13C 
NMR (75 MHz, CDCl3) δC = 176.6, 152.5, 142.3, 136.8, 129.2, 128.8, 128.5, 127.0, 126.0, 125.8, 
82.3, 75.5, 63.5, 43.4, 35.4, 28.2, 26.5, 22.3, 21.3, 14.0, 12.4; IR cm-1 ν = 3497 (OH), 1769 
(C=Oox), 1692 (C=O); HRMS: m/z (ES) 430.1977, C25H29NNaO4 [M+Na]
+ requires 430.1994;  
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The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R)-3-hydroxy-2,5-dimethylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 476 (0.58 g, 1.68 
mmol), diethylzinc (8.39 mL, 8.40 mmol, 1 M in hexane) and diiodomethane (0.67 mL, 8.40 
mmol) in dichloromethane (40 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.47] to afford (S)-4-benzyl-3-((2S,3R)-3-((S)-
2,2-dimethylcyclopropyl)-3-hydroxy-2-methylpropanoyl)-5,5-dimethyloxazolidin-2-one 495 
(0.59 g, 1.64 mmol) as a colourless oil in 98% yield. 1H NMR (300 MHz, CDCl3) δH = 7.31-7.18 
(5H, m, Ph), 4.51 (1H, dd, J = 9.2, 4.3 Hz, CHN), 3.94 (1H, qd, J = 7.1, 3.4 Hz, CHCH3), 3.51 (1H, 
dd, J = 9.3, 3.4 Hz, CHOH), 3.08 (1H, dd, J = 14.4, 4.2 Hz, CHAHBPh), 2.88 (1H, dd, J = 14.3, 9.3 
Hz, CHAHBPh), 2.63 (1H, broad s, OH), 1.36 (3H, s, OC(CH3)(CH3)), 1.35 (3H, s, OC(CH3)(CH3)), 
1.23 (3H, d, J = 7.1 Hz, CHCH3), 1.05 (3H, s, CH-cyclopropyl-(CH3)(CH3)), 1.03 (3H, s, CH-
cyclopropyl-(CH3)(CH3)), 0.86-0.78 (1H, m, CH-cyclopropyl-(CH3)(CH3)), 0.57-0.53 (1H, m, 
cyclopropyl-CHAHB), 0.31-0.28 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 177.3, 
152.5, 136.8, 129.2, 128.8, 127.0, 82.3, 72.8, 63.6, 42.9, 35.5, 28.6, 27.6, 27.3, 22.3, 20.7, 18.5, 
16.5, 11.4; IR cm-1 ν = 3598 (OH), 1760 (C=Oox), 1700 (C=O); HRMS: m/z (ES) 382.1981, 
C21H29NNaO4 [M+Na]
+ requires 382.1994;  
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The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-methylundec-4-enoyl)-5,5-dimethyloxazolidin-2-one 477 (0.43 g, 1.04 
mmol), diethylzinc (5.17 mL, 5.173 mmol, 1 M in hexane) and diiodomethane (0.42 mL, 5.17 
mmol) in dichloromethane (20 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.40] to afford (S)-4-benzyl-3-((2S,3R)-3-
((1S,2S)-2-hexylcyclopropyl)-3-hydroxy-2-methylpropanoyl)-5,5-dimethyloxazolidin-2-one 496 
(0.42 g, 1.01 mmol) as a colourless oil in 98% yield. 1H NMR (300 MHz, CDCl3) δH = 7.30-7.17 
(5H, m, Ph), 4.51 (1H, dd, J = 9.3, 4.0 Hz, CHN), 3.97 (1H, qd, J = 7.1, 3.3 Hz, CHCH3), 3.21 (1H, 
dd, J = 8.4, 3.3 Hz, CHOH), 3.08 (1H, dd, J = 14.3, 4.1 Hz, CHAHBPh), 2.87 (1H, dd, J = 14.3, 9.3 
Hz, CHAHBPh), 2.53 (1H, broad s, OH), 1.36-1.13 (19H, m, C5H10, CHCH3, d, J = 7.1 Hz, 
C(CH3)(CH3)), 0.88-0.84 (3H, m, C5H10CH3), 0.78-0.63 (2H, m, CHOHCHCHAHB and cyclopropyl-
CH-alkyl), 0.54-0.48 (1H, m, cyclopropyl-CHAHB), 0.36-0.30 (1H, m, cyclopropyl-CHAHB); 
13C NMR 
(75 MHz, CDCl3) δC = 176.9, 152.4, 136.8, 129.1, 128.7, 126.9, 82.2, 75.8, 63.5, 42.9, 35.4, 33.7, 
31.9, 29.4, 29.2, 28.5, 22.7, 22.3, 22.1, 16.6, 14.2, 11.3, 10.7; IR cm-1 ν = 3527 (OH), 1763 
(C=Oox), 1699 (C=O); HRMS: m/z (ES) 438.2600, C25H37NNaO4 [M+Na]
+ requires 438.2620;  
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The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-isopropylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 480 (0.66 g, 1.84 
mmol), diethylzinc (9.18 mL, 9.18 mmol, 1 M in hexane) and diiodomethane (0.73 mL, 9.18 
mmol) in dichloromethane (30 mL). The crude product was purified using flash silica 
chromatography [1:9 EtOAc:Petroleum ether, Rf 0.11] to afford (S)-4-benzyl-3-((S)-2-((R)-
hydroxy((1S,2S)-2-methylcyclopropyl)methyl)-3-methylbutanoyl)-5,5-dimethyloxazolidin-2-one 
497 (0.68 g, 1.82 mmol) as a colourless oil in 97% yield. 1H NMR (300 MHz, CDCl3) δH = 7.28-
7.13 (5H, m, Ph), 4.56 (1H, dd, J = 10.3, 3.3 Hz, CHN), 4.17 (1H, dd, J = 8.5, 6.5 Hz, (C=O)CH), 
3.30 (1H, dd, J = 8.9, 6.5 Hz, CHOH), 3.16 (1H, dd, J = 14.4, 3.3 Hz, CHAHBPh), 2.80 (1H, dd, J = 
14.4, 10.3 Hz, CHAHBPh), 2.21 (1H, m, CH(CH3)(CH3)), 1.93 (1H, broad s, OH), 1.29 (3H, s, 
C(CH3)(CH3)), 1.27 (3H, s, C(CH3)(CH3)), 0.99 (3H, d, J = 6.0 Hz, cyclopropyl-CH3), 0.96 (3H, d, J = 
6.7 Hz, CH(CH3)(CH3)), 0.94-0.87 (1H, m, CHCH3), 0.88 (3H, d, J = 6.7 Hz, CH(CH3)(CH3)), 0.74-
0.66 (1H, m, CHOHCHCHAHB), 0.43-0.37 (1H, m, cyclopropyl-CHAHB), 0.24-0.18 (1H, m, 
cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 174.6, 153.3, 137.1, 129.1, 128.8, 126.8, 
81.8, 75.4, 64.0, 54.1, 35.5, 28.6, 28.4, 23.3, 22.4, 20.9, 20.7, 18.5, 12.7, 10.4; IR cm-1 ν = 3526 
















The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-methyl-5-(4-nitrophenyl)pent-4-enoyl)-5,5-dimethyloxazolidin-2-one 
478 (0.20 g, 0.46 mmol), diethylzinc (2.28 mL, 2.28 mmol, 1 M in hexane) and diiodomethane 
(0.18 mL, 2.28 mmol) in dichloromethane (20 mL). The crude product was purified using flash 
silica chromatography [3:7 EtOAc:Petroleum ether, Rf 0.25] to afford (S)-4-benzyl-3-((2S,3R)-3-
hydroxy-2-methyl-3-((1S,2S)-2-(4-nitrophenyl)cyclopropyl)propanoyl)-5,5-dimethyloxazolidin-
2-one 498 (0.19 g, 0.42 mmol) as a yellow oil in 98% yield. 1H NMR (300 MHz, CDCl3) δH = 8.11 
(2H, d, J = 8.9 Hz, C6H2H2NO2), 7.33-7.22 (5H, m, Ph), 7.17 (2H, d, J = 8.9 Hz, C6H2H2NO2), 4.49 
(1H, dd, J = 8.9, 4.6 Hz, CHN), 4.02 (1H, qd, J = 7.0, 3.5 Hz, CHCH3), 3.60 (1H, dd, J = 7.1, 3.5 Hz, 
CHOH), 3.05 (1H, dd, J = 14.2, 4.6 Hz, CHAHBCH3) 2.89 (1H, dd, J = 14.2, 9.0 Hz, CHAHBCH3), 2.04-
1.98 (1H, m, cyclopropyl-C6H4NO2), 1.65 (1H, broad s, OH), 1.46-1.38 (1H, m, CHOHCHCHAHB), 
1.38 (3H, s, C(CH3)(CH3)), 1.32-1.27 (1H, m, cyclopropyl-CHAHB), 1.27 (3H, s, C(CH3)(CH3)), 1.22 
(3H, d, J = 7.0 Hz, CHCH3), 1.14-1.07 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 
176.5, 152.5, 151.0, 146.0, 136.6, 129.1, 128.8, 127.0, 126.3, 123.8, 82.4, 74.0, 63.4, 43.2, 35.4, 
28.3, 27.9, 22.2, 20.9, 15.2, 12.0; IR cm-1 ν = 3512 (OH), 1769 (C=Oox), 1691 (C=O); HRMS: m/z 
(ES) 475.1835, C25H28N2NaO6 [M+Na]
+ requires 475.1845; 
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The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-methyl-5-(4-nitrophenyl)pent-4-enoyl)oxazolidin-2-one 517 (0.20 g, 
0.49 mmol), diethylzinc (2.44 mL, 2.44 mmol, 1 M in hexane) and diiodomethane (0.20 mL, 
2.44 mmol) in dichloromethane (20 mL). The crude product was purified using flash silica 
chromatography [3:7 EtOAc:Petroleum ether, Rf 0.12] to afford (S)-4-benzyl-3-((2S,3R)-3-
hydroxy-2-methyl-3-((1S,2S)-2-(4-nitrophenyl)cyclopropyl)propanoyl)oxazolidin-2-one 518 
(0.167 g, 0.39 mmol) as an orange oil in 81% yield. 1H NMR (300 MHz, CDCl3) δH = 8.03 (2H, d, J 
= 8.9 Hz, C6H2H2NO2), 7.29-7.18 (3H, m, Ph), 7.10 (2H, d, J = 8.4 Hz, C6H2H2NO2), 7.11-7.08 (2H, 
m, Ph), 4.58-4.50 (1H, m, CHN), 4.07-3.97 (2H, m, CHAHBCHN and CHCH3), 3.87 (1H, app. t, J = 
8.4 Hz, CHAHBCHN), 3.50 (1H, dd, J = 7.4, 4.1 Hz, CHOH), 3.13 (1H, dd, J = 13.4, 3.2 Hz, 
CHAHBPh), 2.70 (1H, dd, J = 13.4, 9.2 Hz, CHAHBPh), 2.51 (1H, broad s, OH), 1.94-1.90 (1H, m, 
cyclopropyl-aryl), 1.46-1.38 (1H, m, CHOHCHCHAHB), 1.27-1.18 (3H, d, J = 7.0 Hz, CHCH3), 1.25-
1.18 (1H, m, cyclopropyl-CHAHB), 1.06-1.00 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, 
CDCl3) δC = 176.3, 153.3, 150.8, 146.2, 135.0, 129.5, 129.1, 127.6, 126.3, 123.9, 74.8, 66.2, 55.2, 
43.1, 27.9, 28.0, 21.0, 15.6, 12.0; IR cm-1 ν = 3556 (OH), 1756 (C=Oox), 1695 (C=O); HRMS: m/z 
(ES) 447.1529, C23H24N2NaO6 [M+Na]
+ requires 447.1532;  
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The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-5-(4-methoxyphenyl)-2-methylpent-4-enoyl)-5,5-dimethyloxazolidin-2-
one 479 (0.66 g, 1.56 mmol), diethylzinc (7.79 mL, 7.79 mmol, 1 M in hexane) and 
diiodomethane (0.63 mL, 7.79 mmol) in dichloromethane (10 mL). The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.09] to afford (S)-4-
benzyl-3-((2S,3R)-3-hydroxy-3-((1S,2S)-2-(4-methoxyphenyl)cyclopropyl)-2-methylpropanoyl)-
5,5-dimethyloxazolidin-2-one 499 (0.49 g, 1.12 mmol) as a colourless oil in 72% yield. 1H NMR 
(300 MHz, CDCl3) δH = 7.33-7.19 (5H, m, Ph), 6.99 (2H, d, J = 8.7 Hz, C6H2H2OMe), 6.79 (2H, d, J 
= 8.7 Hz, C6H2H2OMe), 4.45 (1H, dd, J = 9.2, 4.2 Hz, CHN), 4.06 (1H, qd, J = 7.0, 4.2 Hz, CHCH3), 
3.76 (3H, s, OCH3), 3.44 (1H, dd, J = 8.0, 4.2 Hz, CHOH), 3.09 (1H, dd, J = 14.3, 4.2 Hz, 
CHAHBCH3), 2.87 (1H, dd, J = 14.3, 9.3 Hz, CHAHBCH3), 2.47 (1H, broad s, OH), 1.88-1.82 (1H, m, 
cyclopropyl-aryl), 1.36 (3H, s, C(CH3)(CH3)), 1.26 (3H, d, J = 7.0 Hz, CHCH3), 1.31-1.21 (1H, m, 
CHOHCHCHAHB), 1.19 (3H, s, C(CH3)(CH3)), 1.06-1.00 (1H, m, cyclopropyl-CHAHB), 0.95-0.89 (1H, 
m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 176.7, 158.0, 152.6, 136.9, 134.3, 129.2, 
128.8, 127.1, 127.0, 114.0, 82.3, 75.7, 63.5, 55.5, 43.4, 35.4, 28.3, 26.0, 22.4, 20.6, 13.6, 12.3; 
IR cm-1 ν = 3490 (OH), 1769 (C=Oox), 1692 (C=O); HRMS: m/z (ES) 460.2107, C26H31NNaO5 
[M+Na]+ requires 460.2099; 
25












The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2S,3R,E)-3-hydroxy-2-(4-methoxyphenyl)hex-4-enoyl)-5,5-dimethyloxazolidin-2-one 481 (0.30 
g, 0.71 mmol), diethylzinc (3.54 mL, 3.54 mmol, 1 M in hexane) and diiodomethane (0.28 mL, 
3.54 mmol) in dichloromethane (25 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.32] to afford (S)-4-benzyl-3-((2S,3R)-3-
hydroxy-2-(4-methoxyphenyl)-3-((1S,2S)-2-methylcyclopropyl)propanoyl)-5,5-
dimethyloxazolidin-2-one 500 (0.21 g, 0.48 mmol) as a colourless oil in 68% yield. 1H NMR (300 
MHz, CDCl3) δH = 7.35 (2H, d, J = 8.7 Hz, C6H2H2OMe), 7.28-7.16 (5H, m, Ph), 6.87 (2H, d, J = 8.7 
Hz, C6H2H2OMe), 5.11 (1H, broad d, J = 3.5 Hz, (C=O)CH), 4.56 (1H, dd, J = 9.8, 3.5 Hz, CHN), 
3.80 (3H, s, OCH3), 3.55 (1H, dd, J = 7.8, 5.8 Hz, CHOH), 2.96 (1H, dd, J = 14.5, 3.2 Hz, 
CHAHBCH3), 2.68 (1H, dd, J = 14.5, 9.5 Hz, CHAHBCH3), 2.61 (1H, broad s, OH), 1.36 (3H, s, 
C(CH3)(CH3)), 1.29 (3H, s, C(CH3)(CH3)), 1.01 (3H, d, J = 6.0 Hz, CHCH3), 0.79-0.70 (1H, m, 
CHCH3), 0.59-0.51 (2H, m, CHOHCHCHAHB and cyclopropyl-CHAHB), 0.30-0.23 (1H, m, 
cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 174.0, 159.2, 151.9, 136.8, 131.3, 129.0, 
128.8, 126.9, 126.2, 114.0, 82.0, 76.3, 63.5, 55.3, 54.0, 34.8, 28.8, 23.8, 22.4, 18.5, 11.7, 11.3; 
IR cm-1 ν = 3506 (OH), 1770 (C=Oox), 1693 (C=O); HRMS: m/z (ES) 460.2093, C26H31NNaO5 
[M+Na]+ requires 460.2099; 
25














The title compound was prepared according to General Procedure 2 from (S)-4-benzyl-3-
((2R,3R,E)-3-hydroxy-2-methyl-5-phenylpent-4-enoyl)-5,5-dimethyloxazolidin-2-one 483 (1.23 
g, 3.13 mmol), diethylzinc (15.6 mL, 15.63 mmol, 1 M in hexane) and diiodomethane (1.26 mL, 
15.63 mmol) in dichloromethane (60 mL). The crude product was purified using flash silica 
chromatography [1:9 EtOAc:Petroleum ether, Rf 0.11] to afford (S)-4-benzyl-3-((2R,3R)-3-
hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoyl)-5,5-dimethyloxazolidin-2-one 
501 (1.26 g, 3.09 mmol) as a colourless oil in 99% yield. 1H NMR (300 MHz, CDCl3) δH = 7.31-
7.14 and 7.05-7.03 (10H, m, Ph and Phox), 4.50 (1H, dd, J = 9.8, 3.5 Hz, CHN), 4.17 (1H, app. 
quin., J = 7.0 Hz, CHCH3), 3.38 (1H, app. t, J = 7.4 Hz, CHOH), 3.09 (1H, dd, J = 14.7, 3.3 Hz, 
CHAHBPh), 2.93 (1H, broad s, OH), 2.62 (1H, dd, J = 14.5, 9.9 Hz, CHAHBPh), 1.94-1.88 (1H, m, 
cyclopropyl-Ph), 1.30-1.17 (m, 10H, C(CH3)(CH3) and CHCH3 and cyclopropyl-CHAHB), 1.11-0.98 
(2H, m, CHOHCHCHAHB and cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 177.1, 152.5, 
142.1, 137.0, 128.9, 128.6, 128.4, 126.7, 125.6, 82.1, 77.2, 63.7, 44.1, 34.8, 28.5, 28.3, 22.2, 
21.4, 14.6, 13.0; IR cm-1 ν = 3500 (OH), 1770 (C=Oox), 1695 (C=O); HRMS: m/z (ES) 430.2023, 
C25H29NNaO4 [M+Na]
+ requires 430.1994; 
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4.1.5 Synthesis of Methyl Esters 506-514 
Synthesis of Methyl Ester – General Procedure 3 
 
The appropriate syn-aldol cyclopropane product 493-501, 518 (1 equiv.) was dissolved in 
dichloromethane under nitrogen. A solution of sodium methoxide (1 equiv., 0.5 M in 
methanol) was added and the reaction was stirred for five minutes. The reaction was 
quenched with saturated ammonium chloride (5 mL) and the organic layer was washed with 



















(2S,3R)-Methyl 3-hydroxy-2-methyl-3-((1S,2S)-2-methylcyclopropyl)propanoate, 506 
 
The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2S,3R)-3-hydroxy-2-methyl-3-((1S,2S)-2-methylcyclopropyl)propanoyl)-5,5-
dimethyloxazolidin-2-one 493 (0.43 g, 1.25 mmol) and sodium methoxide (2.49 mL, 1.25 mmol, 
0.5 M in methanol) in dichloromethane (40 mL). The crude product was purified using flash 
silica chromatography [1:4 EtOAc:Hexane, Rf 0.14] to afford (2S,3R)-methyl 3-hydroxy-2-
methyl-3-((1S,2S)-2-methylcyclopropyl)propanoate 506 (0.16 g, 0.93 mmol) as a colourless oil 
in 76% yield. 1H NMR (300 MHz, CDCl3) δH = 3.69 (3H, s, OCH3), 3.08 (1H, dd, J = 8.7, 5.1 Hz, 
CHOH), 2.67 (1H, qd, J = 7.0, 5.1 Hz, (C=O)CH), 2.26 (1H, broad s, OH), 1.24 (3H, d, J = 7.0 Hz, 
(C=O)CHCH3), 0.98 (3H, d, J = 5.9 Hz, cyclopropyl-CH3), 0.69-0.54 (2H, m, CHOHCHCHAHB and 
CHCH3), 0.54-0.46 (1H, m, cyclopropyl-CHAHB), 0.31-0.26 (1H, m, cyclopropyl-CHAHB); 
13C NMR 
(75 MHz, CDCl3) δC = 175.9, 76.8, 51.8, 45.6, 23.9, 18.3, 12.4, 11.4, 11.3; IR cm
-1 ν = 3444 (OH), 
1718 (C=O); HRMS: m/z (ES) 195.0995 C9H16NaO3 [M+Na]+ requires 195.0997;  
25
D][  = +32.0 














(2S,3R)-Methyl 3-hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoate, 507 
 
The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2S,3R)-3-hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoyl)-5,5-
dimethyloxazolidin-2-one 494 (0.50 g, 1.23 mmol) and sodium methoxide (2.45 mL, 1.23 mmol, 
0.5 M in methanol) in dichloromethane (50 mL). The crude product was purified using flash 
silica chromatography [3:7 EtOAc:Petroleum ether, Rf 0.49] to afford (2S,3R)-methyl 3-hydroxy-
2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoate 507 (0.27 g, 1.15 mmol) as a white 
crystalline solid in 94% yield. 1H NMR (300 MHz, CDCl3) δH = 7.28-7.23 (2H, m, Ph), 7.18-7.13 
(1H, m, Ph), 7.06-7.04 (2H, m, Ph), 3.61 (3H, s, OCH3), 3.44 (1H, dd, 8.0, 4.7 Hz, CHOH), 2.76 
(1H, qd, J = 7.2, 4.7 Hz, CHCH3), 2.51 (1H, broad s, OH), 1.87-1.80 (1H, m, cyclopropyl-Ph), 1.38-
1.31 (1H, m, CHOHCHCHAHB), 1.28 (3H, d, J = 7.2 Hz, CHCH3), 1.12-1.05 (1H, m, cyclopropyl-
CHAHB), 1.01-0.95 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 176.0, 142.1, 
128.5, 126.0, 125.9, 75.8, 51.9, 45.3, 26.4, 21.3, 14.0, 12.1; IR cm-1 ν = 3439 (OH), 1730 (C=O); 
HRMS: m/z (ES) 257.1148, C14H18NaO3 [M+Na]
+ requires 257.1153;  
25
D][  = +74.0 (c = 0.5 













(2S,3R)-Methyl 3-((S)-2,2-dimethylcyclopropyl)-3-hydroxy-2-methylpropanoate, 508 
 
The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2S,3R)-3-((S)-2,2-dimethylcyclopropyl)-3-hydroxy-2-methylpropanoyl)-5,5-
dimethyloxazolidin-2-one 495 (0.20 g, 0.56 mmol) and sodium methoxide (1.11 mL, 0.56 mmol, 
0.5 M in methanol) in dichloromethane (20 mL). The crude product was purified using flash 
silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.47] to afford (2S,3R)-methyl 3-((S)-2,2-
dimethylcyclopropyl)-3-hydroxy-2-methylpropanoate 508 (0.09 g, 0.49 mmol) as a colourless 
liquid in 89% yield. 1H NMR (300 MHz, CDCl3) δH = 3.71 (3H, s, OCH3), 3.49 (1H, dd, J = 9.6, 4.1 
Hz, CHOH), 2.64 (1H, qd, J = 7.1, 4.4 Hz, (C=O)CH), 2.25 (1H, s, OH), 1.26 (3H, d, J = 7.1 Hz, 
CHCH3), 1.06 (3H, s, (CH3)(CH3)), 1.03 (3H, s, (CH3)(CH3)), 0.82-0.74 (1H, m, CHOHCHCHAHB), 
0.59-0.55 (1H, m, cyclopropyl-CHAHB), 0.34-0.31 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, 
CDCl3) δC = 176.0, 73.2, 51.9, 45.5, 28.3, 27.3, 20.7, 18.6, 16.9, 11.3; IR cm
-1 ν = 3451 (OH), 1721 
(C=O); HRMS: m/z (ES) 209.1136, C10H18NaO3 [M+Na]
+ requires 209.1153;  
25
D][  = +46.0 (c = 














(2S,3R)-Methyl 3-((1S,2S)-2-hexylcyclopropyl)-3-hydroxy-2-methylpropanoate, 509 
 
The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2S,3R)-3-((1S,2S)-2-hexylcyclopropyl)-3-hydroxy-2-methylpropanoyl)-5,5-dimethyloxazolidin-
2-one 496 (0.43 g, 1.05 mmol) and sodium methoxide (2.10 mL, 1.05 mmol, 0.5 M in methanol) 
in dichloromethane (40 mL). The crude product was purified using flash silica chromatography 
[1:4 EtOAc:Petroleum ether, Rf 0.41] to afford (2S,3R)-methyl 3-((1S,2S)-2-hexylcyclopropyl)-3-
hydroxy-2-methylpropanoate 509 (0.19 g, 0.78 mmol) as a colourless liquid in 74% yield. 1H 
NMR (300 MHz, CDCl3) δH = 3.70 (3H, s, OCH3), 3.16 (1H, dd, J = 8.6, 4.3 Hz, CHOH), 2.68 (1H, 
qd, J = 7.1, 4.3 Hz, CHCH3), 2.15 (1H, broad s, OH), 1.27 (3H, d, J = 7.1 Hz, CHCH3), 1.30-1.11 
(10H, m, C5H10), 0.90-0.85 (3H, m, C5H10CH3), 0.74-0.47 (3H, m, CHCH3, CHOHCHCHAHB, 
cyclopropyl-CHAHB), 0.37-0.31 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 176.1, 
76.5, 51.9, 45.2, 33.7, 32.0, 29.5, 29.3, 22.8, 22.6, 17.2, 14.2, 11.7, 10.6; IR cm-1 ν = 3473 (OH), 
1736 (C=O); HRMS: m/z (ES) 265.1777, C14H26NaO3 [M+Na]
+ requires 265.1779;  
25
D][  = +38.0 
















The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-((S)-2-
((R)-hydroxy((1S,2S)-2-methylcyclopropyl)methyl)-3-methylbutanoyl)-5,5-dimethyloxazolidin-
2-one 497 (0.41 g, 1.10 mmol) and sodium methoxide (2.19 mL, 1.10 mmol, 0.5 M in methanol) 
in dichloromethane (40 mL). The reaction was stirred for 24 hours before quenching with 
brine. The crude product was purified using flash silica chromatography [1:9 EtOAc:Petroleum 
ether, Rf 0.39] to afford (S)-methyl-2-((R)-hydroxy((1S,2S)-2-methylcyclopropyl)methyl)-3-
methylbutanoate 510 (0.18 g, 0.90 mmol) as a colourless liquid in 82% yield. 1H NMR (300 
MHz, CDCl3) δH = 3.69 (3H, s, OCH3), 3.18 (1H, app. t, J = 8.0 Hz, CHOH), 2.53 (1H, dd, J = 8.0, 6.1 
Hz, (C=O)CH), 2.21 (1H, app. sex., J = 6.8 Hz, CHCH(CH3)(CH3)), 1.70 (1H, broad s, OH), 1.00-0.97 
(9H, m, CH(CH3)(CH3) and cyclopropyl-CH3), 0.78-0.64 (2H, m, CHOHCHCHAHB and CHCH3), 0.50-
0.44 (1H, m, cyclopropyl-CHAHB), 0.30-0.24 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, 
CDCl3) δC = 173.9, 74.9, 58.4, 51.2, 27.3, 25.3, 21.6, 18.9, 18.4, 12.6, 10.9; IR cm
-1 ν = 3451 (OH), 
1731 (C=O); HRMS: m/z (ES) 223.1293, C11H20NaO3 [M+Na]
+ requires 223.1305;  
25
D][  = +12.0 















The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2S,3R)-3-hydroxy-2-methyl-3-((1S,2S)-2-(4-nitrophenyl)cyclopropyl)propanoyl)oxazolidin-2-
one 498 (0.40 g, 0.94 mmol) and sodium methoxide (1.88 mL, 0.94 mmol, 0.5 M in methanol) 
in dichloromethane (40 mL). The crude product was purified using flash silica chromatography 
[2:3 EtOAc:Petroleum ether, Rf 0.20] to afford (2S,3R)-methyl3-hydroxy-2-methyl-3-((1S,2S)-2-
(4-nitrophenyl)cyclopropyl)propanoate 511 (0.20 g, 0.72 mmol) as an orange crystalline solid in 
76% yield. 1H NMR (300 MHz, CDCl3) δH = 8.10 (2H, d, J = 8.9 Hz, C6H2H2NO2), 7.15 (2H, d, J = 8.8 
Hz, C6H2H2NO2), 3.61 (3H, s, OCH3), 3.54 (1H, dd, J = 7.2, 4.6 Hz, CHOH), 2.73 (1H, qd, J = 7.1, 
4.7 Hz, (C=O)CH), 2.47 (1H, broad s, OH), 1.99-1.92 (1H, m, CH-aryl), 1.44-1.35 (1H, m, 
CHOHCHCHAHB), 1.30-1.22 (1H, m, cyclopropyl-CHAHB), 1.26 (3H, d, J = 7.1 Hz, (C=O)CHCH3)), 
1.10-1.04 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 175.8, 150.7, 146.2, 126.3, 
123.9, 74.6, 52.0, 45.3, 28.0, 21.2, 15.1, 12.2; IR cm-1 ν = 3483 (OH), 1706 (C=O); HRMS: m/z 
(ES) 302.1003, C14H17NNaO5 [M+Na]
+ requires 302.1004;  
25

















The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2S,3R)-3-hydroxy-3-((1S,2S)-2-(4-methoxyphenyl)cyclopropyl)-2-methylpropanoyl)-5,5-
dimethyloxazolidin-2-one 499 (0.08 g, 0.18 mmol) and sodium methoxide (0.37 mL, 0.18 mmol, 
0.5 M in methanol) in dichloromethane (10 mL). The crude product was purified using flash 
silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.29] to afford (2S,3R)-methyl-3-
hydroxy-3-((1S,2S)-2-(4-methoxyphenyl)cyclopropyl)-2-methylpropanoate 512 (0.03 g, 0.11 
mmol) as a white crystalline solid in 62% yield. 1H NMR (300 MHz, CDCl3) δH = 6.97 (2H, d, J = 
8.7 Hz, C6H2H2COMe), 6.80 (2H, d, 8.7 Hz, C6H2H2COMe), 3.77 (3H, s, C6H4COCH3), 3.61 (3H, s, 
OCH3), 3.39 (1H, dd, J = 8.2, 4.7 Hz, CHOH), 2.75 (1H, qd, J = 7.1, 4.7 Hz, CHCH3), 2.44 (1H, 
broad s, OH), 1.82-1.75 (1H, m, cyclopropyl-aryl), 1.30-1.21 (1H, m, CHOHCHCHAHB), 1.27 (3H, 
d, J = 7.1 Hz, CHCH3), 1.04-0.98 (1H, m, cyclopropyl-CHAHB), 0.91-0.87 (1H, m, cyclopropyl-
CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 175.9, 157.9, 134.0, 127.1, 114.0, 76.0, 55.4, 51.9, 45.4, 
25.9, 20.6, 13.5, 12.2; IR cm-1 ν = 3508 (OH), 1721 (C=O); HRMS: m/z (ES) 287.1246, C15H20NaO4 
[M+Na]+ requires 287.1259; 
25















The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2S,3R)-3-hydroxy-2-(4-methoxyphenyl)-3-((1S,2S)-2-methylcyclopropyl)propanoyl)-5,5-
dimethyloxazolidin-2-one 500 (0.09 g, 0.21 mmol) and sodium methoxide (0.41 mL, 0.21 mmol, 
0.5 M in methanol) in dichloromethane (10 mL). The crude product was purified using flash 
silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.13] to afford (2S,3R)-methyl-3-
hydroxy-2-(4-methoxyphenyl)-3-((1S,2S)-2-methylcyclopropyl)propanoate 513 (0.03 g, 0.11 
mmol) as a white crystalline solid in 55% yield. 1H NMR (300 MHz, CDCl3) δH = 7.32 (2H, d, J = 
8.7 Hz, C6H2H2COMe), 6.88 (2H, d, J = 8.7 Hz, C6H2H2COMe), 3.80 (3H, s, C6H4COCH3), 3.72-3.69 
(1H, m, CH-aryl), 3.70 (3H, s, OCH3), 3.47-3.40 (1H, m, CHOH), 2.14 (1H, broad s, OH), 0.99 (3H, 
d, J = 6.0 Hz, CHCH3), 0.73-0.56 (3H, m, CHOHCHCHAHB, CHCH3 and cyclopropyl-CHAHB), 0.33-
0.26 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 173.6, 159.3, 130.4, 127.5, 
114.2, 77.0, 57.4, 55.4, 52.0, 24.2, 18.3, 11.7, 11.6; IR cm-1 ν = 3436 (OH), 1727 (C=O); HRMS: 
m/z (ES) 287.1248, C15H20NaO4 [M+Na]
+ requires 287.1259; 
25














(2R,3R)-Methyl 3-hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoate, 514 
 
The title compound was prepared according to General Procedure 3 from (S)-4-benzyl-3-
((2R,3R)-3-hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoyl)-5,5-
dimethyloxazolidin-2-one 510 (1.23 g, 3.02 mmol) and sodium methoxide (6.03 mL, 3.02 mmol, 
0.5 M in methanol) in dichloromethane (35 mL). The crude product was purified using flash 
silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.11] to afford (2R,3R)-methyl 3-
hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoate 514 (0.55 g, 2.35 mmol) as a 
colourless oil in 78% yield. 1H NMR (300 MHz, CDCl3) δH = 7.28-7.23 (2H, m, Ph), 7.18-7.13 (1H, 
m, Ph), 7.06-7.03 (2H, m, Ph), 3.69 (3H, s, OCH3), 3.39 (1H, app. t, J = 7.7, CHOH), 3.12 (1H, 
broad s, OH), 2.72 (1H, app. quin., J = 7.2 Hz, CHCH3), 1.92-1.85 (1H, m, cyclopropyl-Ph), 1.24 
(3H, d, J = 7.2 Hz, CHCH3 and 1H, m, CHOHCHCHAHB), 1.10-1.04 (1H, m, cyclopropyl-CHAHB), 
1.00-0.94 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 176.1, 142.0, 128.3, 125.7, 
76.2, 51.7, 46.4, 27.4, 21.6, 13.9, 12.6; IR cm-1 ν = 3456 (OH), 1719 (C=O); HRMS: m/z (ES) 
257.1138, C14H18NaO3 [M+Na]
+ requires 257.1153; 
25














4.1.6 Synthesis of Highly Substituted δ-Lactones 526-532 
Synthesis of δ-Lactones – General Procedure 4 
 
Mercury trifluoroacetate (2.5 equiv.) was added in one portion to a stirred solution of the 
appropriate methyl ester syn-aldol cyclopropane 506-514 (1 equiv.) in dichloromethane. The 
resulting yellow solution was stirred at ambient temperature for 24 hours under nitrogen, 
before being quenched with brine and stirred for a further one hour. The organic layer was 
extracted with brine and the aqueous layer was extracted further with ethyl acetate. The 
organic layers were combined, dried over MgSO4 and concentrated to afford the 
corresponding organomercurial δ-lactone. This was subsequently dissolved in methanol and 
cooled to 0 ˚C under nitrogen. Sodium borohydride (3 equiv.) was dissolved in 3.5 M sodium 
hydroxide and was added in one portion to the solution of organomercurial δ-lactone. The 
resulting dark grey solution was stirred for two minutes at 0 ˚C and was then quenched with 1 
M HCl solution to pH 2. The methanol was evaporated, the aqueous layer was saturated with 
NaCl and the resulting brine solution was extracted with three portions of ethyl acetate. The 
organic extracts were combined, dried over MgSO4 and concentrated to afford the 
corresponding tetrasubstituted δ-lactone. The crude product was purified using flash silica 













The title compound was prepared according to General Procedure 4 from (2S,3R)-methyl 3-
hydroxy-2-methyl-3-((1S,2S)-2-methylcyclopropyl)propanoate 506 (0.10 g, 0.58 mmol) and 
mercury trifluoroacetate (0.62 g, 1.45 mmol) in dichloromethane (10 mL). The reaction was 
stirred for 24 hours before being quenched with brine. The organomercurial δ-lactone 
underwent reductive demercuration with sodium borohydride (0.066 g, 1.74 mmol) dissolved 
in 3.5 M NaOH (2.8 mL) and methanol (3 mL). The crude product was purified using flash silica 
chromatography [3:7 EtOAc:Petroleum ether, Rf 0.20] to afford (3S,4R,5R,6S)-4-hydroxy-3,5,6-
trimethyltetrahydro-2H-pyran-2-one 526 (0.065 g, 0.41 mmol) as a white solid in 71% yield. 1H 
NMR (300 MHz, CDCl3) δH = 3.99 (1H, dq, J = 10.3, 6.2 Hz, OCHCH3), 3.29 (1H, app. t, J = 10.0 Hz, 
CHOH), 2.39 (1H, dq, J = 10.0, 7.1 Hz, COCHCH3), 1.95 (1H, broad s, OH), 1.64 (1H, ddq, J = 10.3, 
10.0, 6.5 Hz, CHOHCHCH3CHCH3), 1.40 (3H, d, J = 7.1 Hz, COCHCH3), 1.40 (3H, d, J = 6.2 Hz, 
OCHCH3), 1.09 (3H, d, J = 6.5 Hz, CHOHCHCH3CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 173.2, 
78.7, 75.4, 44.7, 43.1, 20.0, 14.0, 13.3; IR cm-1 ν = 3423 (OH), 1711 (C=O); HRMS: m/z (ES) 
181.0834, C8H14NaO3 [M+Na]
+ requires 181.0840;  
25















The title compound was prepared according to General Procedure 4 from (2S,3R)-methyl 3-
hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoate 507 (0.27 g, 1.14 mmol) and 
mercury trifluoroacetate (1.21 g, 2.84 mmol) in dichloromethane (50 mL). The reaction was 
stirred for 24 hours before being quenched with brine. The organomercurial δ-lactone 
underwent reductive demercuration with sodium borohydride (0.13 g, 3.41 mmol) dissolved in 
3.5 M NaOH (5.6 mL) and methanol (6 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.08] to afford (3S,4R,5R,6R)-4-hydroxy-3,5-
dimethyl-6-phenyltetrahydro-2H-pyran-2-one 527 (0.20 g, 0.92 mmol) as a white solid in 81% 
yield. 1H NMR (300 MHz, CDCl3) δH = 7.39-7.28 (5H, m, Ph), 4.76 (1H, d, J = 10.8 Hz, CHPh), 3.48 
(1H, app. t, J = 10.1 Hz, CHOH), 2.57 (1H, dq, J = 10.0, 7.0 Hz, COCHCH3), 2.16 (1H, broad s, OH), 
2.04 (1H, ddq, J = 10.8, 10.1, 6.5 Hz, CHOHCHCH3), 1.48 (3H, d, J = 7.0 Hz, COCHCH3), 0.92 (3H, 
d, J = 6.6 Hz, CHOHCHCH3); 
13C NMR (75 MHz, CDCl3) δC = 173.1, 137.8, 129.1, 128.8, 127.5, 
84.8, 75.5, 44.9, 42.8, 14.0, 13.3; IR cm-1 ν = 3426 (OH), 1686 (C=O); HRMS: m/z (ES) 243.0986, 
C13H16NaO3 [M+Na]
+ requires 243.0997;  
25














The title compound was prepared according to General Procedure 4 from (2S,3R)-methyl 3-
((S)-2,2-dimethylcyclopropyl)-3-hydroxy-2-methylpropanoate 508 (0.17 g, 0.91 mmol) and 
mercury trifluoroacetate (0.99 g, 2.34 mmol) in dichloromethane (30 mL). The reaction was 
stirred for 24 hours before being quenched with brine. The organomercurial δ-lactone 
underwent reductive demercuration with sodium borohydride (0.10 g, 2.74 mmol) dissolved in 
3.5 M NaOH (4.6 mL) and methanol (5 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.09] to afford (3S,4R,5R)-4-hydroxy-3,5,6,6-
tetramethyltetrahydro-2H-pyran-2-one 528 (0.081 g, 0.48 mmol) as a colourless gum in 52% 
yield. 1H NMR (300 MHz, CDCl3) δH = 3.45 (1H, app. t, J = 9.9 Hz, CHOH), 2.36 (1H, dq, J = 9.7, 
7.0 Hz, COCHCH3), 2.12 (1H, broad s, OH), 1.83 (1H, dq, J = 10.8, 6.8 Hz, 
CHOHCHCH3C(CH3)(CH3)), 1.43 (3H, s, C(CH3)(CH3)), 1.39 (3H, d, J = 7.0 Hz, COCHCH3), 1.24 (3H, 
s, C(CH3)(CH3)), 1.11 (3H, d, J = 6.8 Hz, CHOHCHCH3 C(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δC = 
173.5, 83.9, 73.3, 45.3, 44.8, 28.9, 23.6, 14.1, 12.9; IR cm-1 ν = 3430 (OH), 1686 (C=O); HRMS: 
m/z (ES) 173.1157, C9H17O3 [M+H]
+ requires 173.1177;  
25















The title compound was prepared according to General Procedure 4 from (2S,3R)-methyl 3-
((1S,2S)-2-hexylcyclopropyl)-3-hydroxy-2-methylpropanoate 509 (0.14 g, 0.58 mmol) and 
mercury trifluoroacetate (0.61 g, 1.44 mmol) in dichloromethane (25 mL). The reaction was 
stirred for 24 hours before being quenched with brine. The organomercurial δ-lactone 
underwent reductive demercuration with sodium borohydride (0.066 g, 1.73 mmol) dissolved 
in 3.5 M NaOH (2.9 mL) and methanol (3 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.17] to afford (3S,4R,5R,6S)-6-hexyl-4-
hydroxy-3,5-dimethyltetrahydro-2H-pyran-2-one 529 (0.087 g, 0.38 mmol) as a white solid in 
66% yield. 1H NMR (300 MHz, CDCl3) δH = 3.89 (1H, m, OCHC6H13), 3.28 (1H, t, J = 10.0 Hz, 
CHOH), 2.37 (1H, dq, J = 10.0, 7.0 Hz, COCHCH3), 1.93 (1H, broad s, OH), 1.82-1.48 (5H, 
complex m, CHOHCHCH3CHC6H13 and C2H4C4H9), 1.40 (3H, d, J = 7.0 Hz, COCHCH3), 1.33-1.28 
(6H, m, C3H6CH3), 1.08 (3H, d, J = 6.5 Hz, CHOHCHCH3CHC6H13), 0.90-0.86 (3H, m, C3H6CH3); 
13C 
NMR (75 MHz, CDCl3) δC = 173.4, 82.0, 75.2, 44.4, 40.5, 33.0, 31.7, 29.2, 24.2, 22.6, 14.1, 13.8, 
13.3; IR cm-1 ν = 3518 (OH), 1707 (C=O); HRMS: m/z (ES) 251.1613, C13H24NaO3 [M+Na]
+ 
requires 251.1623;  
25














The title compound was prepared according to General Procedure 4 from (S)-methyl-2-((R)-
hydroxy((1S,2S)-2-methylcyclopropyl)methyl)-3-methylbutanoate 510 (0.11 g, 0.55 mmol) and 
mercury trifluoroacetate (0.58 g, 1.37 mmol) in dichloromethane (20 mL). The reaction was 
stirred for 24 hours before being quenched with brine. The organomercurial δ-lactone 
underwent reductive demercuration with sodium borohydride (0.062 g, 1.65 mmol) dissolved 
in 3.5 M NaOH (2.7 mL) and methanol (3 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.20] to afford (3S,4R,5R,6S)-4-hydroxy-3-
isopropyl-5,6-dimethyltetrahydro-2H-pyran-2-one 530 (0.073 g, 0.40 mmol) as a colourless 
gum in 72% yield. 1H NMR (300 MHz, CDCl3) δH = 3.95 (1H, dq, J = 10.3, 6.3 Hz, OCHCH3), 3.48 
(1H, dd, J = 10.1, 7.5 Hz, CHOH), 2.45 (1H, dd, J = 7.6, 3.8 Hz, COCH), 2.42-2.33 (1H, m, J = 6.9, 
3.8 Hz, CH(CH3)2), 1.77 (1H, broad s, OH), 1.59 (1H, app. tq, J = 10.2, 6.6 Hz, CHOHCHCH3), 1.36 
(3H, d, J = 6.3 Hz, COCHCH3), 1.11 (3H, d, J = 6.8 Hz, CH(CH3)(CH3)), 1.08 (3H, d, J = 6.6 Hz, 
CHOHCHCH3), 1.06 (3H, d, J = 6.8 Hz, CH(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δC = 172.3, 77.3, 
72.2, 56.4, 43.0, 29.9, 20.5, 19.8, 19.6, 13.4; IR cm-1 ν = 3412 (OH), 1702 (C=O); HRMS: m/z (ES) 
209.1152, C10H18NaO3 [M+Na]
+ requires 209.1153;  
25














The title compound was prepared according to General Procedure 4 from (2S,3R)-methyl-3-
hydroxy-2-methyl-3-((1S,2S)-2-(4-nitrophenyl)cyclopropyl)propanoate 511 (0.11 g, 0.40 mmol) 
and mercury trifluoroacetate (0.43 g, 1.01 mmol) in dichloromethane (15 mL). The reaction 
was stirred for five days before being quenched with brine. The organomercurial δ-lactone 
underwent reductive demercuration with sodium borohydride (0.046 g, 1.21 mmol) dissolved 
in 3.5 M NaOH (2.0 mL) and methanol (3 mL). The crude product was purified using flash silica 
chromatography [3:7 EtOAc:Petroleum ether, Rf 0.17] to afford (3S,4R,5R,6R)-4-hydroxy-3,5-
dimethyl-6-(4-nitrophenyl)tetrahydro-2H-pyran-2-one 531 (0.055 g, 0.21 mmol) as a white 
solid in 51% yield. 1H NMR (300 MHz, CDCl3) δH = 8.24 (2H, d, J = 8.8 Hz, C6H2H2CNO2), 7.49 (2H, 
d, J = 8.8 Hz, C6H2H2CNO2), 4.90 (1H, d, J = 10.8 Hz, CHAr), 3.50 (1H, app. t, J = 10.0 Hz, CHOH), 
2.61 (1H, dq, J = 9.9, 7.0 Hz, COCH), 1.99 (1H, ddq, J = 10.8, 10.2, 6.5 Hz, CHArCHCH3), 1.47 (3H, 
d, J = 7.0 Hz, COCHCH3), 0.92 (3H, d, J = 6.5 Hz, CHArCHCH3); 
13C NMR (75 MHz, CDCl3) δC = 
172.7, 148.3, 144.8, 128.4, 124.0, 83.4, 75.2, 44.9, 42.9, 13.9, 13.1; IR cm-1 ν = 3477 (OH), 1713 
(C=O); HRMS: m/z (ES) 288.0821, C13H15NNaO5 [M+Na]
+ requires 288.0847;  
25
D][  = -8.0 (c = 














The title compound was prepared according to General Procedure 4 from (2R,3R)-methyl 3-
hydroxy-2-methyl-3-((1S,2S)-2-phenylcyclopropyl)propanoate 514 (0.250 g, 1.07 mmol) and 
mercury trifluoroacetate (1.13 g, 2.67 mmol) in dichloromethane (25 mL). The reaction was 
stirred for 24 hours before being quenched with brine. The organomercurial δ-lactone 
underwent reductive demercuration with sodium borohydride (0.12 g, 3.20 mmol) dissolved in 
3.5 M NaOH (5.3 mL) and methanol (6 mL). The crude product was purified using flash silica 
chromatography [3:7 EtOAc:Petroleum ether, Rf 0.25] to afford (3R,4R,5R,6R)-4-hydroxy-3,5-
dimethyl-6-phenyltetrahydro-2H-pyran-2-one 532 (0.18 g, 0.82 mmol) as a white solid in 77% 
yield. 1H NMR (300 MHz, CDCl3) δH = 7.34 (5H, app. s, Ph), 4.71 (1H, d, J = 10.7 Hz, CHPh), 3.87 
(1H, app. t, J = 3.9 Hz, CHOH), 2.82 (1H, qd, J = 6.8, 4.3 Hz, COCHCH3), 2.74 (1H, broad s, OH), 
2.13 (1H, m, CHCH3CHPh), 1.32 (3H, d, J = 6.9 Hz, COCHCH3), 0.92 (3H, d, J = 7.1 Hz, 
CHOHCHCH3CHPh);
 13C NMR (75 MHz, CDCl3) δC = 174.6, 137.7, 128.9, 128.6, 127.6, 84.1, 75.0, 
44.7, 39.4, 15.6, 11.2; IR cm-1 ν = 3423 (OH), 1709 (C=O); HRMS: m/z (ES) 243.0983, C13H16NaO3 
[M+Na]+ requires 243.0997;  
25












4.1.7 Synthesis of Compounds for Highly Substituted δ-Lactones with a Synthetic Handle 
(Z)-4-(Benzyloxy)but-2-en-1-ol, 534 
 
Based on a literature procedure,187 sodium hydride (0.48 g, 11.35 mmol, 60% dispersion in 
mineral oil) was added portionwise to N,N-dimethylformamide (40 mL) at -20 ˚C under 
nitrogen. The resulting suspension was stirred for five minutes before (Z)-but-2-ene-1,4-diol 
(1.00 mL, 11.35 mmol) was added dropwise. The solution was stirred for a further 20 minutes 
before benzyl bromide (1.45 mL, 11.35 mmol) was added dropwise. The resulting solution was 
then stirred at -20 ˚C for five hours. The reaction was warmed to room temperature and was 
quenched with water (60 mL). The mixture was extracted three times with ether, combined 
organic extracts were dried over MgSO4 and concentrated. The crude product was purified 
using flash silica chromatography [1:3 EtOAc:Petroleum ether, Rf 0.45] to afford (Z)-4-
(benzyloxy)but-2-en-1-ol 534 (1.55 g, 8.70 mmol) as a colourless liquid in 73% yield. 1H NMR 
(300 MHz, CDCl3) δH = 7.27-7.17 (5H, m, Ph), 5.78-5.61 (2H, m, CH=CH), 4.44 (2H, s, OCH2Ph), 
4.08 (2H, d, J = 5.9 Hz, CH2O), 4.01 (2H, d, J = 5.9 Hz, CH2O), 1.91 (1H, broad s, OH); 
13C NMR (75 
MHz, CDCl3) δC = 138.0, 132.5, 128.6, 128.5, 128.0, 127.9, 72.7, 65.8, 58.9; IR cm
-1 ν = 3295 
(OH); HRMS: m/z (ES) 201.0885, C11H14NaO2 [M+Na]
















Based on a literature procedure,187 oxalyl chloride (0.26 mL, 3.09 mmol) was dissolved in dry 
dichloromethane (10 mL) at -55 ˚C under nitrogen. Dimethylsulfoxide (0.39 mL, 5.61 mmol) 
was added and the resulting solution was stirred for two minutes. (Z)-4-(benzyloxy)but-2-en-1-
ol 534 (0.50 g, 2.81 mmol) in dichloromethane (1 mL) was added dropwise to the solution to 
form a light yellow cloudy mixture, which was stirred for 15 minutes at -55 ˚C. Triethylamine 
(1.96 mL, 14.03 mmol) was then added and the resulting solution was stirred for a further 15 
minutes at -55 ˚C. The thick white slurry was warmed to room temperature and was quenched 
with the addition of water (10 mL). The layers were separated and the aqueous layer was 
extracted three times with dichloromethane (20 mL). The combined organic layers were 
washed with 1 M HCl (10 mL) and saturated NaHCO3 before being dried over MgSO4 and 
concentrated. The crude product was purified using flash silica chromatography [1:8 
EtOAc:Petroleum ether, Rf 0.25] to afford (Z)-4-(benzyloxy)but-2-enal 535 (0.42 g, 2.39 mmol) 
as a colourless liquid in 84% yield. The pure material was initially a 50:50 mixture of cis and 
trans alkene, but after cooling in the fridge overnight at 4 ˚C, the cis isomer was present in a 
99:1 ratio. 1H NMR (300 MHz, CDCl3) δH = 10.05 (1H, d, J = 6.8 Hz, CHO), 7.37-7.31 (5H, m, Ph), 
6.64 (1H, dt, J = 11.6, 5.8 Hz, CH=CHCHO), 6.06 (1H, ddt, J = 11.6, 6.8, 1.9 Hz, CHCHO), 4.59 (2H, 
s, OCH2Ph), 4.53 (2H, dd, J = 5.5, 1.9 Hz, CH2OBn); 
13C NMR (75 MHz, CDCl3) δC = 191.6, 147.7, 













Based on a literature procedure,187 (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 95 
(0.50 g, 1.91 mmol) was dissolved in dry dichloromethane (20 mL) at -10 ˚C under nitrogen and 
was stirred for 20 minutes. Dibutylboron triflate (2.29 mL, 2.30 mmol, 1.0 M in 
dichloromethane) was added dropwise followed by triethylamine (0.35 mL, 2.49 mmol) and 
the resulting solution was stirred for 30 minutes at 0 ˚C. The reaction was cooled to -78 ˚C and 
(Z)-4-(benzyloxy)but-2-enal 535 (0.37 g, 2.11 mmol) was added dropwise. The solution was 
stirred at -78 ˚C for 45 minutes and then warmed to 0 ˚C and stirred for a further three hours. 
The reaction was cooled to -10 ˚C and pH 7 buffer solution (Na2PO4/NaH2PO4) (10 mL) was 
added followed by methanol (8 mL) and hydrogen peroxide (4 mL). The methanol was 
evaporated, the solution diluted with dichloromethane and washed with saturated NaHCO3 
and brine. The combined organic extracts were dried over MgSO4 and concentrated. The crude 
product was purified using flash silica chromatography [1:2 EtOAc:Petroleum ether, Rf 0.63] to 
afford (S)-4-benzyl-3-((2S,3R,Z)-6-(benzyloxy)-3-hydroxy-2-methylhex-4-enoyl)-5,5-
dimethyloxazolidin-2-one 536 (0.74 g, 1.68 mmol) as a colourless gum, which crystallised on 
standing to form white crystals in 88% yield. 1H NMR (300 MHz, CDCl3) δH = 7.29-7.12 (10H, m, 
Ph), 5.71-5.52 (2H, m, CH=CH), 4.63-4.49 (1H, m, CHOH), 4.44-4.39 (3H, m, CH2OBn and CHN), 
4.10 (1H, ddd, J = 12.7, 6.5, 1.3 Hz, CHAHBOBn), 4.00 (1H, ddd, J = 12.6, 5.5, 1.3 Hz, CHAHBOBn), 
3.87 (1H, m, CHCH3), 2.97 (1H, dd, J = 14.3, 4.5 Hz, CHAHBPh), 2.81 (1H, dd, J = 14.3, 9.0 Hz, 
CHAHBPh), 2.73 (1H, broad s, OH), 1.30 (3H, s, C(CH3)(CH3)), 1.26 (3H, s, C(CH3)(CH3)), 1.11 (3H, 
d, J = 7.0 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 175.9, 152.6, 138.1, 136.7, 132.1, 129.6, 
129.2, 128.7, 128.5, 127.9, 127.8, 126.9, 82.4, 72.5, 69.0, 66.2, 63.4, 43.1, 35.5, 28.4, 22.2. 
12.4; IR cm-1 ν = 3477 (OH), 1771 (C=Oox), 1692 (C=O); HRMS: m/z (ES) 460.2097, C26H31NNaO5 
[M+Na]+ requires 460.2099; [α]D






Based on a literature procedure,187 oxalyl chloride (0.26 mL, 3.09 mmol) was dissolved in dry 
dichloromethane (10 mL) at -55 ˚C under nitrogen. Dimethylsulphoxide (0.39 mL, 5.61 mmol) 
was added and the resulting solution was stirred for two minutes. (Z)-4-(benzyloxy)but-2-en-1-
ol 534 (0.50 g, 2.81 mmol) in dichloromethane (1 mL) was added dropwise to the solution to 
form a light yellow cloudy mixture, which was stirred for 15 minutes at -55 ˚C. Triethylamine 
(1.96 mL, 14.03 mmol) was then added and the resulting solution was stirred for a further 15 
minutes at -55 ˚C. The thick white slurry was warmed to room temperature and was quenched 
with the addition of water (10 mL). The layers were separated and the aqueous layer was 
extracted three times with dichloromethane (20 mL). The combined organic layers were 
washed with 1 M HCl (10 mL) and saturated NaHCO3 before being dried over MgSO4 and 
concentrated. The crude product was purified using flash silica chromatography [1:8 
EtOAc:Petroleum ether, Rf 0.25] to afford a 50:50 mixture of cis 535 and trans 537 alkene (0.42 
g, 2.39 mmol) as a colourless liquid in 84% yield. The pure material was dissolved in 
dichloromethane (1 mL) with a catalytic amount of p-TSA and left at room temperature 
overnight to isomerise to the trans isomer (E)-4-(benzyloxy)but-2-enal 537 in a 99:1 ratio. 1H 
NMR (300 MHz, CDCl3) δH = 9.58 (1H, d, J = 7.9 Hz, CHO), 7.39-7.28 (5H, m, Ph), 6.85 (1H, dt, J = 
15.8, 4.1 Hz, CH=CHCHO), 6.41 (1H, ddt, J = 15.8, 7.9, 1.9 Hz, CHCHO), 4.60 (2H, s, OCH2Ph), 
4.29 (2H, dd, J = 4.1, 1.9 Hz, CH2OBn); 
13C NMR (75 MHz, CDCl3) δC = 193.4, 153.2, 137.5, 131.9, 
128.6, 128.1, 127.8, 73.1, 68.7; IR cm-1 ν = 1681 (C=O); HRMS: m/z (ES) 199.0737, C11H12NaO2 











Based on a literature procedure,187 (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 95 
(1.95 g, 7.46 mmol) was dissolved in dry dichloromethane (50 mL) at -10 ˚C under nitrogen and 
was stirred for 20 minutes. Dibutylboron triflate (8.97 mL, 8.95 mmol, 1.0 M in 
dichloromethane) was added dropwise followed by triethylamine (1.35 mL, 9.70 mmol) and 
the resulting solution was stirred for 30 minutes at 0 ˚C. The reaction was cooled to -78 ˚C and 
(E)-4-(benzyloxy)but-2-enal 537 (1.45 g, 8.21 mmol) was added dropwise. The solution was 
stirred at -78 ˚C for 45 minutes and then warmed to 0 ˚C and stirred for a further three hours. 
The reaction was cooled to -10 ˚C and pH 7 buffer solution (Na2PO4/NaH2PO4) (30 mL) was 
added followed by methanol (24 mL) and hydrogen peroxide (12 mL). The methanol was 
evaporated, the solution diluted with dichloromethane and washed with saturated NaHCO3 
and brine. The combined organic extracts were dried over MgSO4 and concentrated. The crude 
product was purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.19] to 
afford (S)-4-benzyl-3-((2S,3R,E)-6-(benzyloxy)-3-hydroxy-2-methylhex-4-enoyl)-5,5-
dimethyloxazolidin-2-one 538 (2.91 g, 6.65 mmol) as a yellow oil in 89% yield. 1H NMR (300 
MHz, CDCl3) δH = 7.27-7.15 (10H, m, Ph and Phox), 5.83 (1H, dtd, J = 15.6, 5.4, 1.0 Hz, 
CH=CHCH2OBn), 5.68 (1H, dd, J = 15.6, 5.4 Hz, CH=CHCH2OBn), 4.48-4.38 (4H, m, CH2OBn, CHN, 
CHOH), 3.96 (2H, d, J = 5.4 Hz, CH2OBn), 3.86 (1H, qd, J = 7.0, 4.2 Hz, CHCH3), 2.99 (1H, dd, J = 
14.2, 4.6 Hz, CHAHBPh), 2.82 (1H, dd, J = 14.4, 9.0 Hz, CHAHBPh), 2.76 (1H, broad s, OH), 1.30 
(3H, s, C(CH3)(CH3)), 1.28 (3H, s, C(CH3)(CH3)), 1.10 (3H, d, J = 7.1 Hz, CHCH3); 
13C NMR (75 MHz, 
CDCl3) δC = 176.3, 152.4, 138.2, 136.6, 132.0, 129.1, 128.7, 128.6, 128.3, 127.7, 127.6, 126.8, 
82.3, 72.2, 72.1, 70.0, 63.3, 42.7, 35.4, 28.3, 22.1, 11.6; IR cm-1 ν = 3473 (OH), 1771 (C=Oox), 
1693 (C=O); HRMS: m/z (ES) 460.2064, C26H31NNaO5 [M+Na]
+ requires 460.2099;  
25
D][  = -28.0 









lidin-2-one 536 (0.50 g, 1.14 mmol) was dissolved in dichloromethane (25 mL) and stirred at -5 
˚C under nitrogen. Diethylzinc (5.71 mL, 5.71 mmol, 1 M in hexane) was added in one portion 
followed by diiodomethane (0.46 mL, 5.74 mmol). The reaction was stirred for two hours 
under nitrogen in the absence of light before being quenched with saturated sodium sulfite (5 
mL). Sufficient 1 M HCl was added to dissolve the white precipitate, the aqueous layer was 
separated and extracted with dichloromethane and the combined organic layers were washed 
with brine, dried over MgSO4 and concentrated. The crude product was purified using flash 
silica chromatography [1:3 EtOAc:Petroleum ether, Rf 0.40] to afford (S)-4-benzyl-3-((2S,3R)-3-
((1S,2R)-2-((benzyloxy)methyl)cyclopropyl)-3-hydroxy-2-methylpropanoyl)-5,5-dimethyloxa 
zolidin-2-one 539 (0.46 g, 1.02 mmol) as a colourless gum in 89% yield. 1H NMR (300 MHz, 
CDCl3) δH = 7.28-7.17 (10H, m, Ph and Phox), 4.49-4.41 (3H, m, OCH2Ph and CHN), 3.94 (1H, qd, J 
= 7.1, 3.0 Hz, CHCH3), 3.67 (1H, dd, J = 8.1, 3.0 Hz, CHOH), 3.51 (1H, dd, J = 10.3, 6.6 Hz, 
CHAHBOBn), 3.41 (1H, dd, J = 10.3, 7.5 Hz, CHAHBOBn), 3.01 (1H, dd, J = 14.3, 4.3 Hz, CHAHBPh), 
2.83 (1H, dd, J = 14.3, 9.1 Hz, CHAHBPh), 1.31 (3H, s, C(CH3)(CH3)), 1.24 (3H, s, C(CH3)(CH3)), 1.23 
(3H, d, J = 7.0 Hz, CHCH3), 1.20-1.05 (2H, m, CHOHCHCHAHB and cyclopropyl-CHCH2OBn), 0.80 
(1H, app. dt, J = 8.4, 4.8 Hz, cyclopropyl-CHAHB), 0.41 (1H, app. dd, J = 10.7, 5.7 Hz, cyclopropyl-
CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 177.5, 152.2, 138.6, 136.8, 129.2, 128.8, 128.4, 127.7, 
127.6, 127.0, 82.3, 72.7, 71.1, 70.3, 63.5, 43.3, 35.5, 28.5, 22.3, 19.2, 15.7. 11.3, 8.1; IR cm-1 ν = 













lidin-2-one 538 (0.50 g, 1.14 mmol) was dissolved in dichloromethane (25 mL) and stirred at -5 
˚C under nitrogen. Diethylzinc (5.71 mL, 5.71 mmol, 1 M in hexane) was added in one portion 
followed by diiodomethane (0.46 mL, 5.71 mmol). The reaction was stirred for two hours 
under nitrogen in the absence of light before being quenched with saturated sodium sulfite (5 
mL). Sufficient 1 M HCl was added to dissolve the white precipitate, the aqueous layer was 
separated and extracted with dichloromethane and the combined organic layers were washed 
with brine, dried over MgSO4 and concentrated. The crude product was purified using flash 
silica chromatography [1:3 EtOAc:Petroleum ether, Rf 0.16] to afford (S)-4-benzyl-3-((2S,3R)-3-
((1S,2S)-2-((benzyloxy)methyl)cyclopropyl)-3-hydroxy-2-methylpropanoyl)-5,5-dimethyloxa 
zolidin-2-one 541 (0.49 g, 1.09 mmol) as a colourless gum in 95% yield. 1H NMR (300 MHz, 
CDCl3) δH = 7.27-7.10 (10H, m, Ph and Phox), 4.45-4.38 (1H, m, CHN), 4.44 (1H, s, OCHAHBPh), 
4.43 (1H, s, OCHAHBPh), 3.91 (1H, qd, J = 7.1, 3.4 Hz, CHCH3), 3.32-3.19 (3H, m, CH2OBn and 
CHOH), 3.00 (1H, dd, J = 14.3, 4.3 Hz, CHAHBPh), 2.80 (1H, dd, J = 14.3, 9.2 Hz, CHAHBPh), 2.49 
(1H, broad s, OH), 1.29 (3H, s, C(CH3)(CH3)), 1.25 (3H, s, C(CH3)(CH3)), 1.18 (3H, d, J = 7.1 Hz, 
CHCH3), 1.10-0.99 (1H, m, cyclopropyl-CH2OBn), 0.89-0.81 (1H, m, CHOHCHCHAHB), 0.63-0.58 
(1H, m, cyclopropyl-CHAHB), 0.49-0.43 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC 
= 176.8, 152.4, 138.6, 136.7, 129.1, 128.7, 128.4, 127.6, 127.5, 126.9, 82.3, 74.7, 73.3, 72.5, 
63.5, 43.0, 35.4, 28.4, 22.3, 20.3, 16.0, 11.5, 8.9; IR cm-1 ν = 3504 (OH), 1769 (C=Oox), 1693 
(C=O); HRMS: m/z (ES) 474.2237, C27H33NNaO5 [M+Na]
+ requires 474.2256; 
25
D][  = -20.0 (c = 










panoyl)-5,5-dimethyloxazolidin-2-one 539 (0.20 g, 0.43 mmol) was dissolved in 
dichloromethane (6 mL) under nitrogen. A solution of sodium methoxide (0.87 mL, 0.43 mmol, 
0.5 M in methanol) was added and the reaction was stirred for five minutes. The reaction was 
quenched with saturated ammonium chloride (5 mL) and the organic layer was washed with 
brine, dried over MgSO4 and concentrated. The crude product was purified using flash silica 
chromatography [1:3 EtOAc:Petroleum ether, Rf 0.40] to afford (2S,3R)-methyl 3-((1S,2R)-2-
((benzyloxy)methyl)cyclopropyl)-3-hydroxy-2-methylpropanoate 540 (0.09 g, 0.32 mmol) as a 
colourless oil in 75% yield. 1H NMR (300 MHz, CDCl3) δH = 7.27-7.20 (5H, m, Ph), 4.46 (1H, d, J = 
11.8 Hz, OCHAHBPh), 4.39 (1H, d, J = 11.8 Hz, OCHAHBPh), 3.65-3.58 (5H, m, OCH3, CHAHBOBn 
and CHOH), 3.25 (1H, dd, J = 10.0, 8.9 Hz, CHAHBOBn), 2.83 (1H, qd, J = 7.3, 2.8 Hz, CHCH3), 2.52 
(1H, broad s, OH), 1.26-1.15 (1H, m, CHOHCHCHAHB), 1.21 (3H, d, J = 7.2 Hz, CHCH3), 1.10-1.01 
(1H, m, cyclopropyl-CHCH2OBn), 0.81 (1H, app. td, J = 8.4, 4.8 Hz, cyclopropyl-CHAHB), 0.36 (1H, 
dd, J = 10.7, 5.6 Hz, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 176.7, 138.2, 128.5, 
127.9, 127.8, 73.1, 71.5, 70.5, 51.9, 44.4, 19.3, 15.8, 10.2, 8.2; IR cm-1 ν = 3457 (OH), 1728 
(C=O); HRMS: m/z (ES) 301.1397, C16H22NaO4 [M+Na]
+ requires 301.1416; 
25
D][  = +38.0 (c = 












panoyl)-5,5-dimethyloxazolidin-2-one 541 (0.39 g, 0.86 mmol) was dissolved in 
dichloromethane (12 mL) under nitrogen. A solution of sodium methoxide (1.73 mL, 0.86 
mmol, 0.5 M in methanol) was added and the reaction was stirred for five minutes. The 
reaction was quenched with saturated ammonium chloride (5 mL) and the organic layer was 
washed with brine, dried over MgSO4 and concentrated. The crude product was purified using 
flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.21] to afford (2S,3R)-methyl 3-
((1S,2S)-2-((benzyloxy)methyl)cyclopropyl)-3-hydroxy-2-methylpropanoate 542 (0.21 g, 0.76 
mmol) as a colourless oil in 88% yield. 1H NMR (300 MHz, CDCl3) δH = 7.30-7.19 (5H, m, Ph), 
4.46 (1H, d, J = 12.1 Hz, OCHAHBPh), 4.41 (1H, d, J = 12.1 Hz, OCHAHBPh), 3.60 (3H, s, OCH3), 
3.26-3.19 (3H, m, CHOH and CH2OBn), 2.63 (2H, qd, J = 7.1, 4.8 Hz, CHCH3 and OH), 1.21 (3H, d, 
J = 7.1 Hz, CHCH3), 1.03-0.92 (1H, m, CHOHCHCHAHB), 0.84-0.77 (1H, m, cyclopropyl-
CHCH2OBn), 0.62-0.57 (1H, m, cyclopropyl-CHAHB), 0.49-0.43 (1H, m, cyclopropyl-CHAHB); 
13C 
NMR (75 MHz, CDCl3) δC = 175.9, 138.4, 128.3, 127.5, 127.5, 75.2, 73.1, 72.5, 51.7, 45.2, 20.8, 
16.3, 11.8, 8.7; IR cm-1 ν = 3451 (OH), 1729 (C=O); HRMS: m/z (ES) 301.1408, C16H22NaO4 
[M+Na]+ requires 301.1415; 
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The title compound was prepared according to General Procedure 4 from (2S,3R)-methyl-3-
((1S,2S)-2-(benzyloxymethyl)cyclopropyl)-3-hydroxy-2-methylpropanoate 542 (0.10 g, 0.36 
mmol) and mercury trifluoroacetate (0.38 g, 0.90 mmol) in dichloromethane (12 mL). The 
reaction was stirred for 24 hours before being quenched with brine. The organomercurial δ-
lactone underwent reductive demercuration with sodium borohydride (0.041 g, 1.08 mmol) 
dissolved in 3.5 M NaOH (3.7 mL) and methanol (4 mL). The crude product was purified using 
flash silica chromatography [3:7 EtOAc:Petroleum ether, Rf 0.11] to afford (3S,4R,5R,6R)-6-
((benzyloxy)methyl)-4-hydroxy-3,5-dimethyltetrahydro-2H-pyran-2-one 544 (0.078 g, 0.30 
mmol) as a white solid in 82% yield. 1H NMR (300 MHz, CDCl3) δH = 7.37-7.26 (5H, m, Ph), 4.63 
(1H, d, J = 12.0 Hz, OHAHBPh), 4.51 (1H, d, J = 12.0 Hz, OHAHBPh), 3.98 (1H, dt, J = 10.4, 3.0 Hz, 
COOCH), 3.73 (1H, dd, J = 11.2, 2.4 Hz, CHAHBOBn), 3.65 (1H, dd, J = 11.2, 3.3 Hz, CHAHBOBn), 
3.30 (1H, app. t, J = 10.2 Hz, CHOH), 2.40 (1H, dq, J = 10.1, 7.1 Hz, COCHCH3), 2.11 (1H, broad s, 
OH), 2.10 (1H, ddq, J = 10.4, 10.2, 6.5 Hz, CHOHCHCH3), 1.39 (3H, d, J = 7.0 Hz, COCHCH3), 1.07 
(3H, d, J = 6.5 Hz, CHOHCHCH3); 
13C NMR (75 MHz, CDCl3) δC = 173.3, 137.9, 128.6, 127.9, 
127.8, 81.7, 75.0, 73.7, 69.6, 44.4, 37.2, 13.7, 13.4; IR cm-1 ν = 3413 (OH), 1712 (C=O); HRMS: 
m/z (ES) 265.1439, C15H21O4 [M+H]
+ requires 265.1439;  
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methylpropanoyl)-5,5-dimethyloxazolidin-2-one 541 (2.56 g, 5.67 mmol) was dissolved in 
toluene (200 mL) at 0 ˚C under nitrogen. LiHMDS (12.48 mL, 12.48 mmol, 1 M in THF) was 
added dropwise and the resulting solution was stirred for three hours. The reaction was 
quenched with saturated ammonium chloride, diluted with diethyl ether and the layers were 
separated. The organic layer was extracted with brine, dried over MgSO4 and concentrated to 
afford the crude product. The crude product was purified using flash silica chromatography 
[1:9 EtOAc:Petroleum ether, Rf 0.32] to afford (1S,2S)-2-
((benzyloxy)methyl)cyclopropanecarbaldehyde 545 (0.99 g, 5.22 mmol) as a colourless oil in 
92% yield. 1H NMR (360 MHz, CDCl3) δH = 9.17 (1H, d, J = 5.0 Hz, CHO), 7.40-7.21 (5H, m, Ph), 
4.53 (2H, s, CH2Ph), 3.50 (1H, dd, J = 10.5, 5.5 Hz, CHAHBOBn), 3.42 (1H, dd, J = 10.5, 5.0 Hz, 
CHAHBOBn), 1.89-1.77 (2H, m, CH-cyclopropyl), 1.33 (1H, dt, J = 8.5, 5.0 Hz, cyclopropyl-CHAHB), 
1.12-1.04 (1H, m, cyclopropyl-CHAHB); 
13C NMR (90 MHz, CDCl3) δC = 200.2, 138.0, 128.4, 127.7, 
127.6, 72.8, 70.9, 28.1, 12.4; IR cm-1 ν = 1708 (C=O); HRMS: m/z (ES) 213.0886, C12H14NaO2 
[M+Na]+ requires 213.0886; 
25













(1S,2S)-2-((Benzyloxy)methyl)cyclopropanecarbaldehyde 545 (0.99 g, 5.22 mmol) and 
dibenzylamine (1.00 mL, 5.22 mmol) were dissolved in dichloroethane (35 mL) along with 4Å 
MS at room temperature under nitrogen. Sodium triacetoxyborohydride (1.77g, 8.35 mmol) 
was added and the resulting mixture was stirred for four hours. The reaction was quenched 
with saturated NaHCO3 and the layers were separated. The aqueous layer was extracted with 
ethyl acetate, the combined organic extracts were combined, dried over MgSO4 and 
concentrated to afford N,N-dibenzyl-1-((1S,2S)-2-((benzyloxy)methyl)cyclopropyl) 
methanamine 546 (1.20 g, 3.24 mmol) as a yellow oil which solidified on standing in 62% yield. 
1H NMR (400 MHz, CDCl3) δH = 7.16-7.40 (15H, m, Ph), 4.47 (2H, s, OCH2Ph), 3.65 (2H, d, J = 
13.5 Hz, NCH2Ph), 3.59 (2H, d, J = 13.5 Hz, NCH2Ph), 3.26-3.32 (2H, m, CH2NBn2), 2.41 (1H, dd, J 
= 6.0, 13.0 Hz, CHAHBOBn), 2.27 (1H, dd, J = 7.0, 13.0 Hz, CHAHBOBn), 0.80-0.86 (2H, m, CH-
cyclopropyl), 0.39 (1H, ddd, J = 5.0, 5.0, 10.5 Hz, cyclopropyl-CHAHB), 0.30 (1H, ddd, J = 5.0, 5.0, 
10.5 Hz, cyclopropyl-CHAHB); 
13C NMR (100 MHz, CDCl3) δC = 140.0, 138.6, 128.7, 128.3, 128.1, 
127.5, 127.4, 126.7, 73.9, 72.4, 58.1, 57.2, 17.9, 14.8, 9.5; HRMS: m/z (ES) 372.2349, C26H30NO 
[M+H]+ requires 372.2322; 
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N,N-Dibenzyl-1-((1S,2S)-2-((benzyloxy)methyl)cyclopropyl)methanamine 546 (1.20 g, 3.24 
mmol) and a few drops of formic acid were dissolved in methanol (120 mL). Palladium on 
carbon (10%, 0.34 g, 0.32 mmol) was added in one portion and the reaction was stirred 
vigorously under a hydrogen atmosphere at room temperature for 16 hours. The resulting 
suspension was filtered through a pad of Celite® and concentrated. The crude product was 
redissolved in methanol (120 mL) and di-tert-butyl dicarbonate (0.71 g, 3.24 mmol) was added 
to the solution, followed by sodium hydroxide (0.13 g, 3.24 mmol). The resulting solution was 
stirred at room temperature for 16 hours. The reaction was quenched with saturated NH4Cl 
and was diluted with diethyl ether. The layers were separated, the organic layer was washed 
with brine, dried over MgSO4 and concentrated to afford a 50:50 mixture of tert-butyl-
benzyl(((1S,2S)-2-(hydroxymethyl)cyclopropyl)methyl)carbamate 547 and tert-butyl-(((1S,2S)-
2-(hydroxymethyl)cyclopropyl)methyl)carbamate 548. The crude mixture was dissolved in THF 
(100 mL) and palladium hydroxide on carbon (20%, 60% wet, 0.90 g, 0.32 mmol) was added in 
one portion. The resulting suspension was stirred vigorously under a hydrogen atmosphere at 
room temperature for two and a half hours. The reaction was filtered through a pad of Celite® 
and concentrated to afford tert-butyl (((1S,2S)-2-(ydroxymethyl)cyclopropyl)methyl)carbamate 
548 (0.65 g, 3.24 mmol) as a colourless oil in quantitative yield. 1H NMR (250 MHz, CDCl3) δH = 
3.57 (1H, dd, J = 4.5, 8.0 Hz, CHAHBOH), 3.28 (1H, dd, J = 5.0, 8.0 Hz, CHAHBOH), 3.09 (1H, dd, J = 
4.5, 9.5 Hz, CHAHBNHBoc), 2.90 (1H, dd, J = 5.0, 9.5 Hz, CHAHBNHBoc), 1.42 (9H, s, (CH3)3C), 
0.93-1.10 (1H, m, CH-cyclopropyl), 0.83-0.91 (1H, m, CH-cyclopropyl), 0.42 (2H, dd, J = 5.0, 5.0 
Hz, CH2-cyclopropyl); 
13C NMR (60 MHz, CDCl3) δC = 156.1, 79.2, 66.0, 44.5, 28.3, 19.9, 17.1, 8.2; 












(1S,2S)-2-(((tert-Butoxycarbonyl)amino)methyl)cyclopropanecarboxylic acid, 549 
 
tert-Butyl (((1S,2S)-2-(ydroxymethyl)cyclopropyl)methyl)carbamate 548 (0.65 g, 3.24 mmol) 
was dissolved in acetone (60 mL) at 0 ˚C. Jones’ reagent (~2% CrO3 basis) was added dropwise 
until the orange tint persisted in the reaction mixture. The solution was stirred at 0 ˚C for two 
hours followed by a further two hours at room temperature. The reaction was quenched with 
isopropyl alcohol, diluted with diethyl ether and extracted with saturated NaHCO3 and brine. 
The combined organic extracts were dried over MgSO4 and concentrated to afford (1S,2S)-2-
(((tert-butoxycarbonyl)amino)methyl)cyclopropanecarboxylic acid 549 (0.44 g, 2.04 mmol) as a 
colourless oil in 63% yield. 1H NMR (360 MHz, CDCl3) δH = 5.62 (1H, broad s, COOH), 4.72 (1H, 
broad s, NH), 3.16-3.30 (1H, m, CHAHBNHBoc), 2.95-3.15 (1H, m, CHAHBNHBoc), 1.60-1.74 (1H, 
m, CH-cyclopropyl), 1.57 (1H, ddd, J = 13.0, 4.5, 4.5 Hz, CH-cyclopropyl), 1.48 (9H, s, (CH3)3C), 
1.23 (1H, ddd, J = 13.0, 4.5, 4.5 Hz, CH-cyclopropyl), 0.93 (1H, dd, J = 7.0, 11.0 Hz, CH-
cyclopropyl); HRMS: m/z (ES) 238.1049, C10H17NNaO4 [M+Na]
+ requires 238.1050; 
20
D][  = +51 














4.1.9 Synthesis of Compounds for (+)-Prelactone B, E and V 
(R)-4-Benzyl-5,5-dimethyloxazolidin-2-one 
 
Potassium tert-butoxide (3.0 g, 26.8 mmol) was added in one portion to a solution of (R)-tert-
butyl(3-hydroxy-3-methyl-1-phenylbutan-2-yl)carbamate (5.0 g, 17.9 mmol) in THF (30 mL) at 
room temperature. The resulting orange solution was stirred for two hours and then THF was 
removed under reduced pressure. The residue was redissolved in diethyl ether and extracted 
with saturated ammonium chloride and brine. The combined organic extracts were dried over 
MgSO4 and concentrated to afford crude product. The crude product was purified via 
recrystallisation from diethyl ether and hexane to afford (R)-4-benzyl-5,5-dimethyloxazolidin-
2-one (2.6 g, 12.8 mmol) as a yellow crystalline solid. 1H NMR (300 MHz, CDCl3) δH = 7.43-7.22 
(5H, m, Ph), 5.27 (1H, broad s, NH), 3.76 (1H, ddd, J = 10.3, 4.2, 0.7 Hz, CHN), 2.90 (1H, dd, J = 
13.4, 4.2 Hz, CHAHBPh), 2.76 (1H, dd, J = 13.4, 10.5 Hz, CHAHBPh), 1.52 (3H, s, C(CH3)(CH3)), 1.51 
(3H, s, C(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δC = 158.1, 137.0, 129.1, 128.9, 127.2, 83.3, 63.2, 
37.2, 27.6, 22.0; IR cm-1 ν = 3250 (N-H), 1717 (C=O); HRMS: m/z (ES) 228.1016, C12H15NNaO2 
[M+Na]+ requires 228.1000;  
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n-BuLi (10.71 mL, 26.8 mmol, 2.5 M solution in hexane) was added to a solution of (R)-4-
benzyl-5,5-dimethyloxazolidin-2-one (5.00 g, 24.3 mmol) in dry THF (150 mL) at -78 ˚C under 
nitrogen and was stirred for 30 minutes. Chloroacetyl chloride (2.07 mL, 26.8 mmol) was 
added in one portion and the resulting solution was stirred for a further two hours. The 
reaction was quenched with saturated ammonium chloride and allowed to warm to ambient 
temperature. The THF was evaporated under reduced pressure, the resulting oil was 
redissolved in dichloromethane and extracted with brine. The combined organic extracts were 
dried over MgSO4 and concentrated to afford crude product. The crude product was purified 
using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.50] to afford (R)-4-benzyl-3-
(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one 550 (5.69 g, 20.1 mmol) as a colourless oil in 
83% yield. 1H NMR (300 MHz, CDCl3) δH = 7.32-7.20 (5H, m, Ph), 4.76 (1H, d, J = 15.8 Hz, 
COCHAHBCl), 4.64 (d, J = 15.8 Hz, COCHAHBCl), 4.49 (1H, dd, J = 9.7, 3.9 Hz, CHN), 3.20 (1H, dd, J 
= 14.4, 3.8 Hz, CHHAHBPh), 2.88 (1H, dd, J = 14.4, 9.8 Hz, CHAHBPh), 1.38 (3H, s, C(CH3)(CH3)), 
1.36 (3H, s, C(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δC = 166.4, 152.4, 136.5, 129.1, 128.9, 
127.1, 83.7, 64.1, 44.0, 35.0, 28.7, 22.4; IR cm-1 ν = 1768 (C=Oox), 1708 (C=O); HRMS: m/z (ES) 
304.0722, C14H16ClNNaO3 [M+Na]
+ requires 304.0716;  
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(R)-4-Benzyl-3-(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one 550 (1.65 g, 5.86 mmol) was 
dissolved in dry dichloromethane (10 mL) at 0 ˚C under nitrogen and was stirred for 30 
minutes. Dibutylboron triflate (6.44 mL, 6.44 mmol, 1 M in dichloromethane) was added 
dropwise. After 30 minutes, N,N-diisopropylethylamine (1.33 mL, 7.61 mmol) was added and 
the resulting solution was stirred for 30 minutes. The reaction was cooled to -78 ˚C. 
Crotonaldehyde (0.63 mL, 7.61 mmol) was added in one portion and the reaction was allowed 
to warm to ambient temperature overnight. The reaction was quenched with pH 7 buffer 
solution (Na2PO4/NaH2PO4) (4 mL) and was stirred for 10 minutes. Hydrogen peroxide (2 mL) 
and methanol (4 mL) were then added, the methanol was evaporated, the solution diluted 
with dichloromethane and washed with saturated NaHCO3 and brine. The combined organic 
extracts were dried over MgSO4 and concentrated to afford the crude product. The crude 
product was purified using flash silica chromatography [15:85 EtOAc:Petroleum ether, Rf 0.27] 
to afford (R)-4-benzyl-3-((2R,3S,E)-2-chloro-3-hydroxyhex-4-enoyl)-5,5-dimethyloxazolidin-2-
one 554 (1.01 g, 2.87 mmol) as a yellow oil in 49% yield. 1H NMR (300 MHz, CDCl3) δH = 7.30-
7.18 (5H, m, Ph), 5.88-5.71 (1H, m, CH=CHCH3), 5.73 (1H, d, J = 5.9 Hz, CHCl), 5.52 (1H, ddd, J = 
15.5, 6.8, 1.0 Hz, CH=CHCH3), 4.53-4.46 (2H, m, CHOH and CHN), 3.34 (1H, broad s, OH), 3.10 
(1H, dd, J = 14.4, 3.7 Hz, CHAHBPh), 2.89 (1H, dd, J = 14.4, 9.4 Hz, CHAHBPh), 1.68 (3H, d, J = 6.4 
Hz, CH=CHCH3), 1.36, (3H, s, C(CH3)(CH3)), 1.33 (3H, s, C(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δc 
= 167.8, 151.8, 136.2, 130.9, 128.9, 128.6, 127.8, 126.7, 82.9, 72.9, 63.7, 58.9, 34.6, 28.1, 21.9, 
17.7; IR cm-1 ν = 3488 (OH), 1770 (C=Oox), 1704 (C=O); HRMS: m/z (ES) 352.1289, C18H23NO4Cl 
[M+H]+ requires 352.1315;  
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(R)-4-Benzyl-3-(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one 550 (1.37 g, 4.86 mmol) was 
dissolved in dry dichloromethane (10 mL) at 0 ˚C under nitrogen and was stirred for 30 
minutes. Dibutylboron triflate (5.35 mL, 5.35 mmol, 1 M in dichloromethane) was added 
dropwise. After 30 minutes, N,N-diisopropylethylamine (1.10 mL, 6.32 mmol) was added and 
the resulting solution was stirred for 30 minutes. The reaction was cooled to -78 ˚C. trans-2-
Pentenal (0.62 mL, 6.32 mmol) was added in one portion and the reaction was allowed to 
warm to ambient temperature overnight. The reaction was quenched with pH 7 buffer solution 
(Na2PO4/NaH2PO4) (4 mL) and was stirred for 10 minutes. Hydrogen peroxide (2 mL) and 
methanol (4 mL) were then added, the methanol was evaporated, the solution diluted with 
dichloromethane and washed with saturated NaHCO3 and brine. The combined organic 
extracts were dried over MgSO4 and concentrated to afford the crude product. The crude 
product was purified using flash silica chromatography [15:85 EtOAc:Petroleum ether, Rf 0.29] 
to afford (R)-4-benzyl-3-((2R,3S,E)-2-chloro-3-hydroxyhept-4-enoyl)-5,5-dimethyloxazolidin-2-
one 555 (0.81 g, 2.19 mmol) as a yellow oil in 45% yield. 1H NMR (300 MHz, CDCl3) δH = 7.30-
7.20 (5H, m, Ph), 5.87 (1H, dt, J = 15.2, 6.0 Hz, CH=CHCH2CH3), 5.73 (1H, d, J = 5.7 Hz, CHCl), 
5.50 (1H, dd, J = 15.7, 6.7 Hz, CH=CHCH2CH3), 4.56-4.47 (2H, m, CHOH and CHN), 3.45 (1H, 
broad s, OH), 3.11 (1H, dd, J = 14.5, 3.7 Hz, CHAHBPh), 2.89 (1H, dd, J = 14.1, 9.5 Hz, CHAHBPh), 
2.08-1.99 (2H, m, CH2CH3), 1.36 (3H, s, C(CH3)(CH3)), 1.32 (3H, s, C(CH3)(CH3)), 0.96 (3H, t, J = 
7.4 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3) δc = 167.7, 151.7, 137.2, 136.1, 128.8, 128.4, 126.6, 
125.4, 82.8, 72.7, 63.5, 58.9, 34.4, 28.0, 24.9, 21.8, 12.8; IR cm-1 ν = 3476 (OH), 1772 (C=Oox), 
1707 (C=O); HRMS: m/z (ES) 388.1368, C19H21NO4ClNa [M+Na]
+ requires 388.1292;  
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(R)-4-Benzyl-3-(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one 550 (5.00 g, 17.75 mmol) was 
dissolved in dry dichloromethane (30 mL) at 0 ˚C under nitrogen and was stirred for 30 
minutes. 9-Borabicyclo[3.3.1]nonyl triflate (39.01 mL, 19.52 mmol, 0.5 M in hexane) was 
added dropwise. After 30 minutes, N,N-diisopropylethylamine (4.01 mL, 23.07 mmol) was 
added and the resulting solution was stirred for 30 minutes. The reaction was cooled to -78 ˚C. 
4-Methyl-2-pentenal (2.68 mL, 23.07 mmol) was added in one portion and the reaction was 
allowed to warm to ambient temperature overnight. The reaction was quenched with pH 7 
buffer solution (Na2PO4/NaH2PO4) (10 mL) and was stirred for 10 minutes. Hydrogen peroxide 
(4 mL) and methanol (8 mL) were then added, the methanol was evaporated, the solution 
diluted with dichloromethane and washed with saturated NaHCO3 and brine. The combined 
organic extracts were dried over MgSO4 and concentrated to afford the crude product. The 
crude product was purified using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 
0.39] to afford (R)-4-benzyl-3-((2R,3S,E)-2-chloro-3-hydroxy-6-methylhept-4-enoyl)-5,5-
dimethyloxazolidin-2-one 556 (5.08 g, 13.38 mmol) as a yellow oil in 75% yield. 1H NMR (300 
MHz, CDCl3) δH = 7.30-7.17 (5H, m, Ph), 5.81 (1H, ddd, J = 15.4, 6.4, 0.8 Hz, 
CH=CHCH(CH3)(CH3)), 5.67 (1H, d, J = 5.2 Hz, CHCl), 5.43 (1H, ddd, J = 15.6, 6.6, 1.4 Hz, 
CH=CHCH(CH3)(CH3)), 4.54 (1H, app. t, J = 5.9 Hz, CHOH), 4.47 (1H, dd, J = 9.5, 3.9 Hz, CHN), 
3.13 (2H, dd, J = 14.5, 3.8 Hz, CHAHBPh and broad s, OH), 2.88 (1H, dd, J = 14.4, 9.5 Hz, 
CHAHBPh), 2.27 (1H, app. sex., J = 6.8 Hz, CH=CHCH(CH3)(CH3)), 1.37 (3H, s, (CH3)C(CH3)), 1.33 
(3H, s, (CH3)C(CH3)), 0.97 (6H, dd, J = 6.8, 1.8 Hz, CH=CHCH(CH3)(CH3)); 
13C NMR (75 MHz, 
CDCl3) δc = 168.1, 151.9, 143.0, 136.4, 129.1, 128.8, 127.0, 123.6, 83.1, 72.8, 64.0, 59.4, 34.8, 
30.8, 28.5, 22.2, 22.0, 21.9; IR cm-1 ν = 3499 (OH), 1772 (C=Oox), 1702 (C=O); HRMS: m/z (ES) 
402.1462, C20H26NO4ClNa [M+Na]
+ requires 402.1448;  
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(0.914 g, 2.60 mmol) was dissolved in dichloromethane (30 mL) and stirred at 0 ˚C under 
nitrogen. Diethylzinc (12.98 mL, 12.98 mmol, 1 M in hexane) was added in one portion 
followed by diiodomethane (1.05 mL, 12.98 mmol). The reaction was stirred for two hours in 
the absence of light. The reaction was quenched with saturated sodium sulphite (10 mL) and 
stirred for 10 minutes before sufficient 1 M HCl was added to dissolve the white precipitate. 
The aqueous layer was separated and extracted with dichloromethane and the combined 
organic layers were washed with brine, dried over MgSO4 and concentrated to afford the 
crude product. The crude product was purified using flash silica chromatography [1:4 
EtOAc:Petroleum ether, Rf 0.34] to afford (R)-4-benzyl-3-((2R,3S)-2-chloro-3-hydroxy-3-
((1R,2R)-2-methylcyclopropyl)propanoyl)-5,5-dimethyloxazolidin-2-one 557, (0.80 g, 2.21 
mmol) as a colourless oil in 85% yield. 1H NMR (300 MHz, CDCl3) δH = 7.31-7.18 (5H, m, Ph), 
5.76 (1H, d, J = 4.2 Hz, CHCl), 4.48 (1H, dd, J = 9.8, 3.5 Hz, CHN), 3.41 (1H, dd, J = 7.8, 4.0 Hz, 
CHOH), 3.18 (1H, dd, J = 14.4, 3.4 Hz, CHAHBPh), 2.87 (1H, dd, J = 14.5, 9.8 Hz, CHAHBPh), 2.52 
(1H, broad s, OH), 1.36 (3H, s, C(CH3)(CH3)), 1.33 (3H, s, C(CH3)(CH3)), 1.00 (3H, d, J = 5.8 Hz, 
CHCH3), 0.89-0.74 (2H, m, CHOHCH-cyclopropyl and cyclopropyl-CH), 0.64-0.58 (1H, m, 
cyclopropyl-CH), 0.39-0.33 (1H, m, cyclopropyl-CH); 13C NMR (75 MHz, CDCl3) δC = 168.1, 151.9, 
136.4, 128.9, 128.6, 126.8, 83.0, 74.9, 63.1, 60.1, 34.5, 28.4, 22.5, 22.1, 18.1, 11.6, 10.9; IR cm-
1 ν = 3505 (OH), 1786 (C=Oox), 1711 (C=O); HRMS: m/z (ES) 388.1278, C19H24ClNNaO4 [M+Na]
+ 
requires 388.1291;  
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(0.81 g, 2.21 mmol) was dissolved in dichloromethane (25 mL) and stirred at 0 ˚C under 
nitrogen. Diethylzinc (11.06 mL, 11.07 mmol, 1 M in hexane) was added in one portion 
followed by diiodomethane (0.89 mL, 11.07 mmol). The reaction was stirred for two hours in 
the absence of light. The reaction was quenched with saturated sodium sulphite (20 mL) and 
stirred for 10 minutes before sufficient 1 M HCl was added to dissolve the white precipitate. 
The aqueous layer was separated and extracted with dichloromethane and the combined 
organic layers were washed with brine, dried over MgSO4 and concentrated to afford the 
crude product. The crude product was purified using flash silica chromatography [1:4 
EtOAc:Petroleum ether, Rf 0.32] to afford (R)-4-benzyl-3-((2R,3S)-2-chloro-3-((1R,2R)-2-
ethylcyclopropyl)-3-hydroxypropanoyl)-5,5-dimethyloxazolidin-2-one 558 (0.58 g, 1.53 mmol) 
as a colourless oil in 69% yield. 1H NMR (300 MHz, CDCl3) δH = 7.30-7.18 (5H, m, Ph), 5.79 (1H, 
d, J = 3.7 Hz, CHCl), 4.49 (1H, dd, J = 9.8, 3.4 Hz, CHN), 3.41 (1H, dd, J = 8.2, 3.6 Hz, CHOH), 3.19 
(1H, dd, J = 14.6, 3.4 Hz, CHAHBPh), 2.87 (2H, dd and broad s, J = 14.4, 9.8 Hz, CHAHBPh and OH), 
1.36 (3H, s, C(CH3)(CH3)), 1.33 (3H, s, C(CH3)(CH3)), 1.36-1.08 (2H, m, CH2CH3), 0.94 (3H, t, J = 
7.3 Hz, CH2CH3), 0.93-0.73 (2H, m, CHOHCH-cyclopropyl and cyclopropyl-CH), 0.64-0.58 (1H, m, 
cyclopropyl-CH), 0.43-0.37 (1H, m, cyclopropyl-CH); 13C NMR (75 MHz, CDCl3) δC = 168.3, 151.9, 
136.5, 129.0, 128.8, 126.9, 83.1, 75.1, 64.1, 60.5, 34.6, 28.6, 26.4, 22.3, 21.6, 18.5, 13.5, 10.7; 
IR cm-1 ν = 3494 (OH), 1770 (C=Oox), 1707 (C=O); HRMS: m/z (ES) 402.1469, C20H26ClNNaO4 
[M+Na]+ requires 402.1448;  
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one 556 (1.85 g, 4.87 mmol) was dissolved in dichloromethane (90 mL) and stirred at 0 ˚C 
under nitrogen. Diethylzinc (24.35 mL, 24.35 mmol, 1 M in hexane) was added in one portion 
followed by diiodomethane (1.96 mL, 24.35 mmol). The reaction was stirred for two hours in 
the absence of light. The reaction was quenched with saturated sodium sulphite (20 mL) and 
stirred for 10 minutes before sufficient 1 M HCl was added to dissolve the white precipitate. 
The aqueous layer was separated and extracted with dichloromethane and the combined 
organic layers were washed with brine, dried over MgSO4 and concentrated to afford the 
crude product. The crude product was purified using flash silica chromatography [1:9 
EtOAc:Petroleum ether, Rf 0.13] to afford (R)-4-benzyl-3-((2R,3S)-2-chloro-3-hydroxy-3-
((1R,2S)-2-isopropylcyclopropyl)propanoyl)-5,5-dimethyloxazolidin-2-one 559 (1.44 g, 3.66 
mmol) as a colourless oil in 76% yield. 1H NMR (300 MHz, CDCl3) δH = 7.30-7.20 (5H, m, Ph), 
5.78 (1H, d, J = 3.0 Hz, CHCl), 4.47 (1H, dd, J = 10.0, 3.3 Hz, CHN), 3.35 (1H, dd, J = 8.4, 3.0 Hz, 
CHOH), 3.19 (1H, dd, J = 14.5, 3.2 Hz, CHAHBPh), 2.86 (1H, dd, J = 10.0, 14.5 Hz, CHAHBPh), 2.63 
(1H, broad s, OH), 1.35 (3H, s, C(CH3)(CH3)), 1.32 (3H, s, C(CH3)(CH3)), 0.96-0.93 (9H, m, 
CH(CH3)(CH3) and CHOHCH-cyclopropyl and cyclopropyl-CHCH(CH3)(CH3)), 0.60-0.56 (1H, m, 
cyclopropyl-CHAHB), 0.46-0.44 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 168.4, 
152.0, 136.5, 129.1, 128.8, 127.0, 83.2, 75.3, 64.2, 60.8, 34.6, 32.5, 28.7, 24.7, 22.4, 22.1, 22.0, 
21.3, 10.5; IR cm-1 ν = 3500 (OH), 1773 (C=Oox), 1709 (C=O); HRMS: m/z (ES) 416.1599, 
C21H28ClNNaO4 [M+Na]
+ requires 416.1596;  
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dimethyloxazolidin-2-one 557, (0.80 g, 2.21 mmol) was dissolved in methanol at room 
temperature under nitrogen. Zinc dust (0.57 g, 8.78 mmol) was added in one portion followed 
by ammonium chloride (0.47 g, 8.78 mmol). The resulting suspension was stirred at room 
temperature for one hour. The reaction was diluted with diethyl ether, filtered through a pad 
of Celite® and concentrated to afford the crude product. The crude product was purified using 
flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.25] to afford (R)-4-benzyl-3-((R)-
3-hydroxy-3-((1R,2R)-2-methylcyclopropyl)propanoyl)-5,5-dimethyloxazolidin-2-one 560 (0.50 
g, 1.52 mmol) as a yellow gum in 69% yield. 1H NMR (300 MHz, CDCl3) δH = 7.33-7.19 (5H, m, 
Ph), 4.51 (1H, dd, J = 9.0, 4.5 Hz, CHN), 3.40 (1H, dd, J = 13.6, 6.1 Hz, CHOH), 3.20 (2H, d, J = 5.9 
Hz, COCH2CHOH), 3.13 (1H, dd, J = 14.4, 4.5 Hz, CHAHBPh), 2.89 (1H, dd, J = 14.3, 9.0 Hz, 
CHAHBPh), 2.51 (1H, broad s, OH), 1.39 (3H, s, C(CH3)(CH3)), 1.37 (3H, s, C(CH3)(CH3)), 1.03 (3H, 
d, J = 5.6 Hz, cyclopropyl-CH3), 0.74-0.53 (3H, m, CHOHCH-cyclopropyl and cyclopropyl-H), 
0.34-0.29 (1H, m, cyclopropyl-H); 13C NMR (75 MHz, CDCl3) δC = 172.3, 152.5, 136.7, 128.9, 
128.5, 126.6, 82.3, 71.5, 63.2, 43.0, 35.1, 28.3, 25.3, 22.0, 18.2, 11.5, 10.3; IR cm-1 ν = 3519 
















dimethyloxazolidin-2-one 558 (0.58 g, 1.53 mmol) was dissolved in methanol at room 
temperature under nitrogen. Zinc dust (0.39 g, 6.11 mmol) was added in one portion followed 
by ammonium chloride (0.33 g, 6.11 mmol). The resulting suspension was stirred at room 
temperature for one hour. The reaction was diluted with diethyl ether, filtered through a pad 
of Celite® and concentrated to afford the crude product. The crude product was purified using 
flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.24] to afford (R)-4-benzyl-3-((R)-
3-((1R,2R)-2-ethylcyclopropyl)-3-hydroxypropanoyl)-5,5-dimethyloxazolidin-2-one 561 (0.37 g, 
1.07 mmol) as a yellow oil in 70% yield. 1H NMR (300 MHz, CDCl3) δH = 7.33-7.19 (5H, m, Ph), 
4.51 (1H, dd, J = 9.0, 4.5 Hz, CHN), 3.41-3.34 (1H, m, CHOH), 3.22-3.20 (2H, m, COCH2CHOH), 
3.13 (1H, dd, J = 14.4, 4.5 Hz, CHAHBPh), 2.89 (1H, dd, J = 14.2, 9.0 Hz, CHAHBPh), 2.62 (1H, 
broad s, OH), 1.42-1.13 (2H, m, CH2CH3), 1.38 (3H, s, C(CH3)(CH3)), 1.37 (3H, s, C(CH3)(CH3)), 
0.94 (3H, app. t, J = 7.3 Hz, cyclopropyl-CH2CH3), 0.77-0.68 (1H, m, cyclopropyl-H), 0.60-0.52 
(2H, m, CHOHCH-cyclopropyl and cyclopropyl-H), 0.39-0.33 (1H, m, cyclopropyl-H); 13C NMR 
(75 MHz, CDCl3) δC = 172.4, 152.5, 136.8, 128.9, 128.6, 126.7, 82.3, 71.8, 63.3, 42.9, 35.2, 28.3, 
26.4, 24.2, 22.1, 18.2, 13.6, 10.4; IR cm-1 ν = 3501 (OH), 1772 (C=Oox), 1694 (C=O); HRMS: m/z 
(ES) 368.1946, C20H27NNaO4 [M+Na]
+ requires 368.1838;  
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dimethyloxazolidin-2-one 559 (1.40 g, 3.55 mmol) was dissolved in methanol at room 
temperature under nitrogen. Zinc dust (0.93 g, 14.22 mmol) was added in one portion 
followed by ammonium chloride (0.76 g, 14.22 mmol). The resulting suspension was stirred at 
room temperature for one hour. The reaction was diluted with diethyl ether, filtered through a 
pad of Celite® and concentrated to afford the crude product. The crude product was purified 
using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.13] to afford (R)-4-benzyl-3-
((R)-3-hydroxy-3-((1R,2S)-2-isopropylcyclopropyl)propanoyl)-5,5-dimethyloxazolidin-2-one 562 
(0.72 g, 2.00 mmol) as a colourless oil in 56% yield. 1H NMR (300 MHz, CDCl3) δH = 7.30-7.17 
(5H, m, Ph), 4.51 (1H, dd, J = 9.2, 4.5 Hz, CHN), 3.35 (1H, td, J = 4.0, 8.0 Hz, CHOH), 3.22-3.19 
(2H, m, COCH2CHOH), 3.12 (1H, dd, J = 14.2, 4.2 Hz, CHAHBPh), 2.87 (2H, dd, J = 14.2, 9.0 Hz, 
CHAHBPh and broad s, OH), 1.35 (3H, s, C(CH3)(CH3)), 1.34 (3H, s, C(CH3)(CH3)), 0.94 (7H, m, 
CH(CH3)(CH3)), 0.80-0.71 (1H, m, CHOHCH-cyclopropyl), 0.56-0.50 (2H, m, cyclopropyl-
CHCH(CH3)(CH3)), and cyclopropyl-CHAHB), 0.47-0.35 (1H, m, cyclopropyl-CHAHB); 
13C NMR (75 
MHz, CDCl3) δC = 172.4, 152.5, 136.8, 128.9, 128.5, 128.4, 126.6, 82.2, 71.8, 63.2, 42.8, 35.2, 
32.2, 28.3, 24.6, 23.6, 22.0, 21.8, 9.8; IR cm-1 ν = 3526 (OH), 1775 (C=Oox), 1696 (C=O); HRMS: 
m/z (ES) 382.2026, C21H29NNaO4 [M+Na]
+ requires 382.1989;  
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(R)-Methyl 3-hydroxy-3-((1R,2R)-2-methylcyclopropyl)propanoate, 563 
 
(R)-4-Benzyl-3-((R)-3-hydroxy-3-((1R,2R)-2-methylcyclopropyl)propanoyl)-5,5-
dimethyloxazolidin-2-one 560 (0.50 g, 1.51 mmol) was dissolved in dichloromethane (15 mL) at 
room temperature under nitrogen. A solution of sodium methoxide (3.02 mL, 1.51 mmol, 0.5 
M in methanol) was added and the reaction was stirred for five minutes. The reaction was 
quenched with saturated ammonium chloride (5 mL) and the organic layer was washed with 
brine, dried over MgSO4 and concentrated to afford crude product. The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.22] to afford (R)-
methyl 3-hydroxy-3-((1R,2R)-2-methylcyclopropyl)propanoate 563 (0.15 g, 0.94 mmol) as a 
colourless oil in 62% yield. 1H NMR (300 MHz, CDCl3) δH = 3.60 (3H, s, OCH3), 3.30-3.23 (1H, m, 
CHOH), 2.90 (1H, broad s, OH), 2.51 (2H, d, J = 6.4 Hz, COCH2CHOH), 0.91 (3H, d, J = 5.4 Hz, 
cyclopropyl-CH3), 0.59-0.51 (2H, m, CHOHCH-cyclopropyl and cyclopropyl-H), 0.49-0.41 (1H, m, 
cyclopropyl-H), 0.22-0.17 (1H, m, cyclopropyl-H); 13C NMR (75 MHz, CDCl3) δC = 172.8, 72.1, 
51.6, 41.7, 25.6, 18.2, 11.4, 10.5; IR cm-1 ν = 3438 (OH), 1725 (C=O); HRMS: m/z (ES) 181.0859, 
C8H14NaO3 [M+Na]
+ requires 181.0840;  
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(R)-Methyl 3-((1R,2R)-2-ethylcyclopropyl)-3-hydroxypropanoate, 564 
 
(R)-4-benzyl-3-((R)-3-((1R,2R)-2-ethylcyclopropyl)-3-hydroxypropanoyl)-5,5-
dimethyloxazolidin-2-one 561 (0.37 g, 1.07 mmol) was dissolved in dichloromethane (12 mL) at 
room temperature under nitrogen. A solution of sodium methoxide (2.14 mL, 1.07 mmol, 0.5 
M in methanol) was added and the reaction was stirred for five minutes. The reaction was 
quenched with saturated ammonium chloride (5 mL) and the organic layer was washed with 
brine, dried over MgSO4 and concentrated to afford crude product. The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.21] to afford (R)-
methyl 3-((1R,2R)-2-ethylcyclopropyl)-3-hydroxypropanoate 564 (0.14 g, 0.78 mmol) as a 
colourless oil in 72% yield. 1H NMR (300 MHz, CDCl3) δH = 3.62 (3H, s, OCH3), 3.26 (1H, ddd, J = 
15.5, 8.3, 5.3 Hz, CHOH), 2.83 (1H, broad s, OH), 2.53 (2H, d, J = 2.3 Hz, CH2CHOH), 1.31-1.16 
(1H, m, CHAHBCH3), 1.13-0.99 (1H, m, CHAHBCH3), 0.85 (3H, t, J = 7.3 Hz, cyclopropyl-CH2CH3), 
0.63-0.42 (3H, m, CHOHCH-cyclopropyl and cyclopropyl-H), 0.28-0.23 (1H, m, cyclopropyl-H); 
13C NMR (75 MHz, CDCl3) δC = 172.9, 72.3, 51.6, 41.5, 26.5, 24.4, 18.4, 13.5, 10.4; IR cm
-1 ν = 
3428 (OH), 1732 (C=O); HRMS: m/z (ES) 195.1052, C9H16NaO3 [M+Na]
+ requires 195.0997;  
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(R)-Methyl 3-hydroxy-3-((1R,2S)-2-isopropylcyclopropyl)propanoate, 565 
 
(R)-4-Benzyl-3-((R)-3-hydroxy-3-((1R,2S)-2-isopropylcyclopropyl)propanoyl)-5,5-
dimethyloxazolidin-2-one 562 (0.71 g, 1.99 mmol) was dissolved in dichloromethane (20 mL) at 
room temperature under nitrogen. A solution of sodium methoxide (3.97 mL, 1.99 mmol, 0.5 
M in methanol) was added and the reaction was stirred for five minutes. The reaction was 
quenched with saturated ammonium chloride (5 mL) and the organic layer was washed with 
brine, dried over MgSO4 and concentrated to afford crude product. The crude product was 
purified using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.27] to afford (R)-
methyl 3-hydroxy-3-((1R,2S)-2-isopropylcyclopropyl)propanoate 565 (0.23 g, 1.25 mmol) as a 
colourless oil in 63% yield. 1H NMR (300 MHz, CDCl3) δH = 3.62 (3H, s, OCH3), 3.23 (1H, m, 
CHOH), 2.89 (1H, broad s, OH), 2.53 (2H, m, CH2CHOH), 0.91-0.86 (7H, m, CH(CH3)(CH3)), 0.68-
0.59 (1H, m, CHOHCH-cyclopropyl), 0.47-0.42 (1H, m, cyclopropyl-CHCH(CH3)(CH3)), 0.38-0.27 
(2H, m, cyclopropyl-CHAHB and cyclopropyl-CHAHB); 
13C NMR (75 MHz, CDCl3) δC = 172.9, 72.3, 
51.6, 41.4, 32.4, 24.9, 23.8, 22.0, 21.9, 9.9; IR cm-1 ν = 3467 (OH), 1735 (C=O); HRMS: m/z (ES) 
209.1151, C10H18NaO3 [M+Na]
+ requires 209.1148;  
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(+)-Prelactone V - (4R,5S,6R)-4-Hydroxy-5,6-dimethyltetrahydro-2H-pyran-2-one, 566 
 
Mercury trifluoroacetate (0.99 g, 2.32 mmol) was added in one portion to a stirred solution of 
(R)-methyl 3-hydroxy-3-((1R,2R)-2-methylcyclopropyl)propanoate 563 (0.147 g, 0.93 mmol) in 
dichloromethane (10 mL). The resulting yellow solution was stirred at ambient temperature for 
24 hours under nitrogen, before being quenched with brine (10 mL) and stirred for a further 
one hour. The organic layer was extracted with brine and the aqueous layer was extracted 
further with ethyl acetate. The organic layers were combined, dried over MgSO4 and 
concentrated to afford the corresponding organomercurial δ-lactone. This was subsequently 
dissolved in methanol (5 mL) and cooled to 0 ˚C under nitrogen. Sodium borohydride (0.105 g, 
2.79 mmol) was dissolved in 3.5 M sodium hydroxide (4 mL) and was added in one portion to 
the solution of organomercurial δ-lactone. The resulting dark grey solution was stirred for two 
minutes at 0 ˚C and was then quenched with 1 M HCl solution to pH 2. The methanol was 
evaporated, the aqueous layer was saturated with NaCl and the resulting brine solution was 
extracted with three portions of ethyl acetate. The organic extracts were combined, dried over 
MgSO4 and concentrated to afford the crude product. The crude product was purified using 
flash silica chromatography [1:1 EtOAc:Petroleum ether, Rf 0.22] to afford (4R,5S,6R)-4-
hydroxy-5,6-dimethyltetrahydro-2H-pyran-2-one 566 (0.087 g, 0.60 mmol) as a gummy solid in 
65% yield. 1H NMR (300 MHz, CDCl3) δH = 3.98 (1H, dq, J = 10.4, 6.4 Hz, COOCHCH3), 3.76 (1H, 
td, J = 8.0, 5.9 Hz, CHOH), 2.91 (1H, dd, J = 17.3, 5.9 Hz, COCHAHBCHOH), 2.50 (1H, dd, J = 17.3, 
8.1 Hz, COCHAHBCHOH), 2.21 (1H, broad s, OH), 1.66-1.53 (1H, m, CHOHCHCH3CHCH3O), 1.40 
(3H, d, J = 6.4 Hz, COOCHCH3), 1.08 (3H, d, J = 6.7 Hz, CHOHCHCH3CHCH3O); 
13C NMR (75 MHz, 
CDCl3) δC = 170.9, 79.2, 69.7, 43.4, 39.2, 19.7, 13.9; IR cm
-1 ν = 3413 (OH), 1718 (C=O); HRMS: 
m/z (ES) 145.0866, C7H13O3 [M+H]
+ requires 145.0864;  
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(+)-Prelactone E - (4R,5S,6R)-6-Ethyl-4-hydroxy-5-methyltetrahydro-2H-pyran-2-one, 567 
 
Mercury trifluoroacetate (0.84 g, 1.96 mmol) was added in one portion to a stirred solution of 
(R)-methyl 3-((1R,2R)-2-ethylcyclopropyl)-3-hydroxypropanoate 564 (0.14 g, 0.78 mmol) in 
dichloromethane (10 mL). The resulting yellow solution was stirred at ambient temperature for 
24 hours under nitrogen, before being quenched with brine (10 mL) and stirred for a further 
one hour. The organic layer was extracted with brine and the aqueous layer was extracted 
further with ethyl acetate. The organic layers were combined, dried over MgSO4 and 
concentrated to afford the corresponding organomercurial δ-lactone. This was subsequently 
dissolved in methanol (5 mL) and cooled to 0 ˚C under nitrogen. Sodium borohydride (0.089 g, 
2.35 mmol) was dissolved in 3.5 M sodium hydroxide (4 mL) and was added in one portion to 
the solution of organomercurial δ-lactone. The resulting dark grey solution was stirred for two 
minutes at 0 ˚C and was then quenched with 1 M HCl solution to pH 2. The methanol was 
evaporated, the aqueous layer was saturated with NaCl and the resulting brine solution was 
extracted with three portions of ethyl acetate. The organic extracts were combined, dried over 
MgSO4 and concentrated to afford the crude product. The crude product was purified using 
flash silica chromatography [1:1 EtOAc:Petroleum ether, Rf 0.21] to afford (4R,5S,6R)-6-ethyl-4-
hydroxy-5-methyltetrahydro-2H-pyran-2-one 567 (0.064 g, 0.41 mmol) as a gummy solid in 
52% yield. 1H NMR (300 MHz, CDCl3) δH = 3.82 and 3.76 (1H, ddd, J = 10.4, 7.4, 3.0 Hz and 1H, 
ddd, J = 13.7, 7.8, 5.9 Hz, CHOH and CHCH2CH3), 2.89 (1H, dd, J = 17.1, 5.9 Hz, COCHAHB), 2.48 
(1H, dd, J = 17.1, 7.8 Hz, COCHAHB), 2.51 (1H, broad s, OH), 1.82 and 1.74-1.48 (1H, app. sex. of 
doublets, J = 7.5, 3.0 Hz and 2H, m, CHCH3 and CH2CH3), 1.06 (3H, d, J = 6.7 Hz, CHCH3), 1.00 
(3H, t, J = 7.4 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3) δC = 172.0, 83.8, 69.4, 40.4, 39.0, 25.7, 











(+)-Prelactone B - (4R,5S,6R)-4-hydroxy-6-isopropyl-5-methyltetrahydro-2H-pyran-2-one, 568 
 
Mercury trifluoroacetate (0.68 g, 1.60 mmol) was added in one portion to a stirred solution of 
(R)-methyl 3-hydroxy-3-((1R,2S)-2-isopropylcyclopropyl)propanoate 565 (0.12 g, 0.64 mmol) in 
dichloromethane (10 mL). The resulting yellow solution was stirred at ambient temperature for 
24 hours under nitrogen, before being quenched with brine (10 mL) and stirred for a further 
one hour. The organic layer was extracted with brine and the aqueous layer was extracted 
further with ethyl acetate. The organic layers were combined, dried over MgSO4 and 
concentrated to afford the corresponding organomercurial δ-lactone. This was subsequently 
dissolved in methanol (4 mL) and cooled to 0 ˚C under nitrogen. Sodium borohydride (0.073 g, 
1.92 mmol) was dissolved in 3.5 M sodium hydroxide (3.5 mL) and was added in one portion to 
the solution of organomercurial δ-lactone. The resulting dark grey solution was stirred for two 
minutes at 0 ˚C and was then quenched with 1 M HCl solution to pH 2. The methanol was 
evaporated, the aqueous layer was saturated with NaCl and the resulting brine solution was 
extracted with three portions of ethyl acetate. The organic extracts were combined, dried over 
MgSO4 and concentrated to afford the crude product. The crude product was purified using 
flash silica chromatography [3:7 EtOAc:Petroleum ether, Rf 0.10] to afford (4R,5S,6R)-4-
hydroxy-6-isopropyl-5-methyltetrahydro-2H-pyran-2-one 568 (0.10 g, 0.60 mmol) as a gummy 
solid in 94% yield. 1H NMR (300 MHz, CDCl3) δH = 3.73 (2H, m, COOCHCH(CH3)(CH3) and CHOH), 
3.41 (1H, broad s, OH), 2.85 (1H, dd, J = 17.1, 5.9 Hz, COCHAHBCHOH), 2.43 (1H, dd, J = 17.1, 7.7 
Hz, COCHAHBCHOH), 1.94 (1H, dhep, J = 6.9, 2.1 Hz, COOCHCH(CH3)(CH3)), 1.70 (1H, m, CHCH3), 
1.03 (6H, m, COOCHCH(CH3)(CH3) and CHCH3), 0.87 (3H, d, J = 6.8 Hz, COOCHCH(CH3)(CH3)); 
13C 
NMR (75 MHz, CDCl3) δC = 172.11, 86.6, 69.5, 39.0, 38.9, 28.9, 20.1, 14.1, 13.7; IR cm
-1 ν = 3467 
(OH), 1712 (C=O); HRMS: m/z (ES) 195.0986, C9H16NaO3 [M+Na]
+ requires 195.0997;  
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4.2 Compounds from Chapter 3 
4.2.1 Synthesis of Non-Commercially Available Aldehydes 
4-(Benzyloxy)butan-1-ol 
 
NaH (0.98 g, 24.41 mmol, 60% dispersion in mineral oil) was added portionwise to THF (20 mL) 
at 0 ˚C. Butane-1,4-diol (2.0 g, 22.19 mmol) was added dropwise followed by benzyl bromide 
(3.17 mL, 26.63 mmol). The resulting suspension was stirred at room temperature for five 
hours before being quenched with water (20 mL). The THF was evaporated under reduced 
pressure, the resulting oil was redissolved in ethyl acetate and extracted with brine. The 
combined organic extracts were dried over MgSO4 and concentrated to afford crude product. 
The crude product was purified using flash silica chromatography [1:4 EtOAc: Petroleum ether, 
Rf 0.21] to afford 4-(benzyloxy)butan-1-ol (1.57 g, 8.65 mmol) as a colourless oil in 39% yield. 
1H NMR (300 MHz, CDCl3) δH = 7.27-7.18 (5H, m, Ph), 4.43 (2H, s, OCH2Ph), 3.50 (2H, t, J = 6.1 
Hz, HOCH2), 5.82 (2H, t, J = 5.8 Hz, CH2OBn), 3.10 (1H, broad s, OH), 1.67-1.50 (4H, m, CH2CH2); 
13C NMR (75 MHz, CDCl3) δC = 138.2, 128.3, 127.6, 127.5, 72.9, 70.2, 62.2, 29.7, 26.4; IR cm
-1 ν = 
3367 (OH); HRMS: m/z (ES) 181.1215, C11H17O2 [M+H]















Oxalyl chloride (1.03 mL, 12.20 mmol) was dissolved in dry dichloromethane (50 mL) at -55 ˚C 
under nitrogen. Dimethylsulphoxide (1.58 mL, 22.20 mmol) was added and the resulting 
solution was stirred for two minutes. 4-(Benzyloxy)butan-1-ol (2.00 g, 11.10 mmol) in 
dichloromethane (5 mL) was added dropwise to the solution to form a light yellow cloudy 
mixture, which was stirred for 15 minutes at -55 ˚C. Triethylamine (7.73 mL, 55.50 mmol) was 
then added and the resulting solution was stirred for a further 15 minutes at -55 ˚C. The thick 
white slurry was warmed to room temperature and was quenched with the addition of water 
(50 mL). The layers were separated and the aqueous layer was extracted three times with 
dichloromethane (50 mL). The combined organic layers were washed with 1 M HCl (10 mL) and 
saturated NaHCO3 before being dried over MgSO4 and concentrated. The crude product was 
purified using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.63] to afford 4-
(benzyloxy)butanal 603 (1.48 g, 8.30 mmol) as a colourless liquid in 75% yield. 1H NMR (300 
MHz, CDCl3) δH = 9.68 (1H, s, CHO), 7.30-7.18 (5H, m, Ph), 4.41 (2H, s, OCH2Ph), 3.43 (2H, t, J = 
6.1 Hz, CH2OBn), 2.45 (2H, t, J = 7.1 Hz, CHOCH2), 1.87 (2H, app. quintet, J = 6.6 Hz, 
CH2CH2CH2OBn); 
13C NMR (75 MHz, CDCl3) δC 202.1, 138.3, 128.3, 127.5, 72.8, 69.0, 40.8, 22.5; 
IR cm-1 ν = 1721 (C=O); HRMS: m/z (ES) 201.0894, C11H14NaO2, [M+Na]














4-(Benzyloxy)butanal 603 (0.50 g, 2.80 mmol) was dissolved in 37% aqueous formaldehyde 
solution (0.27 mL, 3.70 mmol). Dimethylamine hydrochloride (0.30 g, 3.70 mmol) was added 
and the mixture was heated at 70 ˚C for 24 hours. The reaction was cooled to room 
temperature, quenched with saturated NaHCO3, extracted into hexane and the combined 
organic fractions were washed with water, dried over MgSO4 and concentrated. The crude 
product was purified using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.31] to 
afford 4-(benzyloxy)-2-methylenebutanal 604 (0.41 g, 2.20 mmol) as a colourless liquid in 78% 
yield. 1H NMR (300 MHz, CDCl3) δH = 9.46 (1H, s, CHO), 7.30-7.19 (5H, m, Ph), 6.31 (1H, s, 
C=CHAHB), 6.00 (1H, s, C=CHAHB), 4.43 (2H, s, OCH2Ph), 3.53 (2H, t, J = 6.4 Hz, CH2OBn), 2.51 
(2H, t, J = 6.4 Hz, CH2=CCH2); 
13C NMR (75 MHz, CDCl3) δC 194.4, 146.9, 138.2, 135.7, 128.4, 
127.6, 127.5, 72.8, 67.9, 28.2; IR cm-1 ν = 1686 (C=O); HRMS: m/z (ES) 213.0912, C12H14NaO2, 

















Oxalyl chloride (0.18 mL, 2.17 mmol) was dissolved in dry dichloromethane (7 mL) at -55 ˚C 
under nitrogen. Dimethylsulfoxide (0.28 mL, 3.94 mmol) was added and the resulting solution 
was stirred for two minutes. 2-(Benzyloxy)ethanol (0.30 g, 1.97 mmol) was added dropwise to 
the solution to form a light yellow cloudy mixture, which was stirred for 15 minutes at -55 ˚C. 
Triethylamine (1.37 mL, 9.86 mmol) was then added and the resulting solution was stirred for 
a further 15 minutes at -55 ˚C. The thick white slurry was warmed to room temperature and 
was quenched with the addition of water (10 mL). The layers were separated and the aqueous 
layer was extracted three times with dichloromethane (20 mL). The combined organic layers 
were washed with 1 M HCl and saturated NaHCO3 before being dried over MgSO4 and 
concentrated. The crude product was purified using flash silica chromatography [1:9 
EtOAc:Petroleum ether, Rf 0.10] to afford 2-(benzyloxy)acetaldehyde 606 (0.27 g, 1.79 mmol) 
as a colourless liquid in 91% yield. 1H NMR (300 MHz, CDCl3) δH = 9.57 (1H, s, CHO), 7.27-7.19 
(5H, m, Ph), 4.50 (2H, s, OCH2Ph), 3.97 (2H, d, J = 0.7 Hz, CHOCH2); 
13C NMR (75 MHz, CDCl3) δC 
= 200.3, 136.8, 128.5, 128.1, 127.9, 75.2, 73.5; IR cm-1 ν = 3411 (OH), 1735 (C=O); HRMS: m/z 
(ES) 173.0601, C9H10NaO2 [M+Na]












(E)-Ethyl 4-(benzyloxy)-2-methylbut-2-enoate, 608 
 
(Carbethoxyethylidene)triphenylphosphorane (0.65 g, 1.80 mmol) was dissolved in 
dichloromethane (1 mL) and cooled to 0 ˚C. 2-(Benzyloxy)acetaldehyde 606 (0.24 g, 1.60 
mmol) in dichloromethane (1 mL) was added dropwise and the resulting solution was stirred 
for 30 minutes. The dichloromethane was removed under reduced pressure and the crude 
product was purified using flash silica chromatography [1:99 EtOAc:Petroleum ether, Rf 0.31] 
to afford (E)-ethyl 4-(benzyloxy)-2-methylbut-2-enoate 608 (0.24 g, 1.04 mmol) as a colourless 
liquid in 65% yield. 1H NMR (300 MHz, CDCl3) δH = 7.27-7.18 (5H, m, Ph), 6.80 (1H, td, J = 5.8, 
1.1 Hz, CH3C=CH), 4.45 (2H, s, OCH2Ph), 4.11 (4H, app. quartet, J = 7.1 Hz, C=CHCH2 and 
CH3CH2OC=O), 1.74 (3H, s, CH3C=CH), 1.20 (3H, t, J = 7.0 Hz, CH3CH2OC=O); 
13C NMR (75 MHz, 
CDCl3) δC = 167.4, 137.9, 137.8, 129.4, 128.4, 127.7, 72.7, 66.8, 60.6, 14.9, 12.8; IR cm
-1 ν = 
1709 (C=O); HRMS: m/z (ES) 257.1139, C14H18NaO3 [M+Na]


















(E)-Ethyl 4-(benzyloxy)-2-methylbut-2-enoate 608 (0.24 g, 1.04 mmol) was dissolved in dry 
diethyl ether (5 mL) at -78 ˚C. DIBAL (1.25 mL, 1.24 mmol, 1M in hexane) was added dropwise 
and the resulting solution was stirred for one hour at -78 ˚C followed by one hour at 0 ˚C. The 
reaction was quenched with saturated ammonium chloride and the layers were separated. The 
organic layer was washed with 1 M HCl and saturated NaHCO3 before being dried over MgSO4 
and concentrated. The crude product was purified using flash silica chromatography [1:4 
EtOAc:Petroleum ether, Rf 0.19] to afford (E)-4-(benzyloxy)-2-methylbut-2-en-1-ol 609 (0.08 g, 
0.43 mmol) as a colourless liquid in 41% yield. 1H NMR (300 MHz, CDCl3) δH = 7.27-7.18 (5H, m, 
Ph), 5.57 (1H, tq, J = 6.6, 1.3 Hz, CH3C=CH), 4.43 (2H, s, CH2OPh), 3.99 (2H, d, J = 6.6 Hz, 
CH2OBn), 3.90 (2H, s, CH2OH), 2.27 (1H, broad s, OH), 1.57 (3H, s, CH3C=CH); 
13C NMR (75 MHz, 
CDCl3) δC = 139.5, 138.3, 128.4, 127.9, 127.7, 121.2, 72.4, 67.8, 66.3, 13.9; IR cm
-1 ν = 3399 
(OH); HRMS: m/z (ES) 215.1096, C12H16NaO2 [M+Na]

















Oxalyl chloride (0.15 mL, 1.74 mmol) was dissolved in dry dichloromethane (6 mL) at -55 ˚C 
under nitrogen. Dimethylsulfoxide (0.22 mL, 3.16 mmol) was added and the resulting solution 
was stirred for two minutes. (E)-4-(Benzyloxy)-2-methylbut-2-en-1-ol 609 (0.30 g, 1.58 mmol) 
in dichloromethane (1 mL) was added dropwise to the solution to form a light yellow cloudy 
mixture, which was stirred for 15 minutes at -55 ˚C. Triethylamine (1.10 mL, 7.91 mmol) was 
then added and the resulting solution was stirred for a further 15 minutes at -55 ˚C. The thick 
white slurry was warmed to room temperature and was quenched with the addition of water 
(10 mL). The layers were separated and the aqueous layer was extracted three times with 
dichloromethane (20 mL). The combined organic layers were washed with 1 M HCl and 
saturated NaHCO3 before being dried over MgSO4 and concentrated. The crude product was 
purified using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.63] to afford (E)-4-
(benzyloxy)-2-methylbut-2-enal 610 (0.27 g, 1.45 mmol) as a colourless liquid in 92% yield. 1H 
NMR (300 MHz, CDCl3) δH = 9.33 (1H, s, CHO), 7.30-7.16 (5H, m, Ph), 6.50 (1H, tq, J = 5.6, 1.3 
Hz, (CH3C=CH)), 4.48 (2H, s, OCH2Ph), 4.25 (2H, dd, J = 5.6, 1.1 Hz, CH2OBn), 1.63 (3H, app. 
quartet, J = 1.1 Hz, CH3C=CH); 
13C NMR (75 MHz, CDCl3) δC = 194.4, 149.5, 139.5, 137.6, 128.6, 
128.0, 127.9, 73.2, 66.8, 9.6; IR cm-1 ν = 1687 (C=O); HRMS: m/z (ES) 213.0883, C12H14NaO2 










4.2.2 Synthesis of syn-Aldol Products 613, 614, 615 
(S)-4-Benzyl-3-((2S,3R)-3-hydroxy-2-methylpent-4-enoyl)-5,5-dimethyloxazolidin-2-one, 613 
 
The title compound was prepared according to General Procedure 1 from 9-BBN-OTf (3.78 mL, 
1.90 mmol), (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 95 (0.40 g, 1.70 mmol), 
N,N-diisopropylethylamine (0.43 ml, 2.50 mmol) and acrolein (0.16 mL, 2.50 mmol) in 
dichloromethane (90 mL). The crude product was purified using flash silica chromatography to 
afford (S)-4-benzyl-3-((2S,3R)-3-hydroxy-2-methylpent-4-enoyl)-5,5-dimethyloxazolidin-2-one 
613 (0.26 g, 0.90 mmol) as a colourless oil in 53% yield. 1H NMR (300 MHz, CDCl3) δH = 7.26-
7.12 (5H, m, Ph), 5.83-5.70 (1H, ddd, J = 10.5, 5.5, 5.3 Hz, CH=CH2), 5.25 (1H, dt, J = 1.5 Hz, 
CHcisHtrans=C), 5.13 (1H, dt, J = 10.5, 1.5 Hz, CHcisHtrans=C), 4.49 (1H, dd, J = 9.0, 4.5 Hz, CHN), 
4.38 (1H, m, CHOH), 3.85 (1H, dq, J = 7.0, 4.0 Hz, CHCH3), 3.0 (1H, dd, J = 14.5, 4.5 Hz, 
CHAHBPh), 2.85 (1H, dd, J = 14.5, 9.0 Hz, CHAHBPh), 2.65 (1H, broad s, OH), 1.33 (3H, s, 
(CH3)C(CH3)), 1.31 (3H, s, (CH3)C(CH3)), 1.10 (3H, d, J = 7.0 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3) 
δC = 176.9 152.8, 137.7, 137.0, 129.5, 129.1, 127.3, 116.8, 82.8, 73.2, 63.8, 42.85, 35.9, 28.8, 
22.6, 11.7; IR cm-1 ν = 3501 (broad OH), 1754 (C=O), 1702 (C=Oox); HRMS: m/z (ES) 340.1577, 
C18H23NNaO4 [M+Na]
+ requires 340.1519; 
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The title compound was prepared according to General Procedure 1 from dibutylboron triflate 
(1.78 mL, 1.80 mmol), (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 95 (0.42 g, 1.60 
mmol), N,N-diisopropylethylamine (0.36 mL, 2.10 mmol) and 4-(benzyloxy)-2-
methylenebutanal 604 (0.40 g, 2.10 mmol) in dichloromethane (5 mL). The crude product was 
purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, Rf 0.27] to afford (S)-4-
benzyl-3-((2S,3S)-6-(benzyloxy)-3-hydroxy-2-methyl-4-methylenehexanoyl)-5,5-dimethyloxa 
zolidin-2-one 614 (0.57 g, 1.30 mmol) as a colourless oil in 78% yield. 1H NMR (300 MHz, CDCl3) 
δH = 7.27-7.16 (10H, m, Ph and Phox), 5.11 (1H, s, C=CHAHB), 4.95 (1H, s, C=CHAHB), 4.45-4.40 
(3H, m, OCH2Ph, CHN), 4.32 (1H, broad d, J = 5.8 Hz, CHOH), 4.00 (1H, app. quintet, J = 6.6 Hz, 
CHCH3), 3.62-3.48 (2H, m, CH2OBn), 3.18 (1H, broad s, OH), 2.99 (1H, dd, J = 14.4, 4.3 Hz, 
CHAHBPh), 2.83 (1H, dd, J = 14.1, 8.7 Hz, CHAHBPh), 2.44-2.35 (1H, m, CHAHBOBn), 2.29-2.21 (1H, 
m, CHAHBOBn), 1.31 (3H, s, C(CH3)(CH3)), 1.26 (3H, s, C(CH3)(CH3)), 1.12 (3H, d, J = 6.9 Hz, 
CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 176.3, 152.2, 146.8, 137.9, 136.7, 129.1, 128.6, 128.4, 
127.7, 127.6, 126.8, 113.3, 82.2, 74.5, 73.0, 70.0, 63.3, 41.5, 35.3, 32.7, 28.2, 22.1, 12.0; IR cm-1 















The title compound was prepared according to General Procedure 1 from dibutylboron triflate 
(1.50 mL, 1.50 mmol), (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 95 (0.36 g, 1.40 
mmol), N,N-diisopropylethylamine (0.31 mL, 1.80 mmol) and (E)-4-(benzyloxy)-2-methylbut-2-
enal246 610 (0.34 g, 1.80 mmol) in dichloromethane (3 mL). The crude product was purified 
using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.24] to afford (S)-4-benzyl-3-
((2S,3S,E)-6-(benzyloxy)-3-hydroxy-2,4-dimethylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 615 
(0.28 g, 0.60 mmol) as a colourless oil in 46% yield. 1H NMR (300 MHz, CDCl3) δH = 7.27-7.15 
(10H, m, Ph and Phox), 5.71 (1H, broad t, J = 6.3 Hz, C=CH), 4.46-4.43 (3H, m, OCH2Ph and CHN), 
4.28 (1H, d, J = 3.7 Hz, CHOH), 4.02 (2H, d, J = 6.6 Hz, CH2OBn), 3.96-3.91 (1H, m, CHCH3), 3.01 
(1H, dd, J = 14.3, 4.0 Hz, CHAHBPh), 2.82 (2H, dd, broad s, J = 14.3, 9.1 Hz, CHAHBPh and OH), 
1.57 (3H, s, CH3C=CH), 1.30 (3H, s, C(CH3)(CH3)), 1.26 (3H, s, C(CH3)(CH3)), 1.05 (3H, d, J = 7.4 
Hz, CHCH3); 
13C NMR (75 MHz, CDCl3) δC = 176.6, 152.3, 138.3, 138.1, 136.7, 129.1, 128.6, 
128.4, 127.8, 127.6, 126.9, 122.9, 82.4, 75.2, 72.1, 66.2, 63.5, 40.6, 35.3, 28.3, 22.1, 13.6, 10.9;  














4.2.3 Upjohn Dihydroxylation for the Synthesis of Hydroxy--Butyrolactones 632-637 
Upjohn Dihydroxylation: Synthesis of Hydroxy--Butyrolactones - General Procedure 5 
Osmium tetroxide (OsO4) (0.1 equiv.) was added in one portion to a stirring solution of the 
appropriate -alkenyl--hydroxy-N-acyloxazolidin-2-one 613-616, 536, 538 (1.0 equiv.) in 
acetone/water (8:1 ratio) under nitrogen. After five minutes, NMO (N-methylmorpholine N-
oxide, 60% by weight in water, 1.1 equiv.) was added in one portion and the solution was 
stirred for 24 hours. The resulting reaction mixture was concentrated under reduced pressure 






















OsO4 (0.022 g, 0.09 mmol) was added to a solution of (S)-4-benzyl-3-((2S,3S)-3-hydroxy-2-
methyl-4-methylenehexanoyl)-5,5-dimethyloxazolidin-2-one 592 (0.31 g, 0.88 mmol) in 
acetone/water (8:1, 3 mL) followed by addition of NMO (60% by weight in water, 0.16 mL, 0.97 
mmol) according to General Procedure 5 to afford the crude product as black oil. The crude 
product was purified using flash silica chromatography [EtOAc:Petroleum ether] to afford 
(3S,4S,5R)-5-ethyl-4-hydroxy-5-(hydroxymethyl)-3-methyldihydrofuran-2(3H)-one 599 (0.12 g, 
0.61 mmol) as a colourless oil in 69 % yield and 49:1 dr. 1H NMR (500 MHz, MeOD) δH = 4.24 
(1H, d, J = 9.4 Hz, CHOH), 3.74 (1H, d, J = 12.1 Hz, CHAHBOH), 3.52 (1H, d, J = 12.2 Hz, CHAHBOH), 
2.68 (1H, qd, J = 9.4, 7.1 Hz, CHCO), 1.81 (1H, dq, J = 15.0, 7.5 Hz, CHAHBCH3), 1.71 (1H, dq, J = 
15.0 , 7.5 Hz, CHAHBCH3), 1.28 (3H, d, J = 7.5 Hz, CH3), 1.01 (3H, t, J = 7.5 Hz, CH2CH3); 
13C NMR 
(75 MHz, MeOD) δC = 179.6, 90.2, 76.5, 64.7, 44.2, 25.0, 13.9, 8.6; IR cm
-1 ν = 3368 (broad OH), 
1751 (C=O); HRMS: m/z (ES) 175.0957, C8H15O4 [M+H]
+ requires 175.0970; 
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OsO4 (0.015 g, 0.06 mmol) was added to a solution of (S)-4-benzyl-3-((2S,3R)-3-hydroxy-2-
methylpent-4-enoyl)-5,5-dimethyloxazolidin-2-one 613 (0.15 g, 0.52 mmol) in acetone/water 
(8:1, 5 mL) followed by addition of NMO (60% by weight in water, 0.09 mL, 0.52 mmol) 
according to General Procedure 5 to afford the crude product as black oil. The crude product 
was purified using flash silica chromatography [EtOAc:Petroleum ether] to afford (3S,4S,5R)-4-
hydroxy-5-(hydroxymethyl)-3-methyldihydrofuran-2(3H)-one 632 (0.06 g, 0.41 mmol) as a 
colourless oil in 79% yield and 3:1 dr. The two diastereoisomers were analysed as a mixture. 
(3S,4S,5R)-major: 1H NMR (500 MHz, MeOD) δH = 4.19-4.17 (1H, m, CHCH2OH), 4.02 – 3.99 (1H, 
m, CHOH), 3.94 (1H, dd, J = 12.8, 2.5 Hz, CHACHBOH), 3.72 (1H, dd, J = 12.8, 4.8 Hz, CHACHBOH), 
2.66 (1H, dq, J = 8.9, 7.1 Hz, CHCH3), 1.30 (3H, d, J = 7.3 Hz, CH3); 
13C NMR (75 MHz, MeOD) δC = 
180.0, 86.8, 75.6, 62.0, 45.7, 13.6; (3S,4S,5S)-minor: 1H NMR (500 MHz, CDCl3) δH = 4.57 (1H, 
dt, J = 5.8, 3.7 Hz, CHCH2OH), 4.27 (1H, t, J = 6.0 Hz, CHOH), 3.90 (2H, d, J = 3.7 Hz, CHACHBOH), 
2.71 (1H, dt, J = 13.6, 7.6 Hz, CHCH3), 1.29 (3H, d, J = 7.5 Hz, CH3); 
13C NMR (75 MHz, MeOD) δC 
= 181.6, 84.1, 76.2, 62.2, 45.5, 14.4; IR cm-1 ν = 3377 (broad OH), 2934 (broad OH), 1763 (C=O); 
HRMS: m/z (ES) 147.0650, C6H11O4 [M+H]
+ requires 147.0657; 
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OsO4 (0.008 g, 0.03 mmol) was added to a solution of (S)-4-benzyl-3-((2S,3S)-6-(benzyloxy)-3-
hydroxy-2-methyl-4-methylenehexanoyl)-5,5-dimethyloxazolidin-2-one 614 (0.14 g, 0.31 
mmol) in acetone/water (8:1, 1.5 mL) followed by addition of NMO (60% by weight in water, 
0.07 mL, 0.34 mmol) according to General Procedure 5 to afford the crude product as black oil. 
The crude product was purified using flash silica chromatography [EtOAc:Petroleum ether] to 
afford (3S,4S,5R)-5-(2-(benzyloxy)ethyl)-4-hydroxy-5-(hydroxymethyl)-3-methyldihydrofuran-
2(3H)-one 633 (0.08 g, 0.28 mmol) as a colourless oil in 93% yield and 10:1 dr. 1H NMR (300 
MHz, CDCl3) δH = 7.31-7.18 (5H, m, Ph), 4.43 (2H, s, OCH2Ph), 4.12 (1H, broad s, OH), 3.96 (1H, 
d, J = 8.4 Hz, CHOH), 3.59-3.49 (4H, m, CH2OBn, CH2OH), 2.80 (1H, broad s, OH), 2.49 (1H, app. 
quintet, J = 7.4 Hz, CHCH3), 2.07-1.91 (2H, m, CH2CH2OBn), 1.20 (3H, d, J = 7.4 Hz, CHCH3); 
13C 
NMR (75 MHz, CDCl3) δC = 177.4, 136.5, 128.8, 128.5, 128.3, 87.8, 76.5, 73.9, 66.4, 64.8, 42.9, 


















 OsO4 (0.006 g, 0.02 mmol) was added to a solution of (S)-4-benzyl-3-((2S,3R,E)-6-(benzyloxy)-
3-hydroxy-2-methylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 538 (0.10 g, 0.22 mmol) in 
acetone/water (8:1, 1.2 mL) followed by addition of NMO (60% by weight in water, 0.04 mL, 
0.25 mmol) according to General Procedure 5 to afford the crude product as black oil. The 
crude product was purified using flash silica chromatography [EtOAc:Petroleum ether] to 
afford (3S,4S,5S)-5-((S)-2-(benzyloxy)-1-hydroxyethyl)-4-hydroxy-3-methyldihydrofuran-2(3H)-
one 634 (0.047 g, 0.17 mmol) as a colourless oil in 77% yield and 4:1 dr. 1H NMR (300 MHz, 
CDCl3) δH = 7.33-7.20 (5H, m, Ph), 4.50 (2H, s, OCH2Ph), 4.04-3.90 (3H, m, CH3CHCHOH, COOCH, 
OCH2CHOH), 3.63-3.52 (3H, m, CH2OBn, OH), 2.95 (1H, d, J = 4.3 Hz, OH), 2.61-2.51 (1H, m, 
CHCH3), 1.22 (3H, d, J = 7.0 Hz, CHCH3);
 13C NMR (75 MHz, CDCl3) δC = 176.6, 137.1, 128.8, 
128.4, 128.1, 84.3, 74.6, 74.0, 71.1, 69.3, 43.2, 12.4; IR cm-1 ν = 3396 (OH), 1760 (C=O); HRMS: 
m/z (ES) 289.1041, C14H18NaO5, [M+Na]
+ requires 289.1051; 
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OsO4 (0.006 g, 0.02 mmol) was added to a solution of (S)-4-benzyl-3-((2S,3R,Z)-6-(benzyloxy)-3-
hydroxy-2-methylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 536 (0.10 g, 0.22 mmol) in 
acetone/water (8:1, 1.2 mL) followed by addition of NMO (60% by weight in water, 0.04 mL, 
0.25 mmol) according to General Procedure 5 to afford the crude product as black oil. The 
crude product was purified using flash silica chromatography [EtOAc:Petroleum ether] to 
afford (3S,4S,5S)-5-((R)-2-(benzyloxy)-1-hydroxyethyl)-4-hydroxy-3-methyldihydrofuran-2(3H)-
one 635 as a colourless oil as a separarable diastereomeric mixture in overall 74% yield and 2:1 
dr. The diastereomers were separated using flash coloum chromatography and analysed 
separately; 635 major (0.028 g, 0.11 mmol, 45% yield), 658 minor (0.013 g, 0.05 mmol, 21% 
yield) and a mixture of 635 major and 658 minor (0.004 g, 0.15 mmol, 7% yield). (3S,4S,5R)-5-
(S)-major: 1H NMR (300 MHz, 50:50 CDCl3:C6H6) δH = 7.32-21 (5H, m, Ph), 4.43 (1H, d, J = 11.6 
Hz, OCHAHBPh), 4.36 (1H, d, J = 11.6 Hz, OCHAHBPh), 4.03 (1H, dd, J = 9.9, 7.3 Hz, CH3CHCHOH), 
3.85 (1H, dd, J = 7.3, 5.1 Hz, COOCH), 3.79-3.75 (1H, m, OCH2CHOH), 3.51 (1H, dd, J = 10.3, 3.3 
Hz, CHAHBOBn), 3.46 (1H, dd, 10.3, 4.2 Hz, CHAHBOBn), 3.21 (1H, broad s, OH), 2.59 (1H, broad 
s, OH), 2.50 (1H, dq, J = 9.9, 7.1 Hz, CHCH3), 1.25 (3H, d, J = 7.1 Hz, CHCH3); 
13C NMR (75 MHz, 
CDCl3) δC = 176.5, 136.9, 128.8, 128.5, 128.2, 83.1, 74.5, 74.3, 70.9, 70.4, 42.7, 12.6; IR cm
-1 ν = 
3419 (OH), 1760 (C=O); HRMS: m/z (ES) 289.1042, C14H18NaO5, [M+Na]
+ requires 289.1051; 
24
D][  = -2.0 (c = 0.50 g/100 mL in CHCl3). (3S,4S,5S)-5-(R)-minor: 
1H NMR (300 MHz, CDCl3) δH 
= 7.40-7.30 (5H, m, Ph), 4.59 (2H, s, OCH2Ph), 4.43 (1H, dd, J = 8.0, 4.7 Hz, COOCH), 4.32 (1H, 
dd, J = 4.7, 2.6 Hz, CH3CHCHOH), 4.18-4.13 (1H, m, OCH2CHOH), 3.79 (1H, dd, J = 9.9, 3.3 Hz, 
CHAHBOBn), 3.69 (1H, dd, J = 9.9, 5.0 Hz, CHAHBOBn), 3.11 (1H, broad s, OH), 2.87 (1H, broad s, 
OH), 2.68 (1H, qd, J = 7.8, 2.5 Hz, CHCH3), 1.30 (3H, d, J = 7.8 Hz, CHCH3);
 13C NMR (75 MHz, 
CDCl3) δC = 178.4, 137.3, 128.8, 128.3, 128.1, 79.2, 75.0, 73.9, 71.0, 69.1, 43.8, 13.8; IR cm
-1 ν = 
3421 (OH), 1774 (C=O); HRMS: m/z (ES) 289.1032, C14H18NaO5, [M+Na]
+ requires 289.1051; 
24







 OsO4 (0.004 g, 0.02 mmol) was added to a solution of (S)-4-benzyl-3-((2S,3S,E)-6-(benzyloxy)-
3-hydroxy-2,4-dimethylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 615 (0.075 g, 0.17 mmol) in 
acetone/water (8:1, 0.7 mL) followed by addition of NMO (60% by weight in water, 0.03 mL, 
0.18 mmol) according to General Procedure 5 to afford the crude product as black oil. The 
crude product was purified using flash silica chromatography [EtOAc:Petroleum ether] to 
afford (3S,4S,5S)-5-((S)-2-(benzyloxy)-1-hydroxyethyl)-4-hydroxy-3,5-dimethyldihydrofuran-
2(3H)-one 636 (0.043 g, 0.15 mmol) as a colourless oil in 93% yield and >49:1 dr. 1H NMR (300 
MHz, CDCl3) δH = 7.31-7.17 (5H, m, Ph), 4.49 (1H, d, J = 11.6 Hz, OCHAHBPh), 4.43 (1H, d, J = 
11.6 Hz, OCHAHBPh), 3.86 (1H, d, J = 10.5 Hz, CHCH3CHOH), 3.77 (1H, dd, J = 7.6, 6.2 Hz, 
CHOHCH2OBn), 3.54 (1H, dd, J = 10.0, 6.2 Hz, CHAHBOBn), 3.47 (1H, dd, J = 9.8, 7.8 Hz, CHA-
HBOBn), 3.42 (1H, broad s, OH), 2.90 (1H, broad s, OH), 2.65-2.53 (1H, m, CHCH3), 1.20-1.16 
(6H, m, CHCH3, CCH3); 
13C NMR (75 MHz, CDCl3) δC = 175.9, 136.6, 128.9, 128.6, 128.3, 87.7, 
76.8, 74.3, 74.0, 70.0, 40.6, 13.9, 12.7; IR cm-1 ν = 3420 (OH), 1761 (C=O); HRMS: m/z (ES) 
281.1368, C15H21O5, [M+H]
+ requires 281.1388; 
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OsO4 (0.014 g, 0.05 mmol) was added to a solution of (S)-4-benzyl-3-((2S,3R)-3-hydroxy-2,5-
dimethylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 616 (0.18 g, 0.53 mmol) in acetone/water 
(8:1, 3 mL) followed by addition of NMO (60% by weight in water, 0.10 mL, 0.59 mmol) 
according to General Procedure 5 to afford the crude product as black oil. The crude product 
was purified using flash silica chromatography [EtOAc:Petroleum ether] to afford (3S,4S,5R)-4-
hydroxy-5-(2-hydroxypropan-2-yl)-3-methyldihydrofuran-2(3H)-one 637 (0.038 g, 0.22 mmol) 
as a colourless oil in 41% yield and 5:1 dr. 1H NMR (300 MHz, CDCl3) δH = 4.94 (1H, d, J = 4.1 Hz, 
OH), 4.26 (1H, app. dt, J = 3.9, 1.5 Hz, CHOH), 4.09 (1H, d, J = 4.1 Hz, CHOCO), 2.96 (1H, broad 
s, OH), 2.68 (1H, qd, J = 7.8, 1.5 Hz, CHC(CH3)2OH), 1.38 (3H, s, (CH3)C(CH3)), 1.36 (3H, s, 
(CH3)C(CH3)), 1.19 (3H, d, J = 7.8 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3) δC = 179.5, 84.0, 76.3, 
73.0, 46.9, 28.7, 25.0, 13.5; IR cm-1 ν = 3295 (broad OH), 1754 (C=O); HRMS: m/z (ES) 175.0970, 
C8H15O4 [M+H]
+ requires 175.0970; 
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AD-mix-β (0.25 g, 1.4 g/mmol of allylic alcohol) was dissolved in a 1:1 mixture of tBuOH and 
water (1.8 mL, 10 mL/mmol of allylic alcohol). MeSO2NH2 (0.017 g, 0.18 mmol) was added and 
the biphasic suspension was cooled to 0 ˚C. (S)-4-Benzyl-3-((2S,3R,Z)-6-(benzyloxy)-3-hydroxy-
2-methylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 536 (0.08 g, 0.18 mmol) dissolved in 
dichloromethane (1 mL) was added dropwise via syringe to the stirring suspension followed by 
OsO4 (0.004 g, 0.18 mmol). The suspension was stirred vigorously whilst slowly warming to 
room temperature. After 48 hours, the reaction was quenched with solid sodium sulfite (0.10 
g) at room temperature. The suspension was filtered through a pad of Celite®/Florisil®, eluting 
with ethyl acetate before the solution was dried over MgSO4 and concentrated. The crude 
product was purified using flash column chromatography [1:1 EtOAc:Petroleum ether, Rf 0.15] 
to afford (3S,4S,5S)-5-((R)-2-(benzyloxy)-1-hydroxyethyl)-4-hydroxy-3-methyldihydrofuran-
2(3H)-one 635 (0.046 g, 0.17 mmol) as a white oil in 95% yield and 17:1 dr. Analytical data 














AD-mix-α (0.25 g, 1.4 g/mmol of allylic alcohol) was dissolved in a 1:1 mixture of tBuOH and 
water (1.8 mL, 10 mL/mmol of allylic alcohol). MeSO2NH2 (0.017 g, 0.18 mmol) was added and 
the biphasic suspension was cooled to 0 ˚C. (S)-4-Benzyl-3-((2S,3R,Z)-6-(benzyloxy)-3-hydroxy-
2-methylhex-4-enoyl)-5,5-dimethyloxazolidin-2-one 536 (0.08 g, 0.18 mmol) dissolved in 
dichloromethane (1 mL) was added dropwise via syringe to the stirring suspension followed by 
OsO4 (0.005 g, 0.18 mmol). The suspension was stirred vigorously whilst slowly warming to 
room temperature. After 48 hours, the reaction was quenched with solid sodium sulfite (0.10 
g) at room temperature. The suspension was filtered through a pad of Celite®/Florisil®, eluting 
with ethyl acetate before the solution was dried over MgSO4 and concentrated. The crude 
product was purified using flash column chromatography [1:1 EtOAc:Petroleum ether, Rf 0.15] 
to afford (3S,4S,5R)-5-((S)-2-(benzyloxy)-1-hydroxyethyl)-4-hydroxy-3-methyldihydrofuran-
2(3H)-one 658 (0.046 g, 0.17 mmol) as a white oil in 95% yield and 4:1 dr. Analytical data 













4.2.4 Synthesis of Compounds for 2-Deoxy-D-Ribonolactone 
(S)-4-Benzyl-3-(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one, 660 
 
n-BuLi (10.71 mL, 26.8 mmol, 2.5 M solution in hexane) was added to a solution of (S)-4-
benzyl-5,5-dimethyloxazolidin-2-one (5.00 g, 24.3 mmol) in dry THF (150 mL) at -78 ˚C under 
nitrogen and was stirred for 30 minutes. Chloroacetyl chloride (2.07 mL, 26.8 mmol) was 
added in one portion and the resulting solution was stirred for a further two hours. The 
reaction was quenched with saturated ammonium chloride and allowed to warm to ambient 
temperature. The THF was evaporated under reduced pressure, the resulting oil was 
redissolved in dichloromethane and extracted with brine. The combined organic extracts were 
dried over MgSO4 and concentrated to afford crude product. The crude product was purified 
using flash silica chromatography [1:9 EtOAc:Petroleum ether, Rf 0.50] to afford (R)-4-benzyl-3-
(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one 660 (5.69 g, 20.1 mmol) as a colourless oil in 
83% yield. 1H NMR (300 MHz, CDCl3) δH = 7.32-7.20 (5H, m, Ph), 4.76 (1H, d, J = 15.8 Hz, 
COCHAHBCl), 4.64 (d, J = 15.8 Hz, COCHAHBCl), 4.49 (1H, dd, J = 9.7, 3.9 Hz, CHN), 3.20 (1H, dd, J 
= 14.4, 3.8 Hz, CHHAHBPh), 2.88 (1H, dd, J = 14.4, 9.8 Hz, CHAHBPh), 1.38 (3H, s, C(CH3)(CH3)), 
1.36 (3H, s, C(CH3)(CH3)); 
13C NMR (75 MHz, CDCl3) δC = 166.4, 152.4, 136.5, 129.1, 128.9, 
127.1, 83.7, 64.1, 44.0, 35.0, 28.7, 22.4; IR cm-1 ν = 1769 (C=Oox), 1709 (C=O); HRMS: m/z (ES) 
304.0722, C14H16ClNNaO3 [M+Na]
+ requires 304.0716; 
25










(S)-4-Benzyl-3-((2S,3R)-2-chloro-3-hydroxypent-4-enoyl)-5,5-dimethyloxazolidin -2-one, 661 
 
The title compound was prepared according to General Procedure 1 from dibutylboron triflate 
(7.70 mL, 7.70 mmol), (S)-4-benzyl-3-(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one 660 (1.97 
g, 7.00 mmol), N,N-diisopropylethylamine (1.58 mL, 9.10 mmol) and acrolein (0.61 mL, 9.10 
mmol) in dichloromethane (15 mL). The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.27] to afford (S)-4-benzyl-3-((2S,3R)-2-
chloro-3-hydroxypent-4-enoyl)-5,5-dimethyloxazolidin-2-one 661 (1.07 g, 3.20 mmol) as a 
colourless oil in 45% yield. 1H NMR (300 MHz, CDCl3) δH = 7.31-7.17 (5H, m, Ph), 5.88 (1H, ddd, 
J = 17.3, 10.5, 5.8 Hz, CH=CH2), 5.72 (1H, d, J = 5.1 Hz, CHCl), 5.40 (1H, dt, J = 17.3, 1.3 Hz, 
CH=CHAHB), 5.28 (1H, dt, J = 10.5, 1.2 Hz, CH=CHAHB), 4.59 (1H, app. t, J = 5.5 Hz, CHOH), 4.48 
(1H, dd, J = 9.5, 3.8 Hz, CHN), 3.14 (1H, dd, J = 14.4, 3.8 Hz CHAHBPh), 3.00 (1H, broad s, OH), 
2.88 (1H, dd, J = 14.4, 9.5 Hz, CHAHBPh), 1.36 (3H, s, C(CH3)(CH3)), 1.33 (3H, s, C(CH3)(CH3)); 
13C 
NMR (75 MHz, CDCl3) δC = 167.9, 152.0, 136.4, 135.0, 129.1, 128.8, 127.0, 118.9, 83.3, 72.9, 
64.0, 59.1, 34.9, 28.5, 22.2; IR cm-1 ν = 3496 (OH), 1771 (C=Oox), 1703 (C=O); HRMS: m/z (ES) 
338.1149, C17H21ClNO4 [M+H]
+ requires 338.1159; 
24















(1.08 g, 3.20 mmol) was dissolved in dry methanol (12 mL) under nitrogen. Zinc dust (0.83 g, 
12.80 mmol) and ammonium chloride (0.69 g, 12.80 mmol) were added and the reaction was 
stirred for one hour. The suspension was filtered through Celite® and concentrated to afford 
the crude product as a yellow oil. The crude product was purified using flash silica 
chromatography [1:4 EtOAc:Petroleum ether, Rf 0.18] to afford (S)-4-benzyl-3-((S)-3-
hydroxypent-4-enoyl)-5,5-dimethyloxazolidin-2-one 662 (0.79 g, 2.60 mmol) as a colourless oil 
in 82% yield. 1H NMR (300 MHz, CDCl3) δH = 7.33-7.24 (5H, m, Ph), 5.89 (1H, ddd, J = 17.3, 10.5, 
5.4 Hz, CH=CH2), 5.32 (1H, d, J = 17.3 Hz, CH=CHAHB), 5.15 (1H, d, J = 10.5 Hz, CH=CHAHB), 4.58-
4.50 (2H, m, CHOH, CHN), 3.16-3.09 (3H, m, CHACHBPh, CH2CHOH), 2.93-2.85 (2H, m, 
CHACHBPh, CHOH), 1.39 (3H, s, C(CH3)(CH3)), 1.37 (3H, s, C(CH3)(CH3));
 13C NMR (75 MHz, CDCl3) 
δC = 172.3, 152.7, 138.8, 136.8, 129.1, 128.9, 127.0, 115.5, 82.7, 68.9, 63.5, 42.6, 35.6, 28.6, 
22.3; IR cm-1 ν = 3483 (OH), 1771 (C=O), 1694 (C=Oox); HRMS: m/z (ES) 304.1511, C17H22NO4, 
[M+H]+ requires 304.1548; 
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2-Deoxy-D-ribonolactone - (4S,5R)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one, 
663 
 
OsO4 (0.016 g, 0.06 mmol) was added to a solution of (S)-4-benzyl-3-((S)-3-hydroxypent-4-
enoyl)-5,5-dimethyloxazolidin-2-one 662 (0.20 g, 0.66 mmol) in acetone/water (8:1, 2.5 mL) 
followed by addition of NMO (60% by weight in water, 0.12 mL, 0.73 mmol) according to 
General Procedure 5 to afford the crude product as black oil. The crude product was purified 
using flash silica chromatography [EtOAc:Petroleum ether] to afford (4S,5R)-4-hydroxy-5-
(hydroxymethyl)dihydrofuran-2(3H)-one 663 (0.076 g, 0.57 mmol) as a colourless oil in 87% 
yield and 9:1 dr. (4S,5R)-major: 1H NMR (500 MHz, MeOD) δH = 4.46 (1H, dt, J = 6.7, 2.3 Hz, 
CHOH), 4.40–4.39 (1H, m, CHCH2OH), 3.79 (1H, dd, J = 12.4, 3.3 Hz, CHAHBOH), 3.72 (1H, dd, J = 
12.4, 3.7 Hz, CHAHBOH), 2.94 (1H, dt, J = 17.9, 6.8 Hz, CHAHBC=O), 2.40 (1H, dd, J = 17.9, 2.5 Hz, 
CHAHBC=O);
 13C NMR (75 MHz, MeOD) δC = 179.5, 91.0, 70.6, 63.4, 40.0; (4S,5S)-minor:
 1H NMR 
(500 MHz, MeOD) δH = 4.63-4.50 (2H, m, CHOH & CHCH2OH), 3.90 (2H, dd, J = 5.4, 1.6 Hz, 
CH2OH), 2.93 (1H, dd, J = 17.6, 5.9 Hz, CHAHBC=O), 2.45 (1H, dd, J = 17.7, 1.6 Hz, CHACHBC=O); 
13C NMR (75 MHz, MeOD) δC = 179.5, 87.4, 69.8, 62.1, 40.9; IR cm
-1 ν = 3356 (OH), 1749 (C=O); 
HRMS: m/z (ES) 155.0333, C5H8NaO4, [M+Na]
+ requires 155.0320; 
25
D][  = +4.0 (c = 0.50 g/100 
mL in MeOH) [lit: 
25
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X-Ray Crystal Structure Data for δ-Lactone 527 
 

















Table i Crystal data and structure refinement for δ-lactone 527 
Empirical formula C13H16O3 
Formula weight 220.26 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P21 
Unit cell dimensions 
a = 7.8508(3) Å  
b = 6.9320(3) Å  
c = 10.6342(4) Å 
α = 90° 
β = 90.905(3)° 
γ = 90° 
Volume 578.66(4) Å3 
Z 2 
Calculated density 1.264 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 236 
Crystal size 0.50 × 0.25 × 0.15 mm 
Theta range for data collection 4.35 to 27.48 ° 
Limiting indices -10 ≤ h ≤ 10, -8 ≤ k ≤ 8, -13 ≤ l ≤ 13 
Reflections collected/unique 12446 / 2642 [R(int) = 0.0781 
Completeness to theta= 27.48 99.4 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9868 and 0.9569 
Refinement method Full-matrix least-squares on F
2 
Data / restraints / parameters 2642/1/151 
Goodness-of-fit on F2 1.055 
Final R indices [I>2sigma(I)] R1 = 0.0392, wR2 = 0.0911 
R indices (all data) R1 = 0.0516, wR2 = 0.0975 
Extinction coefficient -0.3(9) 





Atomic coordinates (×104) and equivalent isotropic displacement parameters (Å2 ×103) for δ-lactone 527. U(eq) is 
defined as one third of the trace of the orthogonalized Uij tensor. 
 x Y z U(eq) 
O(1) 6413(2) 13800(2) 10229(1) 35(1) 
O(2) 7816(2) 7270(2) 11124(1) 36(1) 
O(3) 7954(1) 8262(1) 9184(1) 31(1) 
C(1) 7480(2) 12228(2) 9874(2) 29(1) 
C(2) 7223(2) 10630(2) 10839(1) 28(1) 
C(3) 8096(2) 11097(2) 12096(2) 37(1) 
C(4) 7706(2) 8626(2) 10404(1) 29(1) 
C(5) 8088(2) 9802(2) 8239(1) 29(1) 
C(6) 7652(2) 8872(2) 6995(1) 30(1) 
C(7) 6043(2) 8082(2) 6778(2) 34(1) 
C(8) 5641(3) 7228(3) 5630(2) 42(1) 
C(9) 6847(3) 7157(3) 4691(2) 49(1) 
C(10) 8438(3) 7929(3) 4900(2) 47(1) 
C(11) 8852(2) 8781(3) 6050(2) 38(1) 
C(12) 6991(2) 11545(2) 8554(1) 29(1) 














Selected bond lengths (Å) for δ-lactone 527 






























































Selected bond angles (°) for δ-lactone 527 









































































) for δ-lactone 527. The anisotropic displacement factor exponent 
takes the form: -2π2[h2a*2U11 + ... + 2hka*b*U12]. 
 U11 U22 U33 U23 U13 U12 
O(1) 33(1) 20(1) 53(1) -5(1) 0(1) 3(1) 
O(2) 49(1) 23(1) 37(1) 3(1) -4(1) 2(1) 
O(3) 41(1) 22(1) 31(1) 1(1) 0(1) 5(1) 
C(1) 26(1) 19(1) 42(1) -2(1) 0(1) 0(1) 
C(2) 26(1) 23(1) 34(1) -2(1) -1(1) 0(1) 
C(3) 41(1) 31(1) 39(1) -6(1) -6(1) 3(1) 
C(4) 26(1) 25(1) 34(1) 0(1) -2(1) -1(1) 
C(5) 29(1) 23(1) 34(1) 4(1) 2(1) 1(1) 
C(6) 38(1) 21(1)) 31(1) 4(1) 4(1) 3(1) 
C(7) 43(1) 27(1) 33(1) 2(1) 2(1) -2(1) 
C(8) 57(1) 32(1) 37(1) 1(1) -7(1) -5(1) 
C(9) 76(1) 37(1) 32(1) -1(1) -2(1) 8(1) 
C(10) 64(1) 42(1) 35(1) 4(1) 12(1) 15(1) 
C(11) 41(1) 32(1) 40(1) 7(1) 8(1) 9(1) 
C(12) 28(1) 21(1) 37(1) 3(1) 1(1) 1(1) 






Hydrogen coordinates (x104) and isotropic displacement parameters (A2 x 103) for δ-lactone 527. 
 x Y z U(eq) 
H(1A) 7010(30) 14710(30) 10433(18) 42(6) 
H(1) 8698 12651 9892 35 
H(2) 5973 10590 11005 33 
H(3A) 9335 11027 12002 56 
H(3B) 7738 10163 12731 56 
H(3C) 7777 12400 12360 56 
H(5) 9303 10232 8217 34 
H(7) 5215 8129 7420 41 
H(8) 4542 6692 5488 50 
H(9) 6573 6575 3905 58 
H(10) 9260 7882 4255 56 
H(11) 9958 9302 6189 45 
(12) 5764 11158 8536 34 
H(13A) 8489 13437 7546 59 
H(13B) 6640 14291 7826 59 





































Table i Crystal data and structure refinement for γ-lactone 633 
Empirical formula C15H20O5 
Formula weight 280.31 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group P 21 21 21 
Unit cell dimensions 
a = 5.8808(2) Å  
b = 11.1665(2) Å  
c = 21.9865(6) Å 
α = 90° 
β = 90° 
γ = 90° 
Volume 1443.81(7) Å3 
Z 4 
Calculated density 1.290 Mg/m3 
Absorption coefficient 0.096 mm-1 
F(000) 600 
Crystal size 0.60 x 0.25 x 0.05 mm 
Theta range for data collection 3.71 to 27.49 ° 
Limiting indices -7 ≤ h ≤ 7, -14 ≤ k ≤ 14, -28 ≤ l ≤ 28 
Reflections collected/unique 19206 / 3314 [R(int) = 0.0834] 
Completeness to theta= 27.48 99.5 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9952 and 0.9445 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 3314/0/190 
Goodness-of-fit on F2 1.079 
Final R indices [I>2sigma(I)] R1 = 0.0408, wR2 = 0.0915 
R indices (all data) R1 = 0.0555, wR2 = 0.0981 
Extinction coefficient 0.2(8) 





Atomic coordinates (×104) and equivalent isotropic displacement parameters (Å2 ×103) for γ-lactone 633. U(eq) is 
defined as one third of the trace of the orthogonalized Uij tensor. 
 x Y z U(eq) 
O(1) 3893(2) 9427(1) 8690(1) 24(1) 
O(2) 1912(2) 11108(1) 8549(1) 33(1) 
O(3) 6849(2) 9827(1) 10107(1) 30(1) 
O(4) 2749(2) 7371(1) 9350(1) 27(1) 
O(5) 9699(2) 7557(1) 8388(1) 25(1) 
C(1) 3148(3) 10521(1) 8869(1) 25(1) 
C(2) 4077(3) 10828(1) 9490(1) 26(1) 
C(3) 2359(3) 11457(2) 9897(1) 37(1) 
C(4) 4969(3) 9636(1) 9721(1) 24(1) 
C(5) 5529(3) 8935(1) 9132(1) 22(1) 
C(6) 5045(3) 7603(1) 9177(1) 26(1) 
C(7) 7918(3) 9211(1) 8901(1) 27(1) 
C(8) 8551(3) 8676(1) 8290(1) 28(1) 
C(9) 10498(3) 7064(1) 7823(1) 30(1) 
C(10) 11976(3) 6002(1) 7958(1) 27(1) 
C(11) 14101(3) 5890(1) 7683(1) 31(1) 
C(12) 15495(3 4924(2) 7810(1) 38(1) 
C(13) 14782(4) 4059(2) 8218(1) 43(1) 
C(14) 12669(4) 4151(2) 8492(1) 42(1) 










Selected bond lengths (Å) for γ-lactone 633 





























































Selected bond angles (°) for γ-lactone 633 
Bond Angle (°) 
C(1)-O(1)-C(5) 110.83(11) 
C(4)-O(3)-H(3) 108.1(15) 



























































































1Anisotropic displacement parameters (Å2 ×103) for γ-lactone 633. The anisotropic displacement factor exponent 
takes the form: -2π2[h2a*2U11 + ... + 2hka*b*U12]. 
 
 U11 U22 U33 U23 U13 U12 
O(1) 25(1) 26(1) 21(1) 0(1) -2(1) 1(1) 
O(2) 34(1) 30(1) 35(1) 7(1) -5(1) 3(1) 
O(3) 39(1) 28(1) 24(1) 0(1) -9(1) 0(1) 
O(4) 29(1) 29(1) 22(1) 2(1) -1(1) -5(1) 
O(5) 27(1) 28(1) 20(1) -1(1) 1(1) 2(1) 
C(1) 23(1) 24(1) 28(1) 3(1) 2(1) -2(1) 
C(2) 28(1) 24(1) 25(1) -1(1) 0(1) -1(1) 
C(3) 41(1) 35(1) 36(1) -8(1) 3(1) 8(1) 
C(4) 27(1) 24(1) 19(1) -1(1) -1(1) -1(1) 
C(5) 22(1) 26(1) 19(1) -1(1) -3(1) 3(1) 
C(6) 26(1) 27(1) 24(1) 0(1) -2(1) -1(1) 
C(7) 25(1) 28(1) 28(1) -4(1) 1(1) 0(1) 
C(8) 26(1) 31(1) 25(1) 2(1) 0(1) 5(1) 
C(9) 36(1) 34(1) 20(1) -3(1) 3(1) 4(1) 
C(10) 34(1) 27(1) 22(1) -5(1) -2(1) -1(1) 
C(11) 35(1) 32(1) 27(1) -4(1) 1(1) -2(1) 
C(12) 38(1) 43(1) 34(1) -11(1) 0(1) 7(1) 
C(13) 57(1) 39(1) 33(1) -7(1) -6(1) 17(1) 
C(14) 65(1) 31(1) 31(1) 1(1) 3(1) 5(1) 









Hydrogen coordinates (x104) and isotropic displacement parameters (A2 x 103) for γ-lactone 633. 
 x Y z U(eq) 
H(2) 5405 11376 9433 31 
H(3A) 3012 11565 10304 56 
H(3B) 977 10970 9927 56 
H(3C) 1982 12241 9724 56 
H(4) 3741 9212 9950 28 
H(6A) 5350 7222 8779 31 
H(6B) 6083 7240 9480 31 
H(7A) 8087 10091 8874 32 
H(7B) 9022 8922 9208 32 
H(8A) 7164 8545 8044 33 
H(8B) 9558 9233 8066 33 
H(9A) 11378 7675 7597 36 
H(9B) 9190 6816 7568 36 
H(11) 14598 6485 7404 38 
H(12) 16935 4855 7617 46 
H(13) 15745 3401 8311 51 
H(14) 12175 3549 8768 51 
H(15) 9828 5180 8556 41 
H(4A) 1960(40) 7470(17) 9047(10) 46(6) 
H(3) 7160(40) 9178(18) 10274(10) 45(6) 
 
 
 
